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This study examined the regulation of two genes, hcp and ogt, that are reported to be 
involved in protection from the effects of reactive nitrogen species in Escherichia coli. 
Biochemical techniques were used to investigate promoter activity and the effects of the 
transcription factors that are reported to regulate expression of the hcp and ogt genes, namely 
NarL / NarP, FNR and NsrR. Transcription activation by NarL was then studied using semi-
synthetic promoters.  
The hcp gene was found to be positively regulated by FNR and negatively regulated by 
NsrR. Contrary to previous reports, NarL and NarP were found to have little direct effect on 
expression of hcp, however, an indirect effect of NarL was detected. This study demonstrates 
that the indirect regulation of hcp expression by NarL is related to repression by NsrR and 
suggests that NarL is involved in the generation of reactive nitrogen species. 
The ogt gene was confirmed to be activated by NarL independently of FNR. Studies 
focussed on characterising the different classes by which NarL / NarP can activate promoter 
activity independently of FNR. NarL was found to activate by class I, II and III mechanisms, 
whilst NarP was capable of class II activation only. 
Activation by NarL was studied and a library of alanine substitutions in the carboxyl 
terminal domain (CTD) of the α subunit of RNA polymerase was used to demonstrate direct 
interaction between NarL and RNA polymerase. NarL, the CTD of NarL, NarXL, NarP and 
the CTD of NarP were expressed from plasmids and transcription activation studied in cells 
lacking chromosomal narL and narP. Full-length NarL activated by Class I, II and III 
mechanisms, whilst the CTD of NarL activated by class II mechanisms only. Both the full-
length NarP and the CTD of NarP activated by class II mechanisms only. 
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1.1. Escherichia coli and its environment 
Escherichia coli is a gram-negative bacterial species that is able to colonise the human 
digestive tract and is also able to survive outside of the body in soil and water (Campbell et 
al., 2001). Although many strains of E. coli are harmless, even beneficial to man, pathogenic 
strains have been identified that can cause fatal disease (Freter and Abrams, 1972). E. coli is 
considered by many to be a model organism for study, due to its amenability to growth in a 
laboratory and the existence of closely related pathogenic and non-pathogenic strains 
(Cronan, 2001, Welch et al., 2002). As such, much bacterial research focuses on E. coli 
making it one of the best-understood organisms, although much remains unsolved (Blattner et 
al., 1997). 
E. coli is a facultative anaerobe and is therefore able to survive in the presence or absence 
of oxygen. E. coli can grow on a variety of carbon sources and adapts to various 
environmental conditions. It is thought that the ability of E. coli to survive in such varying 
conditions is a product of its lifestyle as a commensal (Cases et al., 2003). During its passage 
through the digestive system, it will encounter variation in oxygen availability, nutrient 
availability, acidity and risks interaction with the host immune system (Jones et al., 2007). 
Once outside the body, it will encounter oxygen, UV, varying availability of nutrients and 
water, all of which it has to be able to survive long enough to colonise a new host. 
During respiration, energy is released during the transfer of electrons from an electron 
donor such as NADH (reduced nicotinamide adenine dinucleotide) through a chain of electron 
carriers to a terminal electron acceptor (Richardson, 2000). A key factor that determines the 
energy available to an organism as a result of this reaction is the difference between the 
midpoint redox potentials of the electron donor and the terminal electron acceptor. The 
midpoint potential of the NADH/NAD+ pair is -0.32 V, therefore, the more positive the 
midpoint potential of the terminal electron acceptor and its reduced product, the more energy 
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will available to the organism. Oxygen is the most powerful oxidant used by bacteria and the 
midpoint potential of the oxygen/H2O pair is +0.82 V. E. coli is able to utilise oxygen as a 
terminal electron acceptor and therefore grows rapidly in aerobic conditions. In the absence of 
molecular oxygen, E. coli is able to utilise alternative electron acceptors such as nitrate (NO3
-
), which is the most powerful oxidant that E. coli can utilise in the absence of oxygen. 
(Bonnefoy and Demoss, 1994). Figure 1.1 illustrates the reduction of nitrate to ammonia. 
When nitrate is reduced by nitrate reductases, it yields nitrite (NO2
-
) in a reaction with a 
midpoint potential of +0.43 V. Nitrite is then reduced further to ammonia (NH4
+
) in a reaction 
with a midpoint potential of +0.34 V. Although energy producing, the reduction of nitrate and 
nitrite also yields toxic by-products, the reactive nitrogen species (RNS) nitric oxide (NO) and 
dinitrogen trioxide (N2O3) (Weiss, 2006). Successful growth in the absence of oxygen 
therefore requires that E. coli be able to utilise the alternative electron acceptors nitrate and 
nitrite, and be able to mitigate the threat posed by the toxic by-products. 
1.2. Reactive nitrogen species 
Reactive nitrogen species, such as NO, are powerful mutagens that are able to induce 
bacteriostasis, cell death or produce mutations in the DNA (Fang, 2004). RNS can cause 
damage by different pathways. RNS are able to interact with proteins and cause nitrosation of 
peptides (Sedgwick, 1997). RNS are also reported to methylate DNA indirectly. It is thought 
that RNS nitrosylate an as-yet unidentified molecule, which in turn methylates DNA upon 
contact (Taverna and Sedgwick, 1996). Methylation of DNA poses a serious risk to the cell as 
it can block replication or introduce lethal inter-strand crosslinks (Noll et al., 2006). NO has 
also been shown to interact with DNA directly, deaminating bases so that they pair incorrectly 
(Spek et al., 2002). This can introduce mutations into the genome following replication. RNS 
can also react with the iron-sulphur clusters at the active sites of many enzymes, producing 
dinitrosyl-iron-complexes (DNIC) (Toledo et al., 2008). The inactivation of proteins 




Figure 1.1 Generation of reactive nitrogen species during nitrate reduction 
From Weiss et al. (2006). Production of the mutagenic nitrosating agents NO and N2O3 






Iron-sulphur containing proteins are involved in many processes, from the catalysis of 
reactions to the regulation of transcription. One important protein that is damaged by RNS is 
IlvD, the producer of branched chain amino acids (Ren et al., 2008). If the iron-sulphur 
cluster of IlvD is nitrosylated, bacteria are unable to grow unless provided with branched 
chain amino acids.  
There are multiple theories as to the primary producer of endogenous RNS during nitrate / 
nitrite metabolism in E. coli. Corker and Poole (2003) reported that the periplasmic nitrite 
reductase Nrf is responsible for NO generation. Conversely, Weiss et al. (2006) reported that 
the nitrite reductase Nir produces NO during nitrite metabolism, whilst the nitrate reductase 
NarG has also been implicated (Metheringham and Cole, 1997). As well as endogenous 
sources of RNS, bacteria may also encounter external sources of RNS, such as that released 
by neutrophils and activated macrophages as a part of the immune response (Fang, 2004). 
NO can be detoxified both aerobically and anaerobically. The flavohaemoglobin Hmp 
oxidises NO to NO3
-
 in aerobic conditions and reduces NO to N2O in anaerobic conditions 
(Laver et al., 2010). The periplasmic nitrite reductase Nrf is also able to reduce NO 
anaerobically, as is the cytoplasmic flavorubredoxin NorV (Poock et al., 2002, Gardner et al., 
2002). E. coli is thought to contain as-yet unidentified enzymes that can detoxify NO, as cells 
lacking Hmp, Nrf and NorV remain able to reduce NO (Claire Vine, University of 
Birmingham, personal communication). 
E. coli is also able to repair the damage done by RNS to DNA. E. coli contains the DNA 
repair enzymes Ada and Ogt (see below) that directly repair methylated DNA (Potter et al., 
1987). Damage such as crosslinks and mis-incorporated nucleotides are repaired by the base 
excision repair system (reviewed by Grossman and Kovalsky, 2001). The protein YtfE has 
recently been identified as responsible for repairing damaged iron-sulphur clusters (Justino et 
al., 2007).  
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Justino et al. (2007) demonstrated that ytfE mutant cells had increased susceptibility to 
reactive nitrogen and oxygen species compared to wild type cells. They also found that cells 
lacking YtfE were found to be unable to repair damaged iron-sulphur clusters and that when 
purified YtfE was incubated in vitro with damaged iron-sulphur cluster containing proteins, it 
was able to repair those clusters. The exact mechanism by which YtfE repairs damaged 
clusters is not yet known although it is thought to involve a di-iron centre (Todorovic et al., 
2008). YtfE is therefore the first di-iron protein proven to be involved in the repair of iron-
sulphur clusters. 
1.3. HCP – the Hybrid Cluster Protein 
The Hybrid Cluster Protein (HCP) was initially isolated from Desulfovibrio vulgaris as a 
contaminant (Pierik et al., 1992). HCP has since been found to be produced by a diverse range 
of bacterial species that exist in a variety of environments (Rodionov et al., 2005). HCP is of 
particular interest to researchers as early work indicated that HCP contains 2 iron-sulphur 
clusters, one of which is thought to be novel (van den Berg et al., 2000).  
The amino acid sequence of HCP shows no homology to any protein except carbon 
monoxide dehydrogenases. The crystal structure reveals that the 2 iron-sulphur clusters are 
located in proximity to each other and hydrophobic solvent channels provide access to them 
(Cooper et al., 2000). The presence of such channels indicates that the substrate for HCP may 
be a soluble gas (Montet et al., 1997). Sequence studies indicate that there are 3 classes of 
HCP (van den Berg et al., 2000): Class 1 HCPs that are found in strictly anaerobic bacteria; 
Class 2 HCPs that have a different spacing of the residues that hold the iron-sulphur cluster 
and are found in facultative anaerobes and class 3 HCPs that resemble class 1 HCPs but 
contain a deletion of residues and are found in hyper-thermophiles and archaea. The 
differences between the classes could indicate that HCP has subtly different functions in the 3 
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groups, or more likely indicates adaptations for the environment of the bacteria, such as 
stability in the presence of oxygen. 
Despite intensive study and the availability of a high-resolution structure, the biological 
function of HCP has yet to be identified. It been established that HCP in E. coli is optimally 
expressed in anaerobic conditions and with nitrate or nitrite present in the growth medium 
(Filenko et al., 2005). This led to the suggestion that HCP may be involved in nitrate / nitrite 
respiration, possibly by detoxifying dangerous by-products of such respiration. It was noted 
that carbon monoxide dehydrogenases, which are similar in structure to HCP, can be modified 
to become hydroxylamine reductases (Wolfe et al., 2002). Hydroxylamine, an RNS, was 
reported to be reduced by HCP, although this theory was later discounted, as the optimum pH 
for the reaction was higher than would be encountered in the cell (pH 9). HCP was also 
identified by a study of genes induced by RNS in Salmonella enterica (Kim et al., 2003). The 
study indicated that HCP expression was induced not only by RNS in the growth medium, but 
also when cells were challenged with activated macrophages. However, the study failed to 
identify a role for HCP in protection from the host immune system although the authors 
hypothesized that it might be involved in NO detoxification. Subsequently an NO sensitive 
transcription factor, NsrR (see below), was found to regulate expression of HCP (Filenko et 
al., 2007). This corroborates the hypothesis that HCP is involved in protection from RNS. An 
alternative hypothesis is that HCP is involved in protection from reactive oxygen species 
(ROS). The results of Almeida et al. (2006) demonstrated that HCP expression is induced by 
hydrogen peroxide and that deletion of OxyR, a hydrogen peroxide sensitive transcription 
factor, increased HCP expression. 
1.4. DNA repair methyltransferases – Ogt and Ada 
Ogt and Ada are the two DNA repair methyltransferases (MTases) of E. coli, which act as 
acceptors of methyl and alkyl groups from methylated or alkylated DNA (Potter et al., 1987). 
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Ada was initially identified in a screen for determinants of DNA MTase activity. While Potter 
and colleagues were attempting to isolate the gene encoding Ada, they encountered a second, 
smaller, DNA fragment that encoded an MTase. The second fragment was initially thought to 
have arisen by partial duplication of ada but was found to encode a distinct MTase, Ogt. Ada 
is both an MTase and a transcription factor that regulates its own expression, and has been 
shown to be the main regulator in the adaptive response to alkylating / methylating agents 
(Teo et al., 1986). Ogt was initially reported to be constitutively expressed, although it has 
since been shown to be induced by nitrate (Squire et al., 2009).  
Both Ogt and Ada are able to repair methyl-guanine and methyl-thymine bases, whilst 
Ada is also able to repair methyl-phosphotriesters (see Figure 1.2). This difference in function 
of Ogt and Ada is reflected in the domain structure. Ada has 2 distinct domains that possess 
different functionalities: the NTD contains the DNA binding region and determinants of 
methyl-phosphotriester MTase activity and the CTD contains determinants of methyl-guanine 
MTase activity (Shevell and Walker, 1991). Ogt is a smaller protein and is similar to the CTD 
of Ada (Potter et al., 1987).   
Modified bases will often mispair, causing mutations following replication. For example, 
whilst guanine pairs with cytosine, O6-methyl-guanine pairs with thymine. In many cases, 
mutations that arise will be silent and therefore harmless, while some mutations may disrupt a 
vital gene. Mutations that are more serious may arise from methylated / alkylated bases 
because the mismatch repair system is believed to interact with the replication machinery at 
such bases, producing a lethal double strand break. Even a single double strand break can be 
fatal to E. coli if not repaired (Lawley and Phillips, 1996). Ogt and Ada are able to transfer 
methyl and alkyl groups from the modified base onto a cysteine residue. Ogt and Ada have 




Figure 1.2 DNA repair catalysed by Ogt and Ada 





methyl-thymine and methyl-phosphotriesters (S-
diastereomer only) lesions in doublestranded DNA are recognized by DNA repair MTases 
and the inappropriate methyl group is transferred to a cysteine residue in the active site of the 
MTase protein. Methyl transfer inactivates the MTase and so these DNA repair proteins have 




Ogt / Ada 




the transfer of a methyl group prevents further MTase activity by the protein. Following 
transfer of a methyl group, Ogt and Ada are believed to be broken down by proteases. 
1.5. Regulation of gene expression 
Like all organisms, E. coli regulates gene expression in response to stimuli. By 
sensingvariation in its environment and responding accordingly, E. coli is able to adapt to 
changes in its situation, which is evidenced by an in silico study that concluded that regulation 
of gene expression showed signs of having been “strongly selected for to enable rapid 
adaptation to environmental conditions” (Cases et al., 2003). Regulation may occur at any 
stage in gene expression. However, the expression of the majority of genes is believed to be 
regulated at the stage of transcription initiation by modulating the affinity of RNA polymerase 
for a promoter or controlling the formation of the elongation complex (covered in detail 
below). Gene expression can also be regulated by factors that affect mRNA stability, which 
dictates how long a transcript persists in the cell and is available for translation. RNA can also 
adopt a secondary structure that may be influenced by the environment and can promote or 
hinder translation. Regulation of gene expression, particularly that at the stage of transcription 
initiation, ensures that minimal cellular resources are wasted on the unnecessary production of 
transcripts and ensuing proteins (Stoebel et al., 2008).  
1.6. The bacterial RNA polymerase 
E. coli contains a single DNA-dependent RNA polymerase (RNAP) that is responsible for 
all transcription in the cell. Figure 1.3, Panel A shows the structure of a bacterial RNAP core 
enzyme and shows that it is a multi-subunit enzyme, with subunits ββ‟α2ω comprising the 
core enzyme (Zhang et al., 1999). Studies have shown that the „crab-claw‟ structure of RNAP 
is conserved from bacteria to man, whilst sequence, structural and functional studies also 
indicate that individual subunits of the bacterial RNAP show significant homology to relevant 





Figure 1.3 Structure of RNA polymerase core enzyme and holoenzyme 
Panel A shows the 3D structure of RNAP core enzyme from T. aquaticus coloured by 
subunit. Subunits are also labelled. Structure from Campbell et al. (2005), PDB ID 1ynj 
Panel B shows the 3D structure of RNAP-σ
70
 holoenzyme coloured by subunit. Sigma 70 is 



















The active site of bacterial RNAP is formed by the interaction of the large β (beta) and β‟ 
(beta prime) subunits and contains a universally conserved Mg
2+
 ion at the centre (Zhang et 
al., 1999). The detailed structure of T. aquaticus RNAP also reveals channels, formed by the 
interaction of β and β‟subunits, that permit DNA access to the active site during 
transcriptionand provide an exit for the nascent RNA chain (Murakami and Darst, 2003).  
The two chemically identical α (alpha) subunits each contain a distinct amino terminal 
domain (NTD) and a carboxyl terminal domain (CTD) that are joined by a flexible linker 
(Blatter et al., 1994). The αNTD interacts heavily with either β or β‟, and is the initiator for 
RNAP assembly, which occurs in the order 2α→α2→βα2→ ββ‟α2→→ ββ‟α2σ (Ebright and 
Busby, 1995, Igarashi et al., 1991). The αCTD contains a DNA binding determinant that 
recognises UP elements at certain promoters (Estrem et al., 1999). 
The ω (omega) subunit is conserved throughout all domains of life although has been 
found to be non-essential during slow growth and in vitro transcription experiments (Burgess, 
1969, Gentry et al., 1991). Sequence, structural and functional studies indicate that the 
bacterial ω subunit is similar to the eukaryotic RNAP subunit RBP6, which chaperones the 
assembly of RNAP and stabilises the overall structure (Minakhin et al., 2001) 
The RNAP core enzyme is competent for transcript elongation but is unable to recognise 
promoter regions specifically. To bind DNA, the core enzyme must incorporate the σ (sigma) 
subunit, becoming the holo enzyme (Burgess et al., 1969). Figure 1.3, panel B shows the 
structure of the Thermus thermophilus RNA polymerase holoenzyme. The σ subunit is a 
multi-domain protein that contains DNA binding determinants that allow σ to bind core 
promoter elements (Burgess and Anthony, 2001). The majority of bacterial σ factors show 




The primary, or „housekeeping‟, σ 
factor in a species is responsible for directing RNAP to transcribe genes needed for growth of 
the cell under standard conditions (Wosten, 1998). Bacteria also contain alternative σ factors 
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that direct RNAP to different classes of promoters, which are typically grouped functionally. 
An example of an alternative σ factor is the E. coli σ
H
, which directs RNAP to transcribe 
genes required for the stress response (Hengge, 2009). However, it has been noted that there 
is significant functional overlap between the genes transcribed by RNAP containing 
alternative σ factors and those transcribed by σ
70
 containing RNAP (Wade et al., 2006).  
1.7. Overview of transcription 
Transcription is a process that comprises 4 steps: promoter binding; RNA chain initiation / 
promoter escape; transcript elongation and transcript termination (Uptain et al., 1997). An 
overview of transcription initiation is shown in Figure 1.4. Figure 1.4, Panel A, depicts RNAP 
bound at a promoter in what is known as the closed complex (RPc). The DNA helix is bound 
by contacts with the σ subunit and is positioned around the surface of polymerase. RPc then 
undergoes a series of conformational changes to become the open complex (RPo), during 
which the DNA is partially unwound and the two strands separated to form a bubble that 
includes the transcription start site and -10 element (Figure 1.4, Panels B and C). It is 
hypothesised that σ is responsible for separating the strands: The region surrounding the 
transcription start site is typically AT-rich and, as well as having weaker inter-strand contacts 
than a GC-rich region, is expected to cause the DNA to „kink‟ placing one strand in proximity 
to conserved residues in region 2.3 of σ. During the change to RPo, sigma domain 1.1, which 
blocks the DNA entry channel in the RPc, is repositioned so that DNA can enter the core of 
polymerase and the template DNA strand is repositioned so that it is in close proximity to the 
RNAP active site (Panel C) (Vassylyev et al., 2002, Murakami et al., 2002).  
Free NTPs enter through the secondary channel and RNAP synthesises short transcripts in 
a process called „abortive initiation‟ (Hsu, 2002). It is thought that this is because a loop in σ 
region 3.2 blocks the RNA exit channel and prevents transcripts from exiting polymerase 




Figure 1.4 Overview of transcription initiation 
From Murakami and Darst (2003). Structural transitions during the steps of transcription 
initiation. Cross sectional views of the RNAP holoenzyme are shown (β flap, blue; σ, orange; 
rest of RNAP, gray; catalytic Mg
2
, yellow sphere), promoter DNA (template strand, dark 
green; non-template strand, light green; -10 and -35 elements, yellow) and the RNA transcript 
(red) at the closed complex (RPc) (panel A), intermediate (I) (Panel B), open complex (RPo) 
and abortive initiation (panel C), end of abortive initiation (panel D), promoter clearance 
(panel E) and transcription elongation complex (panel F) stages of transcription initiation. The 
view is looking down on top of the β subunit, but with most of β removed, revealing the 








repositions the loop in σ region 3.2 so that the channel is no longer blocked (Figure 1.4, panel 
D). RNAP then clears the promoter and commences transcription as the elongation complex 
(Figure 1.4, panels E and F). It is thought that in order to clear the promoter, σ must dissociate 
from polymerase and the repositioning of σ by the nascent RNA strand may sufficiently 
weaken the interaction of σ and polymerase so that dissociation occurs. However, a growing 
body of work suggests that it is not necessary for σ to dissociate for transcription to occur and 
that some polymerase molecules may retain σ throughout transcription (Abbondanzieri et al., 
2005, Mooney et al., 2005).  
RNAP is thought to transcribe from the DNA template one base at a time using a 
„Brownian ratchet‟ (Herbert et al., 2008). In this model, RNAP fluctuates at each position 
between the pre- and post-translocated position until the incorporation of an NTP stabilises it. 
Rates of nucleotide incorporation have been reported to be around 100 nt / second in vivo 
(Vogel and Jensen, 1994). RNA polymerases are processive enzymes, meaning that if it 
releases the RNA transcript before it has completed the transcript, it is unable to rebind the 
transcript and continue (Uptain et al., 1997). Transcriptional pausing and arrest are therefore 
mechanisms for RNA polymerase to overcome problems such as low NTP availability by 
simply pausing until transcription is once again possible. At some pause sites, RNAP 
backtracks along the DNA, which removes the 3′ end of the RNA transcript from the active 
site. Elongation factors GreA and GreB bind to RNAP and stimulate cleavage of the 
backtracked portion of the transcript, allowing RNAP to re-attempt transcription of the region 
(Borukhov and Severinov, 2002). Transcriptional pausing and arrest can also be induced by 
other factors such as regulatory proteins and mRNA secondary structure, and are recognised 
points of regulation for the expression of certain genes (Artsimovitch and Landick, 2000). 
Transcription continues until it is terminated by one of two methods: intrinsic termination 
or factor dependent termination. Intrinsic termination is reported to be the mechanism of 
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termination for ~50% of genes and is characterised by a 3′-terminal DNA sequence that 
encodes a hairpin loop, followed by a run of T residues (Lesnik et al., 2001). Such a structure 
is thought to induce termination by disrupting contacts between RNAP and the nucleic acids 
being processed. The run of T residues is reported as introducing a transcriptional pause 
exactly at the point of termination and thereby allows the hairpin to form (Gusarov and 
Nudler, 1999). Factor dependent termination is where an additional protein induces 
termination. There are currently 2 known host termination factors: Rho, which acts to 
terminate transcription of many genes; and MFD, which terminates transcription when 
polymerase is stalled by DNA lesions (Nudler and Gottesman, 2002). Rho binds to extended 
sites in the RNA transcript and then migrates along the transcript until it reaches polymerase 
(Jin et al., 1992) but is not able to terminate transcription without interaction with NusG 
(Sullivan and Gottesman, 1992). It has been recently suggested that during coupled 
transcription / translation, NusG is interacts with the ribosomal protein NusE. Once the 
ribosome has reached the end of an operon, NusG is released, and is able to interact with Rho 
to terminate transcription (Burmann et al., 2010, Proshkin et al., 2010). Crucial transcripts 
that are not occupied by ribosomes, such as rRNAs, are protected from Rho-dependent 
termination by an anti-termination complex comprising NusA, NusB, NusE and NusG 
(Condon et al., 1995). 
1.8. Promoter recognition by RNAP 
Having integrated a σ subunit and become the holoenzyme, RNAP is thought to locate 
promoters by moving randomly about the chromosome using a combination of migrating 
along the DNA and changing strands (von Hippel and Berg, 1989). A σ
70
-dependent promoter 
can contain up to 4 core types of element that are recognised by the holoenzyme: the -10 
element; the extended -10 element; the -35 element and the UP element. Figure 1.5 shows the 




Figure 1.5 RNA Polymerase bound at a promoter 
From Browning et al. (2004). A model based on crystallographic studies of the initial docking 
of the RNA polymerase holoenzyme to a promoter. The DNA strands are shown in green, 
with the –10 and –35 elements highlighted in yellow and the TGn extended –10 and the UP 
elements highlighted in red. RNA polymerase is shown with the β and β′ subunits coloured 
light blue and pink, respectively, αNTDs are coloured grey and the different domains of σ are 
coloured red. Grey spheres labelled I and II, represent the domains of αCTD that bind to the 
promoter. The RNA polymerase active site is denoted by the Mg
2+
















The -10 element, sometimes referred to as the Pribnow box, is a hexamer with the 
consensus sequence TATAAT and is located ~10 bp upstream of the transcription start site 
(Pribnow, 1975). High resolution structural studies indicate that the -10 element is recognised 
by a helix-turn-helix DNA binding determinant in region 2.4 of σ (Murakami et al., 2002). 
The extended -10 element, if present in a promoter, is found immediately upstream of the -10 
element and has a consensus sequence TGn, where „n‟ is any base. The extended -10 element 
is typically found at promoters with non-consensus -35 elements and is believed to improve 
transcription from otherwise weak promoters (Mitchell et al., 2003). Studies indicate that the 
extended -10 element is recognised by region 3 of σ
70
, which supports its classification as a 
distinct element from the -10 element (Sanderson et al., 2003). 
The -35 element is a hexamer with the consensus sequence TTGACA and is located ~35 
upstream of the transcription start (Rosenberg and Court, 1979). Numerous studies have 
shown that the spacing between the -10 and -35 elements is crucial for promoter activity, and 
that the optimum distance between the 2 sites is 17 bp. The -35 element is recognised by a 
helix-turn-helix domain in region 4.2 of σ
70 
(Russell and Bennett, 1982, Hidalgo and Demple, 
1997).  
At certain promoters, RNAP makes contacts with the promoter through the αCTD in 
addition to those contacts made through σ
70
. The αCTD recognises an A / T rich sequence 
called an UP element that lies upstream of the -35 element and is around 20 bp long (Estrem 
et al., 1999). UP elements are found at a variety of promoters although are often found at 
promoters for rRNAs and tRNAs (Gourse and Gaal, 2000). This is likely to be because such 
genes need to be expressed at high levels and UP elements can improve transcription of a 
gene by between 10 and 100-fold (Ebright and Busby, 1995). 
The strength of a promoter is generally considered to be a function of the resemblance of 
its core promoter elements to the consensus sequences for such elements (Hawley and 
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McClure, 1983). Therefore, a promoter with core promoter elements that closely resemble the 
consensus elements will be highly active (Rhodius and Mutalik, 2010). It should be noted 
however, that no natural promoter contains core elements that perfectly match the consensus 
sequences as such a promoter would bind RNAP tightly and prevent it from clearing the 
promoter and initiating transcription  (Ellinger et al., 1994). 
1.9. Regulation of transcription initiation 
The majority of genes in E. coli are not constitutively expressed. Instead, their expression 
is regulated, commonly during transcription initiation. Transcription initiation is regulated by 
transcription factors, which are able to bind DNA and up-regulate or down-regulate 
transcription.  
Different transcription factors regulate the expression of different numbers of operons. 
Figure 1.6 shows an overview of the transcriptional regulatory network of E. coli. A small 
number of transcription factors, such as CRP, have been designated „global regulators‟ 
because they regulate large amounts of the genome. Martinez-Antonio and Collado-Vides 
(2003) proposed that there are 7 such regulators in E. coli that regulate in response to stimuli 
such as aerobiosis, anaerobiosis or the presence of glucose. The remaining transcription 
factors fall into 2 loose groups, a „middle management‟ layer that regulate the expression of 
multiple genes but are not considered global transcription factors and „local‟ transcription 
factors that regulate the expression only one or two operons. 
The activity of transcription factors themselves can be regulated by 4 mechanisms: 
binding of a ligand; covalent modification of the factor; sequestration of the factor or 
expression level of the factor. Transcription factors that bind a ligand can be activated or 
deactivated by the ligand in question. An example would be the lac repressor, LacI. When 
LacI binds its ligand allolactose, it becomes unable to recognise its DNA site and thus 




Figure 1.6 Global and local transcription factors in E. coli 
From Martinez-Antonio and Collado-Vides, (2003). Overview of the transcriptional 
regulatory network of E. coli. Regulated genes are shown as yellow ovals, TFs are shown as 
green ovals and TFs considered to be global regulators are shown as blue ovals. The green 
lines indicate activation, red lines indicate repression and dark blue lines indicate dual 




covalently modified by chemicals or other proteins, which cause a conformational change that 
activates or de-activates the factor. In some cases, it can be difficult to distinguish between 
activation of a transcription factor by ligand binding and activation of a factor by covalent 
modification. For example, NsrR (covered in detail below) is deactivated by NO modification 
of an iron-sulphur cluster. Regulation of NsrR by NO could be described as either ligand 
interaction or covalent modification. Transcription factors can be sequestered in the 
cytoplasm by other proteins, which prevents them from being able to regulate (Plumbridge, 
2002). Finally, the activity of some transcription factors (such as SoxS) is regulated by the 
expression level of the factor itself (Demple, 1996). 
The majority of transcription factors in bacteria are one-component systems (Ulrich et al., 
2005), meaning that the transcription factor does not require another protein to activate it in 
response to a stimulus. However, there are a number of two-component systems (TCS) in 
bacteria that play important roles in regulation (Oshima et al., 2002). A TCS is a system 
comprised of a sensor kinase protein and a response regulator protein (Hoch, 2000). The 
sensor kinase protein is often transmembrane and interacts with its ligand present in the 
periplasm. When the sensor kinase protein interacts with its ligand, it auto-phosphorylates on 
its cytoplasmic region. The phosphorylated sensor kinase then phosphorylates its cognate 
response regulator and therefore activates it by covalent modification. The response regulator 
typically undergoes a conformational change once phosphorylated, which makes it competent 
to bind DNA. TCSs are therefore an effective method for regulating in response to an 
extracellular ligand. Research suggests that despite the fact that two-component systems 
function by similar mechanisms, there is little biologically significant cross talk between non-
related systems (Bijlsma and Groisman, 2003). Many sensor kinase proteins aid the 
prevention of crosstalk by dephosphorylating the response regulator in the absence of the 
stimulating ligand. Thus, if the response regulator is activated by a non-cognate sensor kinase, 
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it will be rapidly dephosphorylated by its own sensor kinase and have little effect on gene 
expression. 
1.10. Simple activation of transcription  
There are 3 basic mechanisms by which transcription factors can induce transcription. The 
first, activation by contacting RNAP / recruitment of RNAP to a promoter, can be divided 
into 3 subgroups: Class I; Class II and Class III activation. Figure 1.7, panel A, depicts class I 
activation. In class I activation, a transcription factor binds to a DNA site upstream of the -35 
element and recruits RNAP to the promoter through contacts with the αCTD. Because the 
αCTD is connected to the αNTD via a flexible linker, the DNA site to which a class I 
activator binds can be many bp upstream of the transcription start. An example of a class I 
activated promoter is that for the lac operon. At the lac promoter, the transcription factor CRP 
binds to a site centred at position -61.5 relative to the transcription start site (Zhou et al., 
1994). From this site, CRP contacts the αCTD, which recruits polymerase to the promoter and 
initiates transcription. 
Figure 1.7, panel B depicts class II activation. In class II activation, a transcription factor 
binds to a site that overlaps the -35 element and recruits polymerase to the promoter. By 
binding to such a site, the transcription factor is positioned in-between the αCTD and 
polymerase and it able to make multiple contacts with polymerase. A transcription factor 
activating by a class II mechanism can contact the αCTD, αNTD, upstream region of σ or 
even the β subunit. Some transcription factors will make a single contact while others will 
make multiple contacts. An example of class II activation is at the nfo operon promoter where 
the SoxS transcription factor binds to a site centred at -37 (Li and Demple, 1994). 
Figure 1.7, panels C and D, depicts 2 derivatives of class III activation, which can be 
viewed as a hybrid of class I and II activation or as two instances of class I activation. At the 








                                        
 
Figure 1.7 The classes of activation 
Diagrams depict RNAP bound to a promoter and activated by various classes of activation. 
Blue rectangles denote a transcription factor. The RNAP α subunits are depicted as yellow 
circles connected by a flexible linker. σ
70
 is depicted as a green shape incorporated into the 
RNAP, σ
54
 is depicted as a purple shape incorporated into RNAP and yellow stars indicate 
possible interactions between the transcription factor and polymerase subunits.   
F 
Activation by Enhancers 
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contact polymerase to up-regulate promoter activity. Class III activation can manifest in 2 
forms: co-dependent class III activation, in which both transcription factors are required for 
activity of the promoter and synergistic class III activation, in which binding of the promoter 
by the second transcription factor merely enhances promoter activity beyond that activated by 
the first (Scott et al., 1995). Class III activation therefore allows for multiple possibilities in 
regulation: The two transcription factors involved can be multiple molecules of the same 
factor or can be different factors, which allows a promoter to be regulated in response to two 
different stimuli (Joung et al., 1994, Joung et al., 1993). The sites to which the transcription 
factors bind can either both be upstream of the -35 element or one will overlap the -35 
element whilst the other is upstream. An example of class III activation is that of the ansB 
promoter, activity of which is activated by dimers of CRP and FNR binding to DNA sites at 
positions -91.5 and -41.5 respectively (Scott et al., 1995). 
The second mechanism by which transcription can be activated is by promoter 
remodelling. Some promoters contain core promoter elements that closely resemble the 
consensus sequences for such elements, but with sub-optimal distances between those 
elements, which prevents RNAP from binding to them (see Figure 1.7, panel E). 
Transcription factors of the MerR family are able to bind multiple DNA sites near the core 
promoter elements and distort the chromosome so that RNAP can recognise the promoter 
(Summers, 1992, Brown et al., 2003). An example of such a factor is Mta, a transcription 
factor from B. subtilis that binds a symmetrical sequence in the 19 bp spacer of its own 
promoter and that of another gene. From this site it is able to manipulate the DNA to bring the 
-35 and -10 elements into correct alignment, thereby activating transcription (Baranova et al., 
1999).  
The final mechanism of activation depicted in Figure 1.7, panel F, is activation by 
enhancer binding proteins (EBPs). RNAP-σ
54
 holoenzyme binds to promoters but is unable to 
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form the open complex and initiate transcription because of a repressive DNA structure. An 
EBP molecule binds to an enhancer upstream of the promoter and loops the DNA so that it 
can contact polymerase. Upon contacting polymerase, the EBP uses energy from ATP 
hydrolysis to cause changes in the RNAP-σ
54
 structure that allows open complex formation 
(Rappas et al., 2007). 
1.11. Simple repression of transcription 
Transcription factors can repress activity by binding to promoters and interfering with one 
or more stages of transcription initiation. There are three broad mechanisms by which they are 
able to do so: steric hindrance; DNA bending and anti-activation. Steric hindrance is a very 
common mechanism of repression and is characterised by a transcription factor preventing 
RNAP or an activator from binding to the DNA by physically obscuring access to the DNA. 
A repressor typically does this by binding to a site that is near to or overlaps a core promoter 
element or target site for an activator. An example of steric hindrance is regulation of the gcd 
gene by CRP. CRP binds to a DNA site centred at position -31.5, which prevents RNAP from 
binding the promoter (Izu et al., 2002). 
Repression by DNA bending is another common mechanism of repression. A transcription 
factor binds to a site or multiple sites upstream of the promoter and distorts the structure of 
the DNA in such a way that transcription initiation is impaired. An example of repression by 
DNA bending is regulation of the nirB promoter by IHF and Fis. Transcription of nirB is 
repressed by IHF and Fis bound to DNA sites centred at positions -88 and +23 / -97 / -142 
respectively. By binding to these sites, IHF and Fis are hypothesized to contort the nirB 
promoter region into a structure that prevents transcription (Browning et al., 2000).  
Repression by anti-activation is when a transcription factor binds to a promoter near an 
activator and interferes with its function. In contrast to the above mechanisms of repression, 
which are widespread, anti-activation following promoter binding by the repressor is rare. 
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Two examples of note are that of CytR, which negatively regulates activity of several 
promoters by binding to a DNA site in between 2 CRP sites and that of FNR, which has been 
reported to interfere with activation by another molecule of FNR at the yfiD promoter (Green 
and Marshall, 1999). CytR anti-activates by binding to its DNA site and then interacting with 
the nearby CRP molecules and preventing them from activating transcription (Holt and 
Senear, 2010). It should be noted that anti-activation, where a protein interferes with an 
activator, is a more widespread mechanism of regulation, but since the vast majority of anti-
activators do not bind DNA, they are not classified as transcription factors. 
1.12. Complex regulation of transcription 
Although some promoters are regulated by a single transcription factor that functions by 
one of the mechanisms described above, the expression of 49% of genes is regulated by 
multiple transcription factors (Martinez-Antonio and Collado-Vides, 2003). This is thought to 
allow the fine-tuning of transcription responses to stimuli and ensure that genes are only 
expressed when it is beneficial for the cell to do so.  
For example, a promoter may be positively regulated by a transcription factor in response 
to stimulus A, but repressed by a different transcription factor in response to stimulus B. Such 
regulation allows the lac operon promoter to be activated in response to the absence of 
glucose by the transcription factor CRP, but repressed in response to the absence of lactose by 
LacI (Lewis, 2005). This makes sense for the cell, as there is little benefit in producing 
proteins to utilise lactose if there is a better carbon source (glucose) available and / or lactose 
is not present.  
Transcription factors are known to bind to some DNA sites preferentially over others. 
Most transcription factors have a consensus binding sequence, i.e. a DNA site to which they 
optimally bind. However, not all examples of a DNA site for a transcription factor will 
perfectly match the consensus sequence and this gives rise to a hierarchy of target sites for a 
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transcription factor: Sites that better resemble the consensus sequence will be bound 
preferentially over those that poorly resemble the consensus sequence. A hierarchy of target 
sites allows the activity of a transcription factor to be analogue as opposed to digital, i.e. 
simply „on‟ or „off‟. While individual molecules of a transcription factor will be active or 
inactive, a cell will contain hundreds or thousands of molecules of a particular transcription 
factor. Therefore, in lower concentrations of the stimulus for that factor, only a subset of 
molecules will be active, which allows for concentration dependent regulation of gene 
expression. For example, the yfiD promoter contains 2 DNA sites for the transcription factor 
FNR, which is active in the absence of oxygen (Marshall et al., 2001). In micro-aerobic 
conditions, small amounts of FNR will be active and will bind preferentially to the site at 
position -40.5 relative to the yfiD transcription start, which better resembles the consensus 
FNR binding sequence than does the site at position -93.5. When bound solely to the DNA 
site at position -40.5, FNR activates transcription of the yfiD gene. However, in the total 
absence of oxygen, there is enough active FNR that the second site at position -93.5 will also 
be occupied and FNR then represses activity of the promoter.  
The combined effect of multiple factors regulating a single promoter and concentration 
dependent binding of DNA sites can make understanding complex regulation of a promoter 
difficult. Many promoters will not simply be active or inactive and transcriptional activity will 
instead be a function of the interplay of the various transcription factors combined with the 
inherent activity of the core promoter elements. An example of the problem posed by such 
complexity is that of regulation of the nrfA promoter, to which up to 8 transcription factors 
have been shown to be involved (Browning et al., 2010). In the face of such complexity, a 
reductionist, „bottom up‟ approach is often taken. Hence, the actions and roles of individual 
transcription factors will be studied, often in the absence of other factors, and then the models 
combined to attempt to understand total regulation of the promoter.  
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The transcription factors that have been studied in this work are FNR, NarL / NarP and 
NsrR, and are introduced below. 
1.13. FNR 
FNR is the master regulator of anaerobic adaption in E. coli and regulates the transcription 
of over 100 genes in response to the absence of oxygen. Because of the number of genes that 
FNR regulates, it is considered to be one of the 6 global transcription factors of E. coli. FNR 
shows significant similarity to the global transcription factor CRP (Shaw et al., 1983). 
However, because of the sensitivity of FNR to oxygen, no high-resolution structures have 
been obtained (Yan and Kiley, 2009). Alignment of the amino acid sequence of FNR to that 
of CRP (the structure of which has been determined) suggests that FNR has a distinct CTD 
and NTD. The CTD contains a DNA binding determinant that closely resembles that of CRP 
and the NTD contains an iron-sulphur cluster, through which FNR senses oxygen. 
It has been suggested that FNR protein is synthesised and loaded with a 4Fe-4S cluster by 
the IscS protein (Schwartz et al., 2000). In such a form, FNR is able to bind to DNA and 
regulate transcription. Interaction with molecular oxygen causes the iron-sulphur cluster to 
oxidise into a 3Fe-4S cluster, rendering FNR unable to bind DNA (Crack et al., 2007). The 
3Fe-4S cluster is then thought to degrade spontaneously to become a 2Fe-2S cluster that is 
found when FNR is recovered in aerobic conditions. 
There is still debate as to how FNR becomes reactivated once the iron-sulphur cluster has 
been degraded. First, it is possible that the degradation of the cluster is reversible and that, in 
the absence of oxygen, the 2Fe-2S cluster can become a 4Fe-4S cluster. This is unlikely to 
occur unaided, and could require one of the E. coli iron-sulphur cluster repair proteins (Vine 
et al., 2010). A more recent observation noted that FNR is a target for the ClpX protease 
implying that when FNR contains a 2Fe-2S cluster, it is simply broken down and a novel 
FNR molecule synthesized and loaded with a 4Fe-4S cluster (Flynn et al., 2003). However, 
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the results of Dibden et al. (2005) show that FNR containing a 2Fe-2S cluster has a half-life 
of 45 minutes in the presence of ClpX. Dibden and colleagues also demonstrated that a 
molecule of FNR that had previously been deactivated by oxygen can become active again. 
This indicates that FNR is not merely broken down once deactivated and that the iron-sulphur 
cluster may be repaired or replaced. They suggest that FNR is constantly supplied with 4Fe-
4S clusters by the iron-sulphur cluster assembly proteins. 
NO is also able to deactivate FNR by interacting with the iron-sulphur cluster. NO 
disrupts the 4Fe-4S cluster in multiple stages, yielding a dinitrosyl-iron-thiol complex (DNIC) 
(Pullan et al., 2007). NO deactivation of FNR has been demonstrated to have a regulatory 
effect in vivo. The hmp gene encodes an NO-detoxifying flavohemoglobin and expression of 
hcp is repressed by FNR. FNR repression of hmp promoter activity is relieved by NO, which 
suggests that FNR may function as a regulator in response to NO as well to anaerobiosis 
(Cruz-Ramos et al., 2002). 
When FNR is in its active form it is able to dimerise and bind DNA. FNR recognises a 5-
4-5 inverted repeat with the consensus sequence TTGATnAAnATCAA (Jayaraman et al., 
1989). It has been noted that the central 4 positions, although not crucial for recognition of the 
site by FNR, are important for the degree of activation (Scott et al., 2003). Work by Scott and 
colleagues showed that promoters with DNA sites for FNR that contain A / T pairs in the 
central 2 positions are induced an order of magnitude more efficiently than those with sites 
that do not contain central A / T pairs. 
FNR activates transcription by a class II mechanism at the majority of promoters from a 
site centred at position -41.5. An initial study examining the spacing requirements of FNR 
reported that FNR can only activate efficiently from a class II position (Bell et al., 1990). 
However, a later study found that FNR can activate by a class I mechanism if the -35 element 
is a sufficiently good match to the consensus sequence for such elements (Wing et al., 1995). 
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The work by Wing and colleagues also showed that FNR activates by a class I mechanism 
most efficiently from DNA sites at positions -61.5, -71.5, -82.5 and -92.5. They also noted 
that activity of synthetic promoters were twice as high if FNR bound at a class II position than 
if FNR bound at a class I position.  
Like CRP, FNR is able to activate transcription by directly contacting RNA polymerase 
and recruiting it to a promoter. There are 3 defined „activating regions‟ that have been 
identified on the surface of FNR, through which FNR can contact subunits of RNA 
polymerase when bound to a promoter (Blake et al., 2002).  
1.14. NarXL and NarQP two component systems 
In E. coli the dual two component systems NarXL and NarQP are responsible for 
detecting external nitrate and nitrite and regulating transcription accordingly (Stewart, 1993). 
The NarXL two component system is the better characterised system and consists of NarX, a 
sensor kinase, and NarL, a response regulator. NarQ is a sensor kinase and is homologous to 
NarX, whilst NarP is a response regulator that is homologous to NarL.  
There is cross regulation between the NarXL and NarQP systems (Noriega et al., 2009). 
NarQ is able to phosphorylate both response regulators NarP and NarL. NarX has a 
preference for phosphorylating NarL. Therefore, when nitrate is present in the periplasm, both 
NarX and NarQ will auto-phosphorylate. NarX will then phosphorylate NarL, and to an 
extent, NarP, whilst NarQ is reported to phosphorylate NarL and NarP without distinction 
(see Figure 1.8). When nitrite is present in the periplasm, only NarQ will auto-phosphorylate 
and will then phosphorylate both NarL and NarP. The presence of nitrite causes NarX to de-
phosphorylate phospho-NarL. Promoters that are activated by NarL, but not NarP, will 
therefore have high activity when cells are grown in the presence of nitrate and low activity 
when cells are grown in the presence of nitrite. 
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NarX and NarQ are transmembrane proteins that span the cytoplasmic membrane 
(Stewart, 2003). Due to the transmembrane nature of NarX and NarQ, it has not been possible 
to obtain high resolution structures of the full length proteins. Sequence analysis reveals that 
they are 32% identical and 68% similar, although the cytoplasmic domains are more similar 
than are the periplasmic domains. However, the periplasmic domains contain a conserved 
region that is thought to be involved in detection of nitrate / nitrite. The cytoplasmic domains 
contain the residues that are responsible for phosphorylation or de-phosphorylation of partner 
proteins. 
The crystal structure of the NarL protein reveals that NarL has two distinct domains, 
connected by a flexible linker (Baikalov et al., 1996). The NTD contains the site of 
phosphorylation by NarX / NarQ and the CTD contains a helix-turn-helix DNA binding 
element that is similar to those of the LuxR family. The flexible linker is believed to be 
unordered and allows the NTD to obscure the DNA binding element of the CTD when not 
phosphorylated. A structure of the NarL CTD bound to DNA shows that the CTD both bends 
the DNA by 40° and distorts the helical structure when it binds (Maris et al., 2002). The 
structure of NarP has not been determined. However, alignment of the amino acid sequence of 
NarP to that of NarL suggests that it adopts a similar structure. 
NarL and NarP recognise a common DNA site, a 7-2-7 inverted repeat that has the 
consensus sequence TACYYMT-nn-AKRRGTA, where Y = C or T, M denotes A or C, K 
denotes G or T, R denotes A or G and n denotes any base (Darwin et al., 1996). NarL is also 
able to bind single heptamers, known as half-sites (Darwin et al., 1997). The crystal structure 
of the NarL CTD bound to DNA shows that NarL binds as a dimer to an inverted repeat. It is 
unknown if NarL binds to a half-site as a monomer or as a dimer, where one molecule makes 





Figure 1.8 Model for NarXLQP phosphorylation 
Figure is a diagram that shows the model for NarXLQP phosphorylation proposed by 
Noriega et al. (2009). The sensor kinases NarX and NarQ are depicted as rounded rectangles 
and sensor kinases NarL and NarP are depicted as ovals. Black arrows indicate 
phosphorylation, whilst a line that ends with a strong horizontal line indicates 
dephosphorylation. 
  
When nitrate is present: 
NarX NarQ 
NarL NarP 





NarL and NarP are able to repress or activate transcription depending on the position of 
the target DNA site relative to other elements at a promoter. If the DNA site for NarL / NarP 
is located in close proximity to promoter elements or activator binding sites, then NarL / NarP 
will repress promoter activity by steric hindrance. An example is that of expression of the 
dcuS gene, which is repressed by NarL binding to a site that overlaps the -35 region of the 
promoter (Goh et al., 2005).  
The majority of promoters that are activated by NarL are also activated by FNR 
(Constantinidou et al., 2006). Co-operative positive regulation by FNR and NarL is logical for 
genes that encode proteins involved in nitrate utilisation. Because oxygen is a more powerful 
oxidiser than is nitrate, it is beneficial to the cell to only express nitrate utilisation genes in the 
absence of oxygen (when FNR is active) and in the presence of nitrate (when NarL is active). 
At promoters for such genes, FNR typically binds to a DNA site centred at or near position -
41.5 and NarL binds to a DNA site centred further upstream. This organisation suggests that 
FNR and NarL may together activate by a class III mechanism. However, unlike FNR, NarL 
has not been shown to interact directly with RNA polymerase. Alternatively, it is possible that 
NarL is unable to activate transcription directly. At the two best understood NarL activated 
promoters, nirB and nrfA, NarL has been shown to overcome repressors and does not activate 
by contacting polymerase (Browning et al., 2004, Browning et al., 2006).  
1.15. NsrR 
E coli contains 2 transcription factors that sense NO and regulate gene expression in 
response: NorR and NsrR. NorR senses NO directly and regulates the expression of itself and 
the NO-detoxifying enzymes NorVW (D'Autreaux et al., 2005). NsrR also senses NO directly 
and is thought to regulate the expression of around 60 genes (Partridge et al., 2009). NorR is 
therefore considered to be a specific regulator, whilst NsrR is thought by some to be a global 
regulator. An attempt was made to identify the NsrR regulon using transcriptomics and 
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revealed 20 genes that were apparently repressed by NsrR and 22 that were apparently 
activated by NsrR (Filenko et al., 2007). Genes repressed by NsrR were genes such as those 
for the periplasmic nitrate reductase napF and the periplasmic nitrite reductase nrfA, the latter 
of which has been confirmed by single promoter study (Browning et al., 2010). However, 
there have been no reports of activation by NsrR from single promoter studies. A more recent 
ChIP-chip study of chromosomal NsrR binding revealed that NsrR binds to 62 sites in or near 
5′ non-coding regions (Partridge et al., 2009). The results of the ChIP-chip study generally 
supported the results of the previous transcriptomics study and suggested that NsrR may also 
regulate genes involved in motility and metabolism. 
Structural studies of E. coli NsrR have been impeded by the oxygen labile nature of the 
protein. Hence, no structure of NsrR has been reported, although NsrR has been identified as 
a member of the RRF2 protein family on the basis of sequence similarity. An alignment of the 
amino acid sequence of NsrR to that of IscR, a better characterised member of the RRF2 
family, indicates that NsrR has 2 distinct domains. An NTD that contains a helix-turn-helix 
DNA binding element and a CTD that contains an iron-sulphur cluster, through which NsrR is 
thought to sense NO. 
It is unclear what form of iron-sulphur cluster the E. coli NsrR contains as both 4Fe-4S 
and 2Fe-2S clusters have been reported in different bacterial strains (Tucker et al., 2008, Yukl 
et al., 2008). As with FNR, NO is thought to nitrosylate the iron-sulphur cluster of NsrR, 
resulting in a DNIC. NsrR containing a DNIC is unable to bind DNA and regulate 
transcription.  
NsrR recognises an 11-1-11 inverted repeat with the consensus sequence 
AAGATGCYTTTnAAARGCATCTT, where Y = C or T and R = A or G (Partridge et al., 
2009). NsrR is thought to bind its site as a dimer, although a recent study indicates that NsrR 
regulates the expression of many genes that contain only a half-site in their regulatory region. 
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It is not known whether NsrR binds such sites as a monomer or a dimer, with the second 
molecule making non-specific contact with the DNA. Many DNA sites for NsrR are located 
close to core promoter elements or activator binding sites. This suggests that NsrR represses 
activity by steric hindrance.  
1.16. Outline of thesis 
This thesis is concerned with the architecture of promoters that respond to reactive 
nitrogen species in E. coli. The products of the hcp and ogt genes of E. coli have been 
implicated in protection from RNS and expression of both genes has been previously shown 
to be up-regulated by nitrate. Furthermore, NarL, a nitrate-dependent regulator (see above), 
has been shown to regulate expression of both genes.  
Chapter 3 focuses on regulation of the hcp gene. Previous work by Nina Filenko and 
colleagues had shown that expression of hcp is positively regulated by FNR, the master 
anaerobic regulator of E. coli and NarL / NarP homologous nitrate / nitrite dependent 
regulators (Filenko et al., 2005). Filenko later demonstrated that the NO-sensitive repressor 
NsrR represses expression of hcp. The regulation of hcp was investigated using promoter 
fragments fused to lacZ. Derivatives of promoter fragments were constructed to probe the 
relative contributions of the different transcription factors and core promoter elements. In 
vitro protein binding to DNA fragments was also studied. 
Chapter 4 focuses on regulation of the ogt gene. Previous work by Derrick Squire and 
colleagues had shown that expression of ogt is activated by NarL independently of FNR. 
NarL activates transcription from the wild type ogt promoter by binding to 2 DNA sites 
(Squire et al., 2009). Promoter derivatives and promoter::lacZ fusions were used to study the 
positions from which NarL and NarP can activate transcription. 
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Chapter 5 focuses on the mechanisms of activation by the nitrate / nitrite responsive 
transcription factors NarL and NarP. Plasmids containing RNAP α subunit carrying alanine 
substitutions in the CTD were used to examine whether there is direct interaction between 
NarL and RNAP at the ogt promoter. NarL and NarP were expressed from plasmids as either 
full-length constructs or the CTD alone, and the ability to activate transcription was assayed. 
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Chemicals were purchased from Sigma-Aldrich or Fisher Scientific unless otherwise 
stated. Radionucleotides were purchased from Perkin Elmer. Oligodeoxyribonucleotides were 
synthesised by Alta Biosciences, University of Birmingham. Restriction endonucleases, DNA 
ladders, Calf alkaline phosphatase, Phusion polymerase, T4 DNA ligase and T4 
polynucleotide kinase were purchased from New England Biolabs. Biomix Red DNA 
polymerase, Biotaq DNA polymerase and dNTP mix were purchased from Bioline. 
TransformAid and 6 X orange loading dye were purchased from Fermentas. Glycogen was 
purchased from Invitrogen and DNase I was supplied by Roche. All enzymes / kits were used 
according to the manufacturer‟s instructions, and in the buffers provided. All chemicals were 
stored as instructed by the manufacturer. Purified FNR and NarL protein were kindly donated 
by Dr. Douglas Browning, University of Birmingham. 
2.2. Buffers, solutions and reagents 
Solutions for use in bacterial growth or DNA manipulations were autoclaved for 20 
minutes + 10 minutes per 100 ml at 120°C and 15 psi, or filter-sterilised using 0.2 µm filters.  
2.2.1. Buffers for Gel electrophoresis of DNA  
Stock 5 X TBE buffer was purchased from National Diagnostics and contained 0.445 M 
Tris base, 0.445 M boric acid (pH 8.3) and 2 mM Na2EDTA. Stock TBE was diluted to 0.5 X 
in distilled water for use as running buffer in agarose gel electrophoresis and to 1 X for use in 
polyacrylamide gel electrophoresis. A stock of 7.5% polyacrylamide solution was prepared 
containing 125 ml of a 30% (w/v) acrylamide, 0.8% bisacrylamide stock solution (ProtoGel - 
National Diagnostics), 100 ml 5 X TBE, and 20 ml glycerol; and was diluted with distilled 
water to 500 ml. Sequencing polyacrylamide gels were prepared using the SequaGel 
Sequencing System, which was purchased from National Diagnostics and used according to 
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the manufacturer‟s instructions. A solution containing 10% (v/v) methanol and 10% (v/v) 
acetic acid was used to fix sequencing gels following electrophoresis. 
2.2.2. Buffers for extraction and purification of nucleic acids 
TE Buffer was prepared in distilled water and contained 10 mM Tris-HCl and 0.5 mM 
EDTA (pH 8.0). TES buffer was prepared in distilled water and contained 50 mM NaCl, 60 
mM Tris (pH 8.0) and 5 mM EDTA 
2.2.3. Buffers used in the preparation of competent cells  
Buffer TFB1 was prepared in sterile distilled water and contained 100 mM RbCl, 50 mM 
MnCl2, 30 mM potassium acetate, 10mM CaCl2 and 15% glycerol (v/v). The pH of the buffer 
was adjusted to 5.8 and the buffer was filter sterilized prior to being stored at -4 °C. Buffer 
TFB2 was also prepared in sterile distilled water and contained 10 mM MOPS, 10 mM RbCl, 
75 mM CaCl2 and 15% glycerol (v/v). The pH was measured and (if necessary) adjusted to 
6.8. Buffer TFB2 was filter sterilized and stored at -4 °C. 
2.2.4. Buffers and solutions used in β-galactosidase assays 
Z-buffer was prepared in distilled water and contained 75 g/l KCl, 0.25 g/l, MgSO4.7H2O, 
8.53 g/l Na2HPO4 and 4.87 g/l NaH2PO4.2H2O. Z-buffer was sterilized and stored at room 
temperature. Immediately prior to use, Z-buffer was supplemented with 2.70 ml/l β-
mercaptoethanol. A 13 mM ONPG (o-nitrophenyl-β-D-galactopyranoside) solution was 
prepared by dissolving 3.92 g/l of ONPG in Z-buffer. 
2.2.5. Buffers used in the purification of cell lysate 
Wash buffer used in the purification of cell lysate contained 20 mM Tris-HCl (pH 8.0), 
5% glycerol, 1 mM DTT, 200 µg/ml phenylmethylsulfonyl fluoride and 4 µg/ml pepstatin. 
2.2.6. Buffers used in electrophoretic mobility shift assays (EMSA) 





ATP (Perkin-Elmer). Unincorporated nucleotides were removed by passing through a 
Sephadex G-50 column. Sephadex G-50 stock was prepared by adding 5 g Sephadex G-50 
(Pharmacia Biotech) into 100 ml TE buffer, which was autoclaved. The suspension was then 
washed three times in 150 ml TE buffer and finally suspended in 50 ml TE buffer. Sephadex 
suspension was stored at 4°C. Hepes-gluatamate buffer was prepared as a 10 X stock, which 
contained 200mM HEPES (pH 8.0), 50 mM MgCl2, 500 mM potassium glutamate and 10 
mM dithiothreitol. HEPES dilution buffer contained 10% (v/v) HEPES glutamate buffer and 
10% (v/v) BSA. FNR binding buffer was prepared as a 10 X stock, which contained 1 M 
potassium glutamate, 10 mM EDTA, 100 mM K2HPO4, 100 mM KH2PO4 (pH 7.5) and 500 
μM DTT. Buffer B1 contained 20 mM potassium Epps (pH 8.0), 125 mM potassium 
glutamate, 5% glycerol (w/v) and 1.5 mM DTT.  
2.2.7. Buffers used in DNase I footprinting 
DNA for use in DNase I footprints was radiolabelled with a 7000 Ci/mmol preparation of 
[γ
32
P]-ATP (Perkin-Elmer). Stocks of FNR binding buffer, buffer B1, HEPES-glutamate 
buffer and HEPES dilution buffer were prepared as described in section 2.2.6. DNase I stop 
solution contained 0.3 M sodium acetate (pH 7.0) and 10 mM EDTA. Following the 
footprinting reaction, samples were mixed with a gel loading buffer that contained 95% (v/v) 
high quality deionized formamide, 20 mM EDTA, 0.05% bromophenol blue and 0.05% 
xylene cyanol FF. Samples were separated on a sequencing gel. 
2.3. Growth media 
2.3.1. Liquid media 
All liquid media were prepared using distilled water and autoclaved for 20 minutes + 10 
minutes per 100 ml at 120°C and 15 psi, and stored at room temperature. Medium was cooled 





yeast extract and 10 g/l
 
NaCl. Minimal salt medium contained 
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4.5 g/l KH2PO4, 10.5 g/l K2HPO4, 1 g/l (NH4)2SO4, 0.5 g/l sodium citrate, 0.1 g/l; 
MgSO4.7H2O, 1 nM sodium selenate, 1 nM ammonium molybdate and 1 ml/l sulphur-free 
trace metal solution (Cole et al., 1974). SOC broth contained: 2% (w/v) tryptone (pancreatic 
digest of casein), 0.5% (w/v) yeast extract, 8.6 mM NaCl, 2.5 mM KCl, 20 mM MgSO4 and 
20 mM glucose. Purchased pre-prepared from Sigma-Aldritch. Stock solutions of sodium 
nitrate and sodium nitrite were prepared in distilled water and sterilised by autoclave 
treatment. Nitrate-supplemented media contained a final concentration of 20 mM sodium 
nitrate and nitrite-supplemented media contained a final concentration of 2.5 mM sodium 
nitrite. 
2.3.2. Solid media 
Solid media were made up using distilled water and autoclaved for 20 minutes + 10 
minutes per 100 ml at 120°C and 15 psi. Plates were poured immediately, allowed to cool and 
then were stored at 4°C. Supplements were added prior to pouring once media had cooled. 
Immediately prior to use, plates were dried in a 60°C oven for 10 minutes. LB agar contained: 
20 g/l tryptone, 10 g/l yeast extract, 10 g/l NaCl, 10 g/l agar. MacConkey-Lactose agar 
contained 50 g/l MacConkey lactose agar (Difco) 
2.3.3. Antibiotics  
All stock solutions were made up in distilled water unless otherwise specified and 
sterilised using 0.2 µm filters. Ampicillin stock was prepared containing 50 mg/ml ampicillin 
and was stored at -20°C. Kanamycin stock was prepared containing 10 mg/ml kanamycin and 
was stored at -20°C. Tetracycline stock was prepared containing 20 mg/ml tetracycline in 
methanol and was stored at -20°C. 
Antibiotics were added to medium to select for strains carrying antibiotic resistance 
markers either chromosomally or on a plasmid. The following final concentrations were used: 
100 µg/ml ampicillin, 50 µg/m kanamycin and 20 µg/ml tetracycline. 
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2.4. Bacterial strains 
The bacterial strains used in this study are listed in Table 2.1. Aseptic technique was used 
at all stages of bacterial growth. Strains were maintained as glycerol stocks at -80°C in LB 
medium with 15% glycerol. Before use, strains were streaked onto an LB plate and incubated 
at 37°C overnight. For overnight cultures, a conical flask was prepared with 2 X LB and 
relevant antibiotics and inoculated with a single colony picked with a wooden toothpick. The 
flask was then incubated overnight at 37 °C with 200 rpm shaking. Growth was monitored by 
measuring the optical density at 650 nm (OD650) using a Helios Gamma spectrophotometer. 
2.5. Plasmids 
Plasmids used in this study are listed in Table 2.2. Plasmid maps are shows in figures. 
2.6. Gel electrophoresis of DNA 
2.6.1. Agarose gel electrophoresis 
DNA fragments greater than 0.2 kb were analysed by agarose gel electrophoresis. A 
solution of 0.5 X TBE containing between 0.8% and 1.5% agarose was prepared and boiled 
until the agarose was fully dissolved and then allowed to cool to below 60°C. To permit 
visualisation of the DNA fragments, Sybrsafe (Invitrogen) was added to the cooled agarose 
solution to a final concentration of 1 X. The gel was poured using a gel casting plate. DNA 
samples were mixed with orange loading buffer (Fermentas) and gels were run in 0.5 X TBE 
buffer at 100 V for 30 to 40 minutes. Gels containing fragments to be excised were imaged 
using a visible spectrum trans-illuminator (Clare Chemical). In all other cases, a UV trans-
illuminator was used. 
2.6.2. Polyacrylamide gel electrophoresis 
Small (100 mm x 70 mm x 1.5 mm) polyacrylamide gels were used to image DNA 
fragments smaller than 0.5 kb. Such polyacrylamide gels contained 7.5% (w/v) stock 







Table 2.1 Bacterial strains used in this work 
 
  
Strain Description Origin 
JCB387 E. coli RV Δnir Δlac  Page et al. (1990) 
JCB3875 ΔnarP252::Tn10d(Cm) derivative of 
JCB387 
Page et al. (1990) 
JCB3883 ΔnarL derivative of JCB387 Tyson et al. (1994) 
JCB3884 ΔnarL ΔnarP252::Tn10d(Cm) 
derivative of JCB387 
Tyson et al. (1994) 
JCB387 ΔnsrR  ΔnsrR derivative of JCB387 Chismon et al. (2010) 
JCB3911 Δfnr Cm
R
derivative of JCB387 Dr Douglas Browning, 
University of 
Birmingham, UK  
JCB38849S Tet
s
 derivative of JCB387 ΔnarL 
ΔnarP253::Tn10dCm 
ΔhimA452::Tn10dTc isolated as a 
fusaric acid resistant colony 
Chismon et al. (2010) 
JCB38849S ΔnsrR ΔnsrR derivative of JCB38849S Chismon et al. (2010) 
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Table 2.2 Plasmids used in this work 
Plasmid Description Origin 
pRW50 Low copy-number lac expression vector used for 
cloning EcoRI-HindIII fragments as transcriptional 
fusions to lacZ. Used in all β-Galactosidase assays 
in this study unless otherwise stated. Encodes 
tetracycline resistance. 
Lodge et al. (1992) 
pRW224 Derivative of pRW50 that allows cloning of 
fragments as translational fusions to lacZ. 
Islam et al.(2010)  
pSR High copy-number plasmid for general cloning. 
Encodes ampicillin resistance. 
Kolb et al. (1995) 
pNF383 pAA182 lac expression plasmid containing the E. 
coli hcp-hcr regulatory region. Encodes ampicillin 
resistance. 
Filenko et al. (2005) 
pSTBlue-1 High copy-number general purpose cloning vector. 
Encodes ampicillin resistance. 
Novagen 
pGIT9 pSTBlue-1 containing E. coli nsrR. Bodenmiller and Spiro 
(2006) 
pJW15 Δ100 pAA121 high copy-number plasmid with an EcoRI-
HindIII fragment containing the melR promoter and 
coding region, with an NsiI site engineered at 
codons 1 and 2 of melR and the first 100 codons of 
melR deleted. Encodes ampicillin resistance. 
Kahramanoglou et al. 
(2006) 
pLG339 Low copy-number cloning vector. Encodes 
kanamycin and tetracycline resistance. 
Stoker et al. (1982) 
pLG339 ΔRS Derivative of pLG339 with a deletion of sequence 
between the EcoRI and SalI sites thereby disrupting 
the tetracycline resistance gene.  
Belyaeva et al.(2000)  
pDLC1 Derivative of pJW15 Δ100 carrying the NsiI-
HindIII fragment NarL-CTD. 
This work 
pDLC2 Derivative of pJW15 Δ100 carrying the NsiI-
HindIII fragment NarL-Full. 
This work 
pDLC3 Derivative of pLG339 carrying the BamHI-EcoRI 
fragment beNarL-CTD. 
This work 
pDLC4 Derivative of pLG339 carrying the BamHI-EcoRI 
fragment beNarL-Full. 
This work 
pDLC5 Derivative of pLG339 with a BamHI-EcoRI 
fragment carrying the narXL operon and regulatory 
region.  
This work 
pDLC6 Derivative of pJW15 Δ100 carrying the NsiI-
HindIII fragment NarP-CTD 
This work 
pDLC8 Derivative of pJW15 Δ100 carrying the NsiI-
HindIII fragment NarP-CTD138 
This work 
pDLC9 Derivative of pJW15 Δ100 carrying the NsiI-
HindIII fragment NarP-CTD148 
This work 
pDLC14 Derivative of pLG339 with a BamHI-EcoRI 






Figure 2.1 Maps of plasmids pSR and pRW50 
Panel A shows a map of the general cloning plasmid pSR. EcoRI-HindIII fragments are 
cloned upstream of the λoop terminator to ensure transcripts are of a defined length. Also 
shown are the origin of replication (ori), ampicillin resistance gene (Amp
R
) and RNA1 gene. 
 
Panel B shows a map of the lac fusion vector pRW50. EcoRI-HindIII fragments are cloned 
into the pUC9 linker region (shown in grey) as transcriptional fusions to the trpBA and 
lacZYA operons. Also shown is the origin of replication (oriV), plasmid replication genes 
(trfA and trfB) and tetracycline resistance gene (tet
R
)  

























Figure 2.2 Map and partial sequence of plasmid pRW224 
Panel A shows a map of the pRW50 derivative, pRW224. The trpBA operon of pRW50 is 
deleted and the cloning region modified to allow fragments to be cloned upstream of the 
lacZYA operon as transcriptional or translational fusions. EcoRI-HindIII fragments utilise the 
galE Shine-Dalgarno sequence (shaded blue), whilst EcoRI-BamHI fragments are 
translational fusions. 
 
Panel B shows a partial sequence of pRW224 which shows the region surrounding the EcoRI 
and Bam

































Figure 2.3 Map and partial sequence of plasmid pJW15 Δ100 
Panel A shows a map of plasmid pJW15 Δ100, a derivative of pJW15 with codons 1 through 
99 of melR deleted. Map also shows the ampicillin resistance gene (Amp
R
), the origin of 
replication (ori) and the galK gene. 
 
Panel B shows a partial sequence of pJW15 Δ100. A binding site for CRP is shown in red and 
the melR -10 element, transcription start (+1) and Shine-Dalgarno (SD) sequence are 



























Figure 2.4 Map of pLG339 
Figure shows a map of the low copy-number cloning plasmid pLG339. The origin of 
replication (ori) is shown in blue and the tetracycline (Tet
R
) and kanamycin (Km
R
) genes are 
shown in red.  
 
































Figure 2.5 Map and partial sequence of pDLC1 
Panel A shows a map of pDLC1, a derivative of pJW15 Δ100. The melR coding region from 
pJW15 Δ100 is deleted and replaced with DNA encoding the CTD of NarL such that 
expression of the NarL CTD is driven by the melR promoter. 
 
Panel B shows the sequence of the EcoRI-HindIII fragment carried by pDLC1. A binding site 
for CRP is shown in red and the melR -10 element, transcription start (+1) and Shine-
Dalgarno (SD) sequence are underlined in bold and labelled. Alternate narL codons are 
underlined. 
  





































Figure 2.6 Map and partial sequence of pDLC2 
Panel A shows a map of pDLC2, a derivative of pJW15 Δ100. The melR coding region from 
pJW15 Δ100 is deleted and replaced with the narL gene such that expression of narL is 
driven by the melR promoter. 
 
Panel B shows a partial sequence of the EcoRI-HindIII fragment carried by pDLC2. A 
binding site for CRP is shown in red and the melR -10 element, transcription start (+1) and 
Shine-Dalgarno (SD) sequence are underlined in bold and labelled. Alternate narL codons are 
underlined. 
  













































Figure 2.7 Map and partial sequence of pDLC3 
Panel A shows a map of pDLC3, a pLG339 derivative. The region of the tetracycline 
resistance gene between the BamHI and EcoRI sites of pLG339 is replaced with the BamHI-
HindIII fragment from pDLC1 that has been modified to replace the HindIII site with an 
EcoRI site.  
 
Panel B shows the sequence of the BamHI-EcoRI fragment carried by pDLC3. Compare with 
Figure 2.5. A binding site for CRP is shown in red and the melR -10 element, transcription 
start (+1) and Shine-Dalgarno (SD) sequence are underlined in bold and labelled. Alternate 
narL codons are underlined. 
 









































Figure 2.8 Map and partial sequence of pDLC4 
Panel A shows a map of pDLC4, a pLG339 derivative. The region of the tetracycline 
resistance gene between the BamHI and EcoRI sites of pLG339 is replaced with the BamHI-
HindIII fragment from pDLC2 that has been modified to replace the HindIII site with an 
EcoRI site.  
 
Panel B shows the sequence of the BamHI-EcoRI fragment carried by pDLC4. Compare with 
Figure 2.6. A binding site for CRP is shown in red and the melR -10 element, transcription 
start (+1) and Shine-Dalgarno (SD) sequence are underlined in bold and labelled. Alternate 
narL codons are underlined. 












































Figure 2.9 Map and partial sequence of pDLC5 
Panel A shows a map of pDLC5, a pLG339 derivative. The region of the tetracycline 
resistance gene between the BamHI and EcoRI sites is replaced with the narXL operon and 
promoter region.  
Panel B shows a partial sequence of the BamHI-EcoRI fragment carried by pDLC5. The 
narXL transcription start site and promoter elements as reported by Nohno et al. (1989) are 
underlined and labelled. Alternate codons of narX are underlined. 















































Figure 2.10 Map and partial sequence of pDLC6 
Panel A shows a map of pDLC6, a pDLC1 derivative. The NsiI-HindIII fragment of pDLC1 
is replaced with DNA encoding the CTD of NarP such that expression of the NarP CTD is 
driven by the melR promoter. 
 
Panel B shows the sequence of the EcoRI-HindIII fragment carried by pDLC6. A binding site 
for CRP is shown in red and the melR -10 element, transcription start (+1) and Shine-
Dalgarno (SD) sequence are underlined in bold and labelled. Alternate narP codons are 
underlined. The plasmid encodes NarP from amino acid 146. 
  












































Figure 2.11 Map and partial sequence of pDLC8 
Panel A shows a map of pDLC8, a pDLC1 derivative. The NsiI-HindIII fragment of pDLC1 
is replaced with DNA encoding the CTD of NarP such that expression of the NarP CTD is 
driven by the melR promoter. 
 
Panel B shows the sequence of the EcoRI-HindIII fragment carried by pDLC8. A binding site 
for CRP is shown in red and the melR -10 element, transcription start (+1) and Shine-
Dalgarno (SD) sequence are underlined in bold and labelled. Alternate narP codons are 
underlined. The plasmid encodes NarP from amino acid 138. 
 
  












































Figure 2.12 Map and partial sequence of pDLC9 
Panel A shows a map of pDLC9, a pDLC1 derivative. The NsiI-HindIII fragment of pDLC1 
is replaced with DNA encoding the CTD of NarP such that expression of the NarP CTD is 
driven by the melR promoter. 
 
Panel B shows the sequence of the EcoRI-HindIII fragment carried by pDLC8. A binding site 
for CRP is shown in red and the melR -10 element, transcription start (+1) and Shine-
Dalgarno (SD) sequence are underlined in bold and labelled. Alternate narP codons are 
underlined. The plasmid encodes NarP from amino acid 148. 
 
  










































Figure 2.13 Map and partial sequence of pDLC14 
Panel A shows a map of pDLC14, a pLG339 derivative. The region of the tetracycline 
resistance gene between the BamHI and EcoRI sites is replaced with the narP gene and 
promoter region.  
 
Panel B shows a partial sequence of the BamHI-EcoRI fragment carried by pDLC14. The 
narP σ
32
-dependent transcription start site as reported by Nonaka et al. (2006) is underlined 
and marked with a bent arrow. The Shine-Dalgarno sequence has been predicted on the basis 
of similarity to the consensus sequence for such an element. Alternate codons of narP are 
underlined. 
 



























(w/v) ammonium persulphate and 0.001 volumes TEMED (N,N,N′,N′-
tetramethylethylenediamine). DNA was mixed with orange loading buffer (Fermentas) prior 
to loading and gels were run in 1 X TBE at 36 mA for 40 minutes. Gels were stained in 1 X 
TBE containing 1 X Sybrsafe (Invitrogen) and visualised using a UV trans-illuminator or a 
visible spectrum trans-illuminator for fragments that were to be excised. 
2.6.3. Sequencing polyacrylamide gel electrophoresis 
For analysis of DNase I protection assays, samples were separated on a large (40cm x 30 
cm x 0.4 mm) 6% acrylamide sequencing gel (SequaGel). The gel was prepared according to 
the manufacturer‟s instructions and run in 1 X TBE buffer at 60 W. The gel was pre-run for 1 
hour prior to loading and DNA samples were mixed with loading buffer and incubated at 
90°C for 2 minutes before loading. Gels were run for up to 2 hours and then fixed in fixing 
solution. Gels were transferred to filter paper and vacuum dried for 30 minutes at 80°C. Gels 
were analysed by exposure to a Phosphor screen (Fuji) for up to 12 hours, which was then 
scanned using a Molecular Imager FX (BioRad). The supplied QuantityOne software was 
used to analyse the images produced.  
2.7. Extraction and purification of nucleic acids 
2.7.1. Phenol-chloroform purification of DNA 
To remove contaminating proteins, solutions containing DNA were mixed with an equal 
volume of phenol-chloroform-isoamyl alcohol (25/24/1, pH 8.0) and mixed vigorously. 
Solutions were centrifuged for 2 minutes at 13,000 rpm to separate the sample into aqueous 
and organic layers. The upper aqueous layer was removed to a separate tube by pipette and 
200 µl of sterile distilled water was added to the tube containing the lower, organic, layer. The 
tube containing the organic layer was then vigorously mixed and then centrifuged for 2 
minutes at 13,000 rpm. The aqueous layer was then carefully removed by pipette and 
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combined with the aqueous layer that had been extracted previously. DNA was then ethanol 
precipitated as described below. 
2.7.2. Extraction of DNA by ethanol precipitation 
Ethanol precipitation was used to concentrate DNA solutions and to extract DNA from 
buffers that did not contain proteins. Samples were gently mixed with 10% sodium acetate 
(v/v) and 1% 1M MgCl2 (v/v). Two volumes of ice-cold 100% ethanol were added to the 
samples, which were then incubated at -80°C for 15 minutes. DNA was sedimented by 
centrifugation at 4°C and 14,000 rpm for 15 minutes. The supernatant was removed and the 
pellet was washed with 1 ml of ice-cold 70% ethanol. The DNA was re-sedimented by 
centrifugation at 4°C and 14,000 rpm for 10 minutes. The supernatant was discarded and the 
pellet was dried under vacuum for 10 minutes. The DNA pellet was then re-suspended in an 
appropriate amount of sterile distilled water.  
2.7.3. Purification of DNA from solution by QiaQuick kit 
DNA was purified following PCR or digestion using a QiaQuick PCR purification kit 
(QIAgen). The manufacturer‟s instructions were followed and DNA was eluted into 50 µl 
buffer EB (provided in kit). 
2.7.4. Extraction and purification of DNA from agarose gels 
A scalpel was used to isolate the region of an agarose gel that contained a DNA fragment 
of interest. The DNA was then purified from the gel fragment using a QiaQuick Gel 
Extraction kit (QIAgen) according to the manufacturer‟s instructions.  
2.7.5. Electroelution from polyacrylamide gels 
A scalpel was used to isolate the region of a polyacrylamide gel that contained a DNA 
fragment of interest. A 5-10 cm length of dialysis tubing, prepared using the method of 
Maniatis et al. (1982), was clipped at one end and filled with 200 µl of 0.1 X TBE. The gel 
fragment was inserted into the dialysis tubing and the tubing sealed. The tube was placed in 
60 
 
an electroelution tank and covered with 0.1 X TBE and run at 26 mA for 30 minutes. The 
tubing was opened and the buffer extracted by pipette to a microcentrifuge tube. DNA was 
purified and extracted by phenol-chloroform treatment and ethanol precipitation (see sections 
2.7.1 and 2.7.2). 
2.7.6. Small scale preparation of plasmid DNA (miniprep) 
An overnight culture of a strain containing the plasmid of interest was grown in medium 
containing appropriate antibiotics. Plasmid DNA was then extracted using the QIAprep Spin 
Miniprep kit (QIAgen) according to the manufacturer‟s instructions. For high copy-number 
plasmids, 1.5 ml of culture was processed and for low copy-number plasmids, 5 ml of culture 
was processed. Following purification, DNA was eluted into 50 µl buffer EB (provided in 
kit). 
2.7.7. Large scale preparation of plasmid DNA (maxiprep) 
The caesium chloride density gradient ultracentrifugation (maxiprep) method described in 
Maniatis et al. (1982) was used for the preparation of large amounts of highly pure plasmid 
DNA. An overnight culture of a strain containing the plasmid of interest was grown in 
medium supplemented with appropriate antibiotics. A 2500 ml culture vessel containing 500 
ml growth medium (LB supplemented with appropriate antibiotics) was then inoculated with 
all of the overnight culture. The culture was grown at 37°C with shaking until an OD650 of 
~0.9. The medium was then supplemented with 50 mg of chloramphenicol to retard protein 
synthesis but allow DNA replication to continue. The culture was incubated overnight at 37°C 
with shaking. The culture was sedimented in a centrifuge at 4°C and at 4,000 rpm for 30 
minutes. The supernatant was discarded and the cell pellet re-suspended in 12 ml of ice-cold 
TES buffer. The solution was transferred to a round bottomed centrifuge tube (Oakridge 
style). The tube was supplemented with 2 ml cold 250 mM EDTA and 3 ml cold TES buffer 
containing 10 mg/ml lysozyme and was mixed and incubated for 15 minutes on ice. 2 ml of 
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10% SDS was added to the tube, which was then mixed and incubated on ice for a further 10 
minutes. 5 ml of ice-cold 5 M NaCl was added to the tube, which was then mixed and 
incubated on ice overnight.  
The cell debris was separated from the DNA by centrifugation at 4°C at 20,000 rpm for 2 
hours. The supernatant was removed to a fresh 40 ml centrifuge tube and warmed to room 
temperature. DNA was precipitated by adding 15 ml of isopropanol and incubating at room 
temperature for 15 minutes. DNA was then sedimented by centrifugation at 20°C at 15,000 
rpm for no more than 15 minutes. The supernatant was discarded and the DNA pellet was air-
dried. The pellet was re-suspended in 5 ml TES buffer and 5.16 g (+/- 10 mg) of CsCl and 
200 µl of ethidium bromide were added to the solution. The solution was transferred to a 10 
ml quick seal tube (Beckman) and filled with TES buffer before being sealed. The sample was 
then centrifuged at 20°C and at 50,000 rpm for 22 hours. 
Following ultracentrifugation, the tube was secured in a clamp and a hole pierced in the 
top of the tube with a heated needle to allow air into the tube. A second heated needle was 
then used to carefully extract the lower of the 2 ethidium bromide stained bands that were 
visible. To remove the ethidium bromide, the sample was purified with water-saturated 
butanol 5 times: The sample was mixed with an equal volume of water-saturated butanol and 
then centrifuged for 4 minutes at 13,000 rpm and the upper layer discarded.  The DNA 
solution was then transferred to dialysis tubing and dialysed overnight in 4 l of 1X TE. 
Following dialysis the DNA was purified with phenol chloroform and extracted by 
ethanol precipitation before being re-suspended in 600 µl 1X TE buffer and quantified on a 
ND1000 spectrophotometer (Thermo) 
2.8. Bacterial transformations 
2.8.1. Preparation of competent cells by rubidium chloride treatment 
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Rubidium chloride was used to prepare cells for transformation with plasmid DNA. A 5 
ml culture of the desired strain was grown overnight and 1 ml used to inoculate 100 ml of 2X 
LB in a 250 ml conical flask. The flask was then incubated at 37°C with shaking until an 
OD650 of ~0.5 was reached. The flask was then placed on ice for 10 minutes and cells 
sedimented in a centrifuge at 4°C and at 4,000 rpm for 9 minutes. The supernatant was 
removed and the cell pellet re-suspended in 30 ml ice-cold TFB1 (see section 2.2.3). The cell 
suspension was incubated on ice for a minimum of 90 minutes and then the cells were 
sedimented in a centrifuge at 4°C and at 4,000 rpm for 9 minutes. The supernatant was 
discarded and the cell pellet re-suspended in 4 ml TFB2. The suspension was then aliquoted 
into micro-centrifuge tubes for future use. Aliquots were snap frozen in liquid nitrogen and 
stored at -80°C. 
2.8.2. Small scale preparation of competent cells  
For small-scale preparation of competent cells, TransformAid (Fermentas) was used 
according to the manufacturer‟s instructions. However, for maximum efficiency, DNA was 
transformed using the method below rather than the method detailed by the manufacturer. 
2.8.3. Transformation of competent cells with plasmid DNA 
An aliquot of competent cells to be transformed was thawed on ice for ~10 minutes. Cells 
were mixed gently with a pipette tip. A 0.5 ml micro-centrifuge tube was prepared with 1 µl 
of miniprep plasmid DNA and a 50 µl aliquot of competent cells, briefly mixed by pipetting, 
and then incubated on ice for 30 minutes. Cells were heat shocked at 42°C for 40 seconds and 
then incubated for a further 5 minutes on ice. SOC broth was pre-warmed to 37°C and 250 µl 
added to the cells. Cells were then incubated at 37°C with shaking for 1 hour. Agar plates 
were pre-warmed to 37°C and the entirety of the transformation mixture plated. Plates were 
incubated at 37°C overnight.  
2.9. DNA manipulations 
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2.9.1. Polymerase Chain Reaction (PCR) 
Standard PCR 
Phusion polymerase (NEB) with the supplied HF buffer was used for standard PCR and 
10 µl of miniprep DNA was used as template. Where plasmid DNA was used as the template, 
it was diluted with sterile distilled water to either 1:100 (for low copy-number plasmids) or 
1:500 (for high copy-number) plasmids. dNTPs (Bioline) were provided as a mixture to a 
final concentration of 0.25 mM for each dNTP. Oligonucleotide primers were added to a final 
concentration of 1 µM (each primer). PCR samples were made up to 50 µl final volume with 
sterile distilled water. An example of a typical cycle is shown in Table 2.3. 
Colony PCR 
Colony PCR was used to check for the presence of a plasmid or a particular fragment on a 
plasmid. A tube was prepared with 25 µl Biomix Red (Bioline), 1 µM of each primer and then 
made up to 50 µl with sterile distilled water. A 200 µl pipette tip was used to pick a colony 
from an agar plate and the PCR mixture agitated with the tip. A modified PCR cycle was used 
to amplify fragments (Table 2.3). 
2.9.2. Restriction digestion of DNA 
DNA was digested according to the manufacturer‟s instructions using either NEB 
enzymes or Fermentas FastDigest enzymes. Enzyme volume used was between 1 μl and not 
more than 10% of the final reaction volume. Restriction digests were incubated at 37°C for 
between 30 minutes and 12 hours. FastDigest enzymes were used for double digests because 
they use a common buffer. Plasmid DNA that had been digested in preparation for cloning 
was prevented from re-ligating by treatment with alkaline phosphatase. Either calf-intestinal 
phosphatase (NEB) or FastAP (Fermentas) was used depending on the restriction enzymes. 
DNA fragments were then separated by gel electrophoresis or, in some cases, purified using a 
Qiaquick spin kit without prior electrophoresis (see Section 2.7.3).  
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Table 2.3 Standard and colony PCR cycles 
The extension time (Tx) was calculated as 30 seconds per kb of DNA to be amplified. If 
product was less than 1 kb long, 30 s was used.  
 
Temperature Time Purpose 
Standard PCR:   
98°C 30 s Initial denaturation 
98°C 10 s Denaturation 
60°C 20 s Primer annealing 
72°C Tx Extension 
72°C 7 min Final extension 
Colony PCR:   
95°C 10 min Cell lysis / Initial denaturation 
95°C 10 s Denaturation 
60°C 20 s Primer annealing 
71°C Tx Extension 
71°C 5 min Final extension 









2.9.3. DNA ligations 
DNA fragments with compatible restriction sites were ligated using T4 DNA ligase 
(NEB) according to the manufacturer‟s instructions. Between 1 µl and 15 µl of digested insert 
DNA and between 3 µl and 6 µl of digested plasmid DNA was used. 2 µl of supplied buffer 
and 1 µl of T4 ligase was used and reactions were made up to 20 µl with sterile distilled 
water. Ligation reactions were placed on ice for 10 minutes and then incubated at room 
temperature for 10 minutes. Between 1 µl and 5 µl of the ligation reactions were then 
transformed into cells using the method described in section 2.8.3. 
2.9.4. DNA sequencing 
DNA was sequenced by the Functional Genomics and Proteomics Laboratory at the 
University of Birmingham using an ABI3730 sequencer. The relevant region of a plasmid was 
amplified by standard PCR and the PCR product purified using a kit (see Section 2.7.3). 6.8 
µl of purified PCR product was mixed with 3.2 µl of 10 µM oligonucleotide primer stock. 
Sequencing primers are listed in Table 2.4. Cloning of promoter fragments into pRW50, 
pRW224 and pSR 
2.10. Cloning of promoter fragments into pRW50, pRW224 and pSR 
2.10.1. Preparation of EcoRI-HindIII promoter fragments by PCR 
Table 2.5 lists all EcoRI-HindIII promoter fragments used in this study and Figures 2.14-
2.16 show the sequence of each fragment. EcoRI-HindIII fragments were generated by PCR 
using a plasmid that contained the fragment of interest as template DNA. In some cases, the 
fragment had the correct restriction sites, whilst in other cases it was necessary to design 
primers that introduced the desired sites. The PCR product was cut with EcoRI and HindIII 
enzymes, purified and ligated into prepared pRW50, pRW224 or pSR. Primers used for 












Table 2.4 Sequencing / screening primers used in this work 
Code Sequence Use 
D10520 CCCTGCGGTGCCCCTCAAG Anneals upstream of EcoRI 




Anneals downstream of 
HindIII site in pRW50 and 
derivatives 
D5431 ACCTGACGTCTAAGAAACC Anneals upstream of EcoRI 
site in pSR and pJW15 Δ100 
D4600 GTAGTCGGTGTGTTCAC Anneals downstream of 
HindIII site in pSR 
D55668 GAGCGGCGACGATAGTCATG Anneals upstream of BamHI 
site in pLG339 and 
derivatives 
D70296 ACCTGACGTCTAAGAAACC Anneals upstream of EcoRI 
site in pJW15 Δ100 and 
derivatives 
D70297 GTAGTCGGTGTGTTCAC Anneals downstream of 






Table 2.5 EcoRI-HindIII promoter fragments used in this work 
A P80T mutation indicates that the nucleotide at position -80 relative to the transcription start 
has been mutated to a T.  
 
Name Description Source 
hcp383-0 Carries the intergenic region between ybjE and hcp which 
includes the hcp regulatory region. Carries nucleotide sequence 
from -285 to +98 
Filenko et 
al. (2005) 
hcp383-1 Derivative of hcp383-0 that carries nucleotide sequence from -
125 to +98 
This study 
hcp383-2 Derivative of hcp383-0 that carries nucleotide sequence from -92 
to +98 
This study 
hcp383-3 Derivative of hcp383-0 that carries nucleotide sequence from -54 
to +98 
This study 
hcp383-1n Fragment hcp383-1 that carries an A to G mutation and a T to G 
mutation at positions +9 and +10 
This study 
hcp383-101 Derivative of the hcp383-1 fragment that carries P110G and  
P99C mutations 
This Study 
hcp383-102 Derivative of the hcp383-1 fragment that carries P78C and P67G 
mutations 
This Study 
hcp383-1ns hcp-hcr promoter fragment that carries nucleotide sequence from 
-125 to +46 and contains carries an A to G mutation and a T to G 
mutation at positions +9 and +10 
This study 
hcp383-1nvs Derivative of hcp383-1ns that carries nucleotide sequence from -
125 to +8 
This study 
hcp383-2n Derivative of hcp383-1n that carries nucleotide sequence from -
92 to +98 
This study 
hcp383-3n Derivative of hcp383-1n that carries nucleotide sequence from -
54 to +98 
This study 
hcp383-3s Derivative of hcp383-3 that carries nucleotide sequence from -54 
to +46 
This study 
hcp383-3ns Derivative of hcp383-1n that carries nucleotide sequence from -
54 to +46 
This study 
ogt100 E. coli ogt promoter fragment carrying nucleotide sequences 
from -270 to +51 
Squire et al. 
(2009) 
ogt101 Derivative of the ogt100 fragment carrying P80T, P77A, P75G 
and P73G mutations 
M. Xu 
ogt102 Derivative of the ogt100 fragment carrying P84G and P63C 
mutations 
M. Xu 




ogt1041 Derivative of the ogt100 fragment carrying P80T, P77A, P75G 
and P73G, P51G and P40C mutations 
D. 
Browning 
ogt1042 Derivative of the ogt100 fragment carrying P84G, P63C, P51G 
and P40C mutations 
D. 
Browning 
ogt105 Derivative of the ogt100 fragment carrying P51C, P48C, P44A 
and P42A mutations 
D. 
Browning 
ogt1051 Derivative of the ogt100 fragment carrying P80T, P77A, P75G 
and P73G, P51C, P48C, P44A and P42A mutations 
D. 
Browning 
ogt1052 Derivative of the ogt100 fragment carrying P84G,P63C, P51C, 





yeaR100 E. coli yeaR promoter fragment carrying nucleotide sequences 
from −294 to +96. 
D. Squire 
ogt106 Derivative of the ogt100 fragment with positions -23 and -24 
deleted 
This Study 
ogt107 Derivative of the ogt100 fragment carrying P51C, P49C, P48A, 
P47A, P44A, and P43A mutations 
This Study 
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Figure 2.14 Sequences of hcp promoter fragments used in this work 
EcoRI and HindIII sites are shaded grey and labelled. The stop codon of ybjE and the start codon of hcp are shown in bold. The hcp transcription start 
(as identified by Filenko et al 2005) is stongly underlined and indicated by a bent arrow labelled +1, The -10 and -35 elements predicted by this study 
are strongly underlined and labelled. The DNA site for NarL proposed by Filenko et al. (2005) is shaded orange and labelled. The DNA site for FNR 
proposed by Filenko et al. (2005) is shaded blue and labelled. The DNA site for NsrR proposed by Filenko et al. (2007) is shaded pink and labelled. 
Panel A shows the sequence of the hcp383-0 fragment. A more detailed diagram of this fragment is shown in Figure 3.1. 
Panel B shows the sequence of the hcp383-1 fragment and indicates mutations introduced to construct derivatives. The hcp383-101 fragment carries 
mutations that disrupt the DNA site for NarL, the hcp383-102 fragment carries mutations that disrupt the DNA site for FNR and the hcp383-1n 
fragment carries mutations that disrupt the DNA site for NsrR. 
Panel C shows the sequence of the hcp383-3 fragment and indicates mutations introduced to construct the derivative hcp383-2n, which carries 
mutations that disrupt the DNA site for NsrR. 
Panel D shows the sequence of the hcp383-3 fragment and indicates the mutations introduced to construct the derivative hcp383-3n, which carries 
mutations that disrupt the DNA site for NsrR. 
Panel E shows the sequence of the hcp383-1ns fragment 
Panel F shows the sequence of the hcp383-1nvs fragment 
Panel G shows the sequence of the hcp383-3s fragment and indicates the mutations introduced to construct the derivative hcp383-3ns, which carries 



































































G G hcp383-1n 
G hcp383-2n G 
A: hcp383-0 
B: hcp383-1 / hcp383-101 / hcp383-102 / hcp383-1n 
C: hcp383-2 / hcp383-2n 
• • • • 
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-10 -35 NsrR (+6) 
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G hcp383-3n G 
HindIII 
-10 -35 











-10 -35 NsrR (+6) 
+1 
EcoRI 
G hcp383-3ns G 
D: hcp383-3 / hcp383-3n 
E: hcp383-1ns 
F: hcp383-1nvs 
G: hcp383-3s / hcp383-3ns 
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• • • • • • • • 
-50 -100 
• • • • • • • • 
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• • • • 
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Figure 2.15 ogt promoter fragments used in this work 
EcoRI and HindIII sites are shaded grey and labelled. The start codon of ogt is shown in bold. The ogt transcription start (as identified by Potter et al 
1987) is strongly underlined and indicated by a bent arrow labelled +1, The -10 elements identified by Potter et al. (1987) is strongly underlined and 
labelled. The DNA sites for NarL identified by Squire et al. (2010) are shaded orange and labelled. 
Panel A shows the sequence of the ogt100 fragment. 
Panel B shows a partial sequence of the ogt promoter fragments used in this work. The ogt promoter fragments used do not differ in sequence from the 
ogt100 fragment outside of the partial sequence shown. Positions shaded in green indicate mutations that improve the DNA site for NarL, relative to 
the consensus sequence for such sites, TACCYMTnnAKRRGTA. Positions shaded in red indicate mutations that worsen the DNA site for NarL 
relative to the consensus sequence for such sites. The ogt101 fragment carries mutations that improve only the NarL I site. The ogt102 fragment carries 
mutations that disrupt only the NarL I site. The ogt104 fragment carries mutations that disrupt only the NarL II site. The ogt1041 fragment carries 
mutations that improve the NarL I site but disrupt the NarL II site. The ogt1042 fragment carries mutations that disrupt both NarL I and NarL II sites. 
The ogt105 fragment carries mutations that improve only the NarL II site. The ogt1051 fragment carries mutations that improve both the NarL I and 
NarL II sites. The ogt1052 fragment carries mutations that disrupt the NarL I site and improve the NarL II site. The ogt106 fragment carries a deletion 
of 2 bases (positions -23 and -24 of ogt100). The NarL II site of the ogt107 fragment is mutated to the sequence of the DNA site for NarL from the 




















     TACYYMTnnAKRRGTA       TACYYMTnnAKRRGTA 
ogt100     TGGGTACTTACTATTCGTTAGTCTTGCCCTATCCACTTATCTTTTTGGTGGTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt101     TGGGTACTTATTAATGGGTAGTCTTGCCCTATCCACTTATCTTTTTGGTGGTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt102     TGGGTAGTTACTATTCGCTAGTCTTGCCCTATCCACTTATCTTTTTGGTGGTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt104     TGGGTACTTACTATTCGTTAGTCTTGCCCTATCCACTTAGCTTTTTGGTGCTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt1041     TGGGTACTTATTAATGGGTAGTCTTGCCCTATCCACTTAGCTTTTTGGTGCTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt1042     TGGGTAGTTACTATTCGCTAGTCTTGCCCTATCCACTTAGCTTTTTGGTGCTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt105     TGGGTACTTACTATTCGTTAGTCTTGCCCTATCCACTTACCTCTTTAGAGGTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt1051     TGGGTACTTATTAATGGGTAGTCTTGCCCTATCCACTTACCTCTTTAGAGGTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt1052     TGGGTAGTTACTATTCGCTAGTCTTGCCCTATCCACTTACCTCTTTAGAGGTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt106     ACTGGGTACTTACTATTCGTTAGTCTTGCCCTATCCACTTATCTTTTTGGTGGTATGGCTGCTGATGTCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
 
ogt107     TGGGTACTTACTATTCGTTAGTCTTGCCCTATCCACTTAACCAATAAATGGTATGGCTGCTGATGTTGCTGGCGTGGTATCTTGTCGGTCTGCCGATAGGTCCGG 
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Figure 2.16 Sequence of the yeaR100 promoter fragment 
EcoRI and HindIII sites are shaded grey and labelled. The start codon of yeaR is shown in bold. The yeaR transcription start (as reported by Squire et 
al 2009) is strongly underlined and indicated by a bent arrow labelled +1, The -10 elements identified by Squire et al. (2009) is strongly underlined and 
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Table 2.6 Primers used to amplify or generate EcoRI-HindIII promoter fragments 
 
  
Code Name Sequence Use 
D10520  CCCTGCGGTGCCCCTCAA
G 




Anneals downstream of HindIII 





Used with D10527 to construct 





Used with D10527 to construct 





Used with D10527 to construct 
hcp383-3 and hcp383-3ns, carries 
EcoRI site 
D59726 PHCP333 DS CCCAAGCTTGCACACAAA
ACATGATCACACCTT 
Used with D10520 to construct 
hcp383-1ns and  hcp383-3s, 
carries HindIII site 
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2.10.2. Cloning into pRW50, pRW224 or pSR 
Vector DNA was prepared by digestion with EcoRI-HindIII restriction enzymes. 
Following digestion, a sample of the digestion mix was examined on an agarose gel to ensure 
complete digestion. The vector was treated with alkaline phosphatase and purified by phenol-
chloroform treatment and ethanol precipitation. EcoRI-HindIII products that had been 
generated by PCR and then cut with EcoRI-HindIII restriction enzymes were purified on an 
agarose gel and ligated into the prepared vector. Plasmids were then transformed into 
competent JCB387 cells. Cells were grown overnight on agar plates supplemented with the 
appropriate antibiotic (tetracycline for pRW50 and pRW224, ampicillin for pSR) and a 
minimum of 3 colonies then used to inoculate separate overnight cultures. Plasmids were 
recovered from overnight cultures and the region encompassing the EcoRI-HindIII fragment 
was amplified by PCR, the product of which was sequenced. 
2.11. Site-directed mutagenesis by megaprimer PCR 
Due to the size of pRW50, it was not possible to use site-directed mutagenesis techniques 
that rely on inverse PCR. Therefore, megaprimer PCR (Perrin and Gilliland, 1990) (see 
Figure 2.17) was used for all site-directed mutagenesis in this project. In the first round of 
PCR, a mutagenic primer and a flanking primer were used to generate a megaprimer. The 
megaprimer was purified by electroelution from a 7.5% polyacrylamide gel and then used in a 
second round of PCR with the opposing flanking primer. The PCR product was analysed on 
an agarose gel, purified, and then amplified in a final round of PCR with both flanking 
primers. The fragment was then digested with EcoRI and HindIII restriction enzymes and 
cloned into pRW50. Mutagenic primers used are given in Table 2.7 and fragments containing 
point mutations are included in Table 2.5 
2.12. Random mutagenesis by error prone PCR 
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Figure 2.17 Overview of megaprimer PCR 
A megaprimer carrying the required point mutation(s) was generated by PCR using plasmid 
pRW50 carrying the fragment of interest as a template. The megprimer was purified and used 
in a second round of PCR with the original template and a flanking primer. The product was 





Table 2.7 Mutagenic primers used in this study 
Code Name Sequence Use 





Used in PCR with D10527 to 
produce megaprimer for 
construction of hcp383-1n 
D69558 HCP-L GCGTAATAGCTCTCTGG
CGCTAGATCCCT 
Used in PCR with D10527 to 
produce megaprimer for 
construction of hcp383-101 
D69559 HCP-F CCAAAATCGCGCTAAA
TCGATCTCCCTTAAAGT 
Used in PCR with D10527 to 
produce megaprimer for 
construction of hcp383-102 
D63522 HCP P35V GAAAAATCCCTTRTATC
CCCGCGTTAAG 
Used in PCR with D10527 to 
produce megaprimer to mutate 
position -35 of the hcp promoter 
D63521 HCP P37V GAAAAATCCCVTTTATC
CCCGCGTTAAG 
Used in PCR with D10527 to 
produce megaprimer to mutate 
position -37 of the hcp promoter 
D61976 P13G OLIGO GCGTTAAGCGTCTTGAC
CTTAAACATGTATATTA
A 
Used in PCR with D10527 to 
produce megaprimer to mutate 
position -13 of of the hcp 
promoter 
D63520 HCP P14V GCGTTAAGCGTCTVAA
CCTTAAACATGTATATT
AA 
Used in PCR with D10527 to 
produce megaprimer to mutate 
position -14 of of the hcp 
promoter 
D63519 HCP P9V GCGTTAAGCGTCTTAAC
CVTAAACATGTATATTA
A 
Used in PCR with D10527 to 
produce megaprimer to mutate 
position -9 of of the hcp promoter 




Used in PCR with D10527 to 
produce megaprimer for 






Used in PCR with D10527 to 
produce megaprimer for 





conditions. Taq polymerase is not a proof-reading enzyme and reaction conditions can be 
altered to decrease fidelity. Mutagenic reactions were prepared with 5 µl of each primer (10 
pM / µl stock), 10 µl template (plasmid miniprep diluted 1:250), 2 µl dNTP stock (containing 
5 mM each dNTP), 5 µl 10 X Taq buffer, 5 µl of 50 nM MgCl2 and 17 µl sterile distilled 
water and 1 µl BioTaq polymerase (Bioline). Reactions using the same cycling protocol as 
standard PCR (see Table 2.3). For error prone PCR, the primers flanked the region to be 
mutagenised (D10520 and D10527) and the products were cut with EcoRI and HindIII and 
cloned into pRW50 upstream of lacZ. Plasmids were then transformed into JCB387, which 
were plated onto MacConkey-lactose to allow visual identification of colonies containing 
plasmids with impaired promoters. 
2.13. Construction of pDLC plasmids 
2.13.1. Construction of pJW15 Δ100 derived plasmids pDLC1, pDLC2, pDLC6, 
pDLC8 and pDLC9 
To express either NarL or NarP from a plasmid, the coding sequence was cloned into 
pJW15 Δ100 (see Figure 2.3) downstream of the melR promoter such that expression of narL 
or narP is driven by the melR promoter. Vector was prepared by digesting pJW15 Δ100 with 
NsiI and HindIII restriction enzymes to remove the melR coding region. The vector was 
treated with alkaline phosphatase and then purified by phenol-chloroform treatment and 
ethanol precipitation. DNA fragments encoding the NarL or NarP CTDs or full length 
proteins (see Table 2.8) were amplified from the chromosome of JCB387 using primers given 
in Table 2.9. To create an NsiI site in the fragment that contained full-length narL, the second 
codon of narL was mutated to CAT (See Figure 2.6, Panel B). For fragments encoding only 
the CTD, the NsiI site was simply appended upstream of the coding region. PCR products 
were then digested with NsiI and HindIII restriction enzymes and purified by phenol-
chloroform treatment and ethanol precipitation. NsiI-HindIII fragments were ligated into 
prepared pJW15 Δ100 vector and transformed into competent JCB3884 cells. 
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Table 2.8 Fragments carrying narL or narP 
Name Description Source 
NarL-CTD NsiI–HindIII fragment encoding the NarL CTD from amino 
acid 147 
This study 
NarL-Full NsiI-HindIII fragment encoding NarL This study 
NarXL BamHI-EcoRI fragment containing the narXL operon and 226 
bp upstream of the translation start 
This study 
NarP-CTD146 NsiI–HindIII fragment encoding the NarP CTD from amino 
acid 146 
This study 
NarP-CTD138 NsiI–HindIII fragment encoding the NarP CTD from amino 
acid 138 
This study 
NarP-CTD148 NsiI–HindIII fragment encoding the NarP CTD from amino 
acid 148 
This study 
NarPop BamHI-EcoRI fragment containing the narp gene and 327 bp 





Table 2.9 Primers used to amplify narL or narP 
Code Name Sequence Use 
D5431  ACCTGACGTCTAAGAAA
CC 
Primer upstream of the 
EcoRI site in JW15 Δ100 
D66640 NARL CTD R CCAAGCTTTCAGAAAAT
GCGCTCCTGATGCACCC
A 
Anneals to 3′ terminal end 
of narL gene and includes 
a HindIII site 
D66639 NARL CTD F CCATGCATGCCACTACT
GAGCGCGATGTTAACCA 
Used with D66640 to 
construct NarL-CTD 
fragment 
D67900 NARL FULL F CCAATGCATAGTAATCA
GGAACCGGCTACTATCC
T 
Used with D66640 to 
construct NarL-Full 
fragment 





Anneals to 3′ terminal end 
of narL gene and includes 





Used with D70418 to 
construct the NarXL 
fragment 
D66642 NARP CTD R CCAAGCTTTTATTGTGCC
CCGCGTTGTTGCAGG 
Anneals to 3′ terminal end 
of narP gene and includes 
a HindIII site 
D70662 NARP CTD F NSII AATATGCATGGCGCGGA
AGAAGATCCCTTCAGCG 
Used with D66642 to 
construct NarL-CTD146 
fragment 
D71499 NARP CTD 138 AATATGCATTTACGTGA
ACGTGAAATGTTTGGC 
Used with D66642 to 
construct NarL-CTD138 
fragment 
D71500 NARP CTD 148 AATATGCATGAAGATCC
CTTCAGCGTGCTGAC 
Used with D66642 to 
construct NarL-CTD148 
fragment 




Anneals to 3′ terminal end 
of narP gene and includes 
an EcoRI site 
D71497 NarP operon full F ATGGATCCTGATGCATT
G AGC TTT CAT CCT AT 
Used with D70607 to 






2.13.2. Transfer of fragments from pJW15 Δ100 to pLG339 – construction of 
pDLC3 and pDLC4 
The fragments carrying DNA encoding the NarL CTD and full length NarL (see Table 2.8) 
were transferred to pLG339  so that comparisons could be made with the narXL operon 
expressed from pLG339 (see below). Vector was prepared by digestion of pLG339 with 
BamHI and EcoRI restriction enzymes (see Figure 2.4). The cut vector was treated with 
alkaline phosphatase and then purified by phenol-chloroform treatment and ethanol 
precipitation. The D5431 primer (see Table 2.9 ), which anneals upstream of the EcoRI site in 
pJW15 Δ100 was used with either the D70418 or D70607 primer that replaces the HindIII site 
at the 3′ end of fragments with an EcoRI site. Resulting PCR products were cut with BamHI 
and EcoRI restriction enzymes, purified by agarose gel electrophoresis, and ligated into 
prepared pLG339 vector (See Figure 2.7 and 2.8). Plasmids were transformed into JCB387 
cells, which were grown overnight. Transformants were selected and plasmids recovered for 
sequencing. 
2.13.3. Cloning of the narXL operon and the narP gene into pLG339 – 
Construction of pDLC5 and pDLC14 
The narXL operon and narP gene were cloned with their regulatory regions into pLG339. 
Vector was prepared by digesting pLG339 with BamHI and EcoRI restriction enzymes. The 
cut vector was treated with alkaline phosphatase and was purified by treatment with phenol-
chloroform and ethanol precipitation. The narXL operon and the narP gene were amplified 
from the chromosome of JCB387 using primers given in Table 2.9. The PCR products were 
digested with BamHI and EcoRI restriction enzymes, purified by agarose gel electrophoresis, 
and ligated into prepared pLG339 (see Figure 2.9 and 2.13). Plasmids were transformed into 





2.14. β-Galactosidase assays 
2.14.1. Preparation of cells for assays 
Plasmids carrying the promoter::lacZ fusions of interest were transformed into competent 
cells that possessed the desired genetic background. Transformants were plated onto 
MacConkey-lactose plates supplemented with relevant antibiotics and grown at 37°C 
overnight. Between 1 and 3 colonies were picked from each plate and used to inoculate 
separate overnight cultures. 
2.14.2. Standard assays 
β-Galactosidase assays were used to measure the activity of promoter::lacZ fusions. 
Unless stated otherwise, cells were assayed following growth to an OD650 of 0.5-0.6 in 
minimal salts medium with 10% LB, 0.4% glycerol and 40 mM sodium fumarate. If the 
aerobic activity of the promoter::lacZ fusion was to be assayed, a 25 ml conical flask was 
prepared with 5 ml of minimal medium as described above. Aerobic flasks were pre-warmed 
to 37°C and inoculated with 50 µl of overnight culture. Aerobic flasks were grown at 37°C 
with 250 rpm shaking. If the anaerobic activity of a promoter was to be assayed, a 16 cm 
growth tube was prepared with 10 ml of minimal salt medium as described above. Tubes were 
pre-warmed to 37°C and inoculated with 400 µl of overnight cultures. Tubes were placed in 
racks and grown at 37°C in an oven.  
Once cultures reached an OD650 between 0.5 and 0.6, growth tubes and flasks were placed 
on ice to slow cell growth. To lyse aerobically grown cells, 30 µl of 1% sodium deoxycholate 
solution and 30 µl of toluene were added to each flask, and flasks were vigorously mixed. To 
lyse anaerobically grown cells, 2 ml of culture was transferred to a fresh tube and 30 µl of 1% 
sodium deoxycholate solution and 30 µl of toluene added to each tube, which was vigorously 
mixed. Toluene was evaporated by incubating growth tubes and flasks (without caps or bungs 
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respectively) at 37°C with 100 rpm shaking for 30 minutes. Tubes and flasks were then 
returned to ice. 
Assay tubes were prepared with 2 ml of Z buffer and pre-warmed to 37°C. Growth vessels 
containing lysate were mixed thoroughly and 100 µl of the relevant lysate was added to each 
assay tube. To start the reaction, 500 µl of 13 mM ONPG solution was added to an assay tube, 
which was briefly mixed and placed in a 37°C water bath. The time until a yellow colour 
developed was measured and the reaction stopped by the addition of 1 ml of 1 M sodium 
carbonate solution. The OD420 of each sample was then measured. In the case of highly active 
promoters, the time until a yellow colour developed was less 1 minute. Thus, lysates from 
cells containing highly expressed promoter::lacZ fusions were diluted 2-fold with Z-buffer 
prior to being assayed. 
β-Galactosidase activity was calculated as nanomols of ONPG hydrolysed per minute per 
milligram of bacterial mass using the equation given below : 
                                           1000 x 2.5 x 3.6 x OD420nm 
               β-gal activity =                                          
                        OD650nm x 4.5 x t x v                                            
                                             
Where: 
 
2.5 = factor for conversion of OD650 into bacterial mass, based on OD650 of 1 being equivalent  
to 0.4 mg/ml bacteria (dry weight).  
 
3.6 = final assay volume (ml) 
 
1000/4.5 = factor for conversion of OD420 into nmol o-nitrophenyl (ONP), based on 1 nmol  
ml
-1 
ONPG having an OD420 of  0.0045 
 
t = incubation time (min) 
 
v = volume of lysate added (in ml)    
 




2.14.3. Time course β-galactosidase assays following induction by nitrate 
A time course assay was used to assay promoter activity following nitrate induction. Cells 
were prepared as in Section 2.14.1. 100 ml Duran bottles were prepared with 40 ml of 
minimal salts medium as described in Section 2.14.2. The bottles were pre-warmed in a 37 °C 
water bath without shaking. Growth medium was inoculated with 1.8 ml of overnight culture 
and mixed gently by pipetting, with care taken to not introduce bubbles. Cells were grown to 
an OD650 of ~0.4 and then the 0 time point taken by removal of 3 ml of culture to a separate 
tube. The OD650 of the sample was taken and the remainder of the sample placed on ice. The 
culture was then supplemented with 0.8 ml of a 1 M sodium nitrate solution or water (control 
flask) and a timer started. At the desired time points, 3 ml of culture was removed to a 
separate tube, the OD650 of the sample measured, and the sample tube placed on ice.  
Once samples for all time points had been extracted the cells were lysed and β-
galctosidase activity measured as in Section 2.14.2. 
2.15. Electro mobility shift assays (EMSAs) 
2.15.1. Preparation of DNA fragments for use in EMSAs 
EcoRI-HindIII promoter fragments to be analysed by EMSA were cloned into pSR and 
transformed into JCB387 cells. Plasmids were recovered as and digested with EcoRI and 
HindIII restriction enzymes. Fragments were dephosphorylated with alkaline phosphatase and 
purified by polyacrylamide gel electrophoresis. DNA fragments were end-labelled with [γ
 32
P] 
on 5′ terminal hydroxyl groups using T4 polynucleotide kinase (New England Biolabs). 5-17 
µl DNA was mixed with 1 µl T4 polynucleotide kinase and 1 µl [γ
 32
P]-ATP in a final volume 
of 20 µl T4 polynucleotide kinase buffer, and incubated for 30 min at 37°C. Unincorporated 
[γ
 32
P]-ATP was removed by passing the sample through a Sephadex G-50 column. Columns 
were prepared by pipetting 400 µl 50% Sephadex G50 suspension into a Bio-Spin column 
(Biorad) and centrifuging for 2 minutes at 3500 rpm. The flow through was discarded and the 
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sample loaded onto the packed Sephadex in the column. The column was placed in a fresh 
tube and centrifuged for 2 minutes at 3500 rpm. The column was then discarded.  
2.15.2. EMSA analysis of NarL binding to promoter fragments 
Purified NarL protein was supplied by Dr Douglas Browning, University of Birmingham. 
NarL protein was diluted to the required concentrations in buffer B1. A micro-centrifuge tube 
was prepared containing 1 µl radiolabelled fragment, 1 µl FNR binding buffer, 1 µl 50% 
glycerol, 0.5 µl BSA, 0.5 µl herring sperm DNA, 1 µl acetyl phosphate and 4 µl sterile 
distilled water. Acetyl phosphate was included as a phosphate donor for NarL. 1 µl of NarL 
protein was added and samples were incubated at 37°C for 20 minutes and then loaded onto a 
6% polyacrylamide gel. Gels were run in 0.5X TBE buffer at 160V for ~90 minutes and then 
soaked in fixing solution for ~30 minutes. Gels were dried and analysed as described in 
Section 2.9.4. 
2.15.3. EMSA analysis of FNR binding to promoter fragments 
Purified FNR-Ala154 protein was supplied by Dr Douglas Browning, University of 
Birmingham. FNR protein was diluted to the required concentrations in HEPES buffer. A 
micro-centrifuge tube was prepared containing 1 µl radiolabelled fragment, 1 µl FNR binding 
buffer, 1 µl 50% glycerol, 0.5 µl BSA, 0.5 µl herring sperm DNA and 5 µl sterile distilled 
water. 1 µl of FNR was added and samples were incubated at 37°C for 20 minutes and then 
loaded onto a 6% polyacrylamide gel. Gels were run in 0.5X TBE buffer at 160V for ~90 
minutes and then soaked in fixing solution for ~30 minutes. Gels were dried and analysed as 
described in Section 2.9.4. 
2.15.4. Preparation of lysate for bandshifts 
It was necessary to use whole cell lysates as a source of NsrR because NsrR is difficult to 
purify. To eliminate other factors known to bind to the hcp promoter region from binding, 
JCB38849S ΔnsrR cells were used. Competent cells were transformed either with pBST-Blue 
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1 (control) or pGIT9, which is pBR322 containing nsrR, and transformants used to inoculated 
overnight cultures. Two conical flasks were prepared with 50 ml of 2X LB and inoculated 
with 0.5 ml of overnight culture of the cells containing either pBST-Blue 1 or pGIT9. 
Cultures were grown to an OD650 of 0.5-0.7 and placed on ice for 10 minutes. Cells were 
sedimented in a centrifuge at 4 °C and 4000 rpm for 10 minutes and re-suspended in 4 ml 
wash buffer. Cells were re-sedimented in a centrifuge at 4 °C and 4000 rpm for 10 minutes 
and re-suspended in 2 ml wash buffer. Cells were lysed by sonication and cell debris removed 
by centrifugation for 30 minutes at 13,000 rpm. Lysates were stored at 4°C before use, 
although not for longer than 48 hours. The protein concentration of lysate was quantified by 
Biorad Protein Assay (Biorad).  
2.15.5. EMSA analysis of whole cell lysate with promoter fragments 
Cell lysate was prepared as described above and diluted to the desired concentrations in 
wash buffer. For each sample and concentration, a microfuge tube was prepared with 1µl 
radiolabelled DNA, 1 µl FNR binding buffer, 1 µl glycerol, 0.5 µl herring sperm DNA, 3 µl 
cell lysate, 0.5 µl BSA and 3 µl of sterile distilled water. Samples were incubated at 37 °C for 
20 minutes and then loaded onto a 6% polyacrylamide gel. Gels were run in 0.5X TBE buffer 
at 160V for ~90 minutes and then soaked in fixing solution for ~30 minutes. Gels were dried 
and analysed as described in Section 2.9.4. 
2.16. DNase I protection assays – ‘footprinting’ 
2.16.1. Preparation of radiolabelled DNA fragments for footprinting 
Fragments to be analysed by footprinting were cloned into pSR. A maxiprep of pSR 
carrying the fragment of interest was prepared as described in Section 2.7.7. and 100 µl 
aliquots were digested by 8 µl HindIII restriction enzyme in a total volume of 120 µl. The 
restriction products were treated with alkaline phosphatase to remove terminal phosphates and 
purified by phenol-chloroform treatment and ethanol precipitation. The DNA was then 
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digested with 8 µl AatI restriction enzyme in a total volume of 80 µl. AatI-HindIII fragments 
were then purified on a polyacrylamide gel followed by phenol-chloroform treatment and 
ethanol precipitation. Fragments were then radiolabelled with [γ-
32
P] on the HindIII end using 
T4 polynucleotide kinase as described in Section 2.15.1)  
2.16.2. Preparation of GA ladder 
A GA ladder is a fragment cleaved at G and A nucleotides and allows calibration of a gel 
to aid determining the position of protein binding. Preparation of the ladder is done according 
to method of Maxam and Gilbert (1980). DNA was prepared for cleavage by depurination by 
formic acid. 4 µl of radiolabelled DNA was diluted to a final volume of 12 µl with sterile 
distilled water and 50 µl of formic acid was mixed with the sample. The sample was 
incubated for 150 seconds at room temperature and the reaction stopped by the addition of 
200 µl 0.3 M sodium acetate (pH 7) and 700 µl of ice-cold ethanol. The DNA was then 
precipitated as described in Section 2.7.2.The DNA pellet was re-suspended in 100 µl of a 1 
M piperidine solution and incubated at 90°C for 30 minutes, during which time piperidine 
cleaves the bases modified by formic acid treatment. The DNA was then precipitated as 
described in Section 2.7.2 and the pellet was re-suspended in 20 µl of loading buffer for use in 
gel calibration. 
2.16.3. DNase I footprinting with FNR protein 
DNase I footprinting was used to determine the position on the hcp promoter fragment 
that FNR binds to. FNR protein stock (provided by Douglas Browning of the University of 
Birmingham) was diluted to the concentrations required in HEPES dilution buffer. Each 
reaction contained 1 µl radiolabelled AatI-HindIII fragment, 2 µl HEPES-Glutamate buffer, 1 
µl BSA, 1 µl herring sperm DNA, 1 µl FNR protein and 14 µl sterile distilled water. Samples 
were incubated at 37°C for 20 minutes to allow FNR to bind the fragment. 3 µl of a 1:1000 
dilution of DNase I (10 U/µl, Roche Applied Science) in sterile water was added to each 
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reaction to digest the DNA. Samples were incubated for ~90 seconds and the reaction was 
stopped by the addition of 200 µl DNase I stop solution. Samples were then purified by 
treatment with phenol-chloroform and ethanol precipitation and analysed by polyacrylamide 
sequencing gel as described in Section 2.6.3 
2.16.4. DNase I footprinting with NarL protein 
DNase I footprinting was used to determine the position on the hcp promoter fragment 
that NarL binds to. NarL protein stock (provided by Douglas Browning of the University of 
Birmingham) was incubated with acetyl phosphate to ensure phosphorylation of the protein. 
The phosphorylation reaction contained 3 µl of NarL stock, 2.7 µl HEPES-glutamate buffer 
and 0.3 µl of a 500 nM acetyl phosphate solution. The phosphorylation reaction was 
incubated at 37°C for 20 minutes and then diluted with buffer B1 to the concentrations 
required for DNase I footprinting. Each reaction contained 1 µl radiolabelled AatI-HindIII 
fragment, 2 µl HEPES-Glutamate buffer, 1 µl BSA, 1 µl herring sperm DNA, 1 µl NarL 
protein and 14 µl sterile distilled water. Samples were incubated at 37°C for 20 minutes to 
allow NarL to bind the fragment. 3 µl of a 1:1000 dilution of DNase I (10 U/µl, Roche 
Applied Science) in sterile water was added to each reaction to digest the DNA. Samples were 
incubated for ~90 seconds and the reaction was stopped by the addition of 200 µl DNase I 
stop solution. Samples were then purified by treatment with phenol-chloroform and ethanol 
precipitation and analysed by polyacrylamide sequencing gel as described in Section 2.6.3 
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Transcription regulation in response to nitrate or nitrite often involves the integration of 
multiple signals at promoters, making it difficult to deduce an accurate picture of regulation 
from data obtained by genomics experiments. Therefore single promoter studies are often 
necessary to understand and uncover the mechanisms of regulation by multiple factors. 
Regulation of the hcp gene is of particular interest as the function of the gene product, 
HCP, is currently unknown, but the hcp promoter has been shown to be highly active when 
fully induced (Filenko et al., 2005). This suggests that the function of HCP is important and 
greater understanding of the regulation of hcp expression could help to ascertain that function. 
The hcp promoter has been studied previously and has been shown to be activated in response 
to anaerobiosis and by the presence of nitrate and nitrite (Filenko et al., 2005). Filenko and 
colleagues also demonstrated that NarL and NarP are necessary for nitrate and nitrite 
induction of hcp expression. A later study reported binding of purified FNR and NarL 
proteins to the hcp promoter region in vitro and identified NsrR as a repressor of hcp 
expression (Filenko et al., 2007). In this work, the regulation of hcp transcription has been 
studied using in vivo and in vitro methods. 
3.2. Deletion analysis of the hcp regulatory region 
The starting fragment for this work was hcp383-0 (see Figure 3.1), a 383 bp fragment that 
contains the entire intergenic region between hcp and the upstream gene ybjE. The fragment 
contains the base sequence from position -285 to +98 relative to the σ
70
-dependent hcp 
transcript start, which was previously identified using 5′ RACE by Filenko et al. (2005). The 
DNA from position -285 to -113 encodes the terminal portion of ybjE but does not include the 
reported σ
24
 dependent hcp promoter (Rhodius et al., 2006). Filenko et al. (2005, 2007) also 
proposed transcription factor binding sites in the hcp regulatory region based on similarities to 













Figure 3.1: The DNA sequence of the hcp383-0 promoter fragment 
Numbered positions are given relative to the hcp transcript start that was identified using 5′ 
RACE by Filenko et al. (2005) and is shown as an underlined, emboldened „T‟ and a „+1‟ 
above the sequence. The emboldened sequence from position -115 denotes the stop codon for 
ybjE. Predicted DNA sites for NarL, FNR and NsrR are underlined and marked with coloured 
arrows underneath the sequence and are aligned with the appropriate consensus binding 
sequence (in bold). Fasta standard ambiguity codes are used: a Y denotes C or T; an M 
denotes A or C; a K denotes G or T; an R denotes A or G and an N denotes any base. The 
centre of the site is given in brackets beneath the arrows. A coordinate finishing in „.5′ 
denotes that the centre of the site falls between two bases. The -10 and -35 elements identified 
in this study are underlined and labelled, as is the published start codon. The starting points of 
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codon is a predicted DNA site for NarL/P, a 7-2-7 inverted repeat centred at position -104.5. 
There is a predicted DNA site for FNR centred at position -72.5 and a predicted DNA site for 
NsrR centred at position +6. The start codon for hcp is located at position +32.  
To study the roles of the predicted transcription factor binding sites upstream of the hcp 
transcript start, a nested series of truncated promoter fragments, derived from the hcp383-0 
fragment, was used (see Figure 3.1). The hcp383-1 fragment carries a deletion of bases that 
encode the terminal portion of ybjE; the hcp383-2 fragment carries a longer deletion that 
includes the DNA site for NarL centred at position -104.5, and the hcp383-3 fragment carries 
a longer deletion that includes the DNA site for FNR centred at position -72.5. Each of the 
fragments was cloned into pRW50 and expression of the resulting promoter::lacZ fusions was 
measured in JCB387 cells grown either aerobically or anaerobically, with or without nitrate or 
nitrite supplements. 
Results illustrated in Figure 3.2 show that expression of the hcp383-0::lacZ fusion is 
induced by anaerobiosis (when FNR is active), further induction is observed with nitrate 
(when NarL is thought to be most active) but, in agreement with Filenko et al (2005),  
maximal activity is found when the cells are grown in the presence of nitrite. Similar patterns 
of expression were observed with the hcp383-1::lacZ fusion, demonstrating that sequence 
upstream of position -125 plays no role in the regulation of hcp promoter activity under the 
conditions tested.  
Results also show that the removal of the DNA site for NarL/P in the hcp383-2 fragment 
prevents induction by nitrate whilst not affecting induction due to nitrite. This suggests that 
NarL is directly responsible for at least some nitrate dependent activation of the hcp promoter. 
In contrast, NarL binding to the DNA site for NarL at position -104.5 is not essential for 




Figure 3.2: Effects of deletions on the activity of the hcp promoter 
Expression from the full-length hcp383-0 fragment and truncated fragments, cloned as 
promoter::lacZ fusions in pRW50, was measured in E. coli strain JCB387 during exponential 
growth (OD650 = 0.5-0.6) in minimal salt medium. Cells were grown aerobically, 
anaerobically, anaerobically with medium supplemented with 20 mM sodium nitrate or 
anaerobically with medium supplemented with 2.5 mM sodium nitrite. Data shown are 





























Finally, removal of the DNA site for FNR in the hcp383-3 fragment prevents all induction 
of the hcp promoter and measured levels of -Galactosidase were similar in all conditions 
tested. This corroborates the hypothesis that FNR binding to the proposed target site at 
position -72.5 induces transcription initiation at the hcp promoter. 
3.3. Predicted DNA sites for NarL and FNR are important in vivo 
To ensure that the effects of truncation on hcp promoter activity (illustrated in Figure 3.2) 
are due to the removal of the intended DNA site and not due to removal of other features, 
point mutations were introduced into the predicted DNA sites.  
To confirm the importance of the DNA site for NarL in vivo, a derivative of the hcp383-1 
fragment, hcp383-101, was constructed with mutations in the DNA site for NarL (see Figure 
3.3, panel A). To confirm the importance of the DNA site for FNR in vivo, a second 
derivative of the hcp383-1 fragment, hcp383-102, was constructed with mutations in the DNA 
site for FNR (see Figure 3.3, panel B). The resulting fragments were cloned into pRW50 and 
expression of the resulting lacZ fusions was measured in JCB387 cells.  
Results illustrated in Figure 3.3, panel C, show that the hcp383-1::lacZ fusion is induced 
by nitrate and is optimally induced by nitrite. The hcp383-101::lacZ fusion, which has 
mutations in the DNA site for NarL, shows an identical pattern of expression to that of the 
hcp383-2::lacZ fusion, in which DNA including the proposed NarL site is deleted. Hence, 
mutation of the DNA site for NarL prevents induction by nitrate, but does not affect induction 
by nitrite. The hcp383-102::lacZ fusion, which has mutations in the DNA site for FNR, shows 
an identical pattern of expression to that of the hcp383-3::lacZ fusion, in which DNA 
including the proposed site for FNR is deleted. Hence, mutation of the DNA site for FNR 
prevents all induction. These results indicate that the proposed DNA sites for NarL and FNR 

















Figure 3.3: Effect of mutations in DNA sites for NarL and FNR on expression from the 
hcp promoter 
Panel A shows a partial sequence of the hcp promoter fragment hcp383-1 that contains the 
DNA site for NarL, and a derivative carrying mutations in the site, hcp383-101. Mutations are 
highlighted in yellow. The DNA site for NarL is indicated by arrows above the sequence and 
the consensus sequence for a DNA site for NarL is given in bold above the sequence. 
Panel B shows a partial sequence of the hcp promoter fragment hcp383-1 that contains the 
DNA site for FNR, and a derivative carrying mutations in the site, hcp383-102. Mutations are 
highlighted in yellow. The DNA site for FNR is indicated by arrows above the sequence and 
the consensus sequence for a DNA site for FNR is given in bold above the sequence. 
Panel C shows expression of hcp383-1::lacZ, hcp383-101::lacZ and hcp383-102::lacZ fusions 
measured in JCB387 cells grown to mid exponential phase (OD650 0.5-0.7) in minimal salt 
medium. Cells were grown anaerobically, anaerobically with medium supplemented with 20 
mM sodium nitrate or anaerobically with medium supplemented with 2.5 mM sodium nitrite. 
Data shown are averages of at 3 biological repeats and error bars show one standard deviation 





























3.4. FNR is an important activator of the hcp promoter 
To investigate further the role of FNR in regulation of hcp promoter activity, the 
expression of the hcpc383-0::lacZ fusion was measured in JCB387 Δfnr cells. Results 
illustrated in Figure 3.4 show that in Δfnr cells, minimal induction of the hcp promoter is 
observed and expression of the fusion remains at the level of cells grown aerobically. This 
confirms that FNR is the major activator of hcp expression. 
3.5. FNR binds in vitro to the DNA site at position -72.5 in the hcp promoter 
Filenko et. al. (2005) predicted a single site DNA site for FNR at position -72.5 at the hcp 
promoter and promoter truncations/mutations support this hypothesis. Purified Ala154-FNR 
protein and 
32
P labelled hcp383-0 fragment was used in an EMSA experiment to confirm that 
FNR binds to the hcp regulatory region. Results in Figure 3.5, panel A, show a single shift at 
the lowest concentration of FNR protein used (0.5 μM) and a supershift when 2 μM or higher 
concentrations of FNR are used. This agrees with that observed by Filenko et. al. (2007) and 
suggests that FNR has a high affinity for its site at the hcp promoter. DNase I footprinting was 
used to map the region to which FNR binds on the hcp383-0 fragment. Results in Figure 3.5, 
panel B, show a single zone of protection that corresponds to the DNA site for FNR predicted 
by Filenko et al. (2005). 
Taken with the in vivo evidence, the in vitro evidence strongly supports the hypothesis 
that FNR is necessary for the activation of the hcp promoter, and that it does so by acting 
from the DNA site centred at position -72.5 on the hcp promoter. 
3.6. NsrR represses hcp promoter activity 
Filenko et al. (2007) showed that NsrR represses hcp promoter activity. To investigate this 
repression, the activity of the hcp promoter carried by each of the promoter fragments 





Figure 3.4: FNR is required for activation of the hcp promoter 
Expression of the hcp383-0::lacZ fusion, cloned in pRW50 and measured in JCB387 cells or 
JCB387 Δfnr cells. Cells were grown to mid exponential phase (OD650 0.5-0.7) in minimal 
salt medium either anaerobically, anaerobically with medium supplemented with 20 mM 
sodium nitrate or anaerobically with medium supplemented with 2.5 mM sodium nitrite. Data 
shown are averages from 3 biological replicates and error bars show one standard deviation 








































Figure 3.5: Binding of FNR to the hcp regulatory region 
Panel A shows the results of an electrophoretic mobility shift assay using the end-labelled 
hcp383-0 promoter fragment, incubated with increasing concentrations of FNR. The 
concentrations of FNR used were: lane 1, no protein; lane 2, 0.5 μM; lane 3, 1.0 μM; lane 4, 
2.0 μM; lane 5, 4.0 μM 
Panel B shows a DNase I footprint of purified FNR binding at the hcp promoter. End-labelled 
hcp383-1 AatII-HindIII fragment was incubated with increasing concentrations of Ala154 
FNR and subjected to DNase I footprint analysis. The concentration of FNR was: lane 1, no 
protein; lane 2, 0.5 μM; lane 3, 1.0 μM; lane 4, 2.0 μM; lane 5, 4.0 μM. The gel was 
calibrated using a Maxam-Gilbert „G+A‟ sequencing reaction (Lane GA) and relevant 
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Results illustrated in Figure 3.6 show that hcp promoter activity (as measured with the 
hcp383-0 and hcp383-1 fragments) is higher in ΔnsrR cells than in JCB387 cells during 
anaerobic growth. The promoter appears to be almost fully induced in the ΔnsrR background 
and there is little further induction by nitrite, although activity is reduced by the presence of 
nitrate. These results confirm that NsrR represses the hcp promoter.     
 Results illustrated in Figure 3.6 also show that removal of the DNA site for NarL in the 
hcp383-2 fragment has no effect on hcp promoter activity in ΔnsrR cells and that removal of 
the DNA site for FNR in the hcp383-3 fragment prevents all induction of hcp promoter 
activity.  Taken together, the results in Figure 3.2 and Figure 3.6 indicate that the hcp 
promoter is activated by FNR in response to anaerobiosis by acting from its DNA site centred 
at position -72.5 and that NsrR is a major regulator of hcp promoter activity whilst NarL 
appears to play a minor role by mediating a small level of induction in response to nitrate in 
cells that contain NsrR. 
3.7. The proposed DNA site for NsrR is important in vivo 
An in vivo effect of NsrR on hcp promoter activity has been demonstrated using cells that 
were deficient in NsrR by Filenko et al. (2007) and by results illustrated in Figure 3.6. To 
confirm the importance of the proposed DNA site for NsrR in vivo, a derivative of the 
hcp383-1 fragment, hcp383-1n, was constructed with mutations in the site. The mutations 
were designed to change positions identified as highly conserved in DNA site for NsrR 
(Rodionov et al., 2005) but to not affect positions in the immediate vicinity of the 
transcription start site for hcp (see Figure 3.7, panel A).  
The hcp383-1n fragment was cloned into pRW50 and the activities of the hcp383-1::lacZ 
fusion and the hcp383-1n::lacZ fusion were measured in JCB387 cells. The results illustrated 
in Figure 3.7, panel B, show that the hcp383-1n::lacZ fusion is more highly expressed than 




Figure 3.6: Activity of truncated hcp promoter fragments in ΔnsrR cells 
Expression from the full-length hcp383-0 fragment and truncated fragments, cloned as 
promoter::lacZ fusions in pRW50, was measured in a ΔnsrR derivative of the E. coli strain 
JCB387 during exponential growth (OD650 = 0.5-0.7). Cells were grown in minimal salt 
medium aerobically, anaerobically, anaerobically with medium supplemented with 20 mM 
sodium nitrate or anaerobically with medium supplemented with 2.5 mM sodium nitrite. Data 
shown are averages from at least 3 biological repeats, and error bars show one standard 



































Figure 3.7: Effects of mutations in the predicted NsrR site on hcp promoter activity 
Panel A shows a partial sequence of the hcp promoter fragment hcp383-1 that contains the 
DNA site for NsrR, and a derivative carrying mutations in the site, hcp383-1n. Mutations are 
highlighted in yellow. The DNA site for NsrR is indicated by arrows above the sequence and 
the consensus sequence for a DNA site for NsrR is given in bold above the sequence.  
 
Panel B shows expression of the hcp383-1::lacZ and hcp383-1n::lacZ fusions cloned in 
pRW50 and measured in JCB387 cells. Cells were grown to mid exponential phase (OD650 
0.5-0.7) in minimal salt medium aerobically, anaerobically, anaerobically with medium 
supplemented with 20 mM sodium nitrate or anaerobically with medium supplemented with 
2.5 mM sodium nitrite. Data shown are means of 3 biological repeats and error bars show one 
standard deviation from the mean.  
 
Panel C shows expression of the hcp383-1::lacZ and hcp383-1n::lacZ fusions cloned in 
pRW50 and measured in a ΔnsrR derivative of JCB387 cells. Cells were grown to mid-
exponential phase (OD650 0.5-0.7) in minimal salt medium aerobically, anaerobically, 
anaerobically with medium supplemented with 20 mM sodium nitrate or anaerobically with 
medium supplemented with 2.5 mM sodium nitrite. Data shown are means of 3 biological 





































































NsrR relieve repression. Activity of the hcp383-1n::lacZ fusion is induced by anaerobiosis 
and by nitrite but does not appear to be induced by nitrate.  
The expression of the hcp383-1:lacZ fusion and the hcp383-1n::lacZ fusion was also 
measured in JCB387 ΔnsrR cells. Results illustrated in Figure 3.7, panel C, show that no 
significant differences in expression between the two fusions are observed. Anaerobiosis 
induces expression of both fusions, whilst nitrate has no effect. Nitrite appears to repress 
activity of both fusions although this effect is less significant.  
3.8. NsrR binds in vitro to the predicted site at position +6 in the hcp 
promoter 
The E. coli NsrR protein is a highly oxygen-labile protein and as such is not available in a 
purified form for use in in vitro studies. Therefore, lysates derived from cells that express 
plasmid encoded NsrR were used as described by Browning et al. (2010). To increase the 
probability of a successful EMSA using whole cell lysate, it is necessary to minimize the 
binding of other factors to the DNA fragment, and so lysate was prepared from cells that are 
deficient in the nucleoid-associated protein IHF, NarL/P and NsrR. The hcp383-3 fragment 
was truncated downstream of the hcp transcript start to produce the hcp383-3s fragment and a 
derivative of the hcp383-3s fragment was constructed, hcp383-3ns, in which the DNA site for 
NsrR was mutated to prevent binding by NsrR. Both fragments were radiolabelled.  
Results illustrated in Figure 3.8 show that when lysate from cells that express NsrR is 
incubated with the hcp383-3s fragment, a single shift is observed at the lowest concentration 
of lysate tested (1.5 mg/ml), which indicates strong binding of NsrR to the fragment. As 
expected, the mutations in the DNA site for NsrR in the hcp383-3ns fragment greatly reduce 
NsrR binding. No lysate concentration-dependent shifts are observed when lysate from cells 
that do not express NsrR is incubated with either the hcp383-3s fragment or the hcp383-3ns 
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Figure 3.8: Effect of NsrR site mutations on binding of NsrR to the hcp promoter region 
The figure shows an autoradiogram from an EMSA with end labelled hcp383-3s fragment 
(lanes 1-5 and 11-15) or the derivative hcp383-3ns fragment with the +9G and +10G 
mutations that abrogate NsrR binding (lanes 6-10 and 16-19). Labelled fragments were 
incubated with increasing amounts of soluble cell extract from strain JCB38849S ΔnsrR 
carrying either pGIT9 which expresses NsrR (+NsrR; lanes 2-5 and 7-10), or empty vector 
pSTBlue-1 (-NsrR; lanes 12-15 and 17-19). The total amount of protein in the extract used in 
each reaction was: lanes 1, 6, 11 and 16, no protein; lanes 2, 7, 12 and 17, 1.5 µg; lanes 3, 8, 
13 and 18, 3 μg; lanes 4, 9, 14 and 19, 6 μg; lanes 5, 10 and 15, 9 μg. The location of the band 




that the engineered mutations at positions +9 and +10 do mostly, but not entirely, prevent 
NsrR from binding to the fragment. 
3.9. NarL is required for maximal activation of the hcp promoter 
Filenko et al. (2005) demonstrated that maximal activity of an hcp promoter::lacZ fusion 
requires NarL or NarP. This observation is apparently at odds with the results illustrated in 
Figure 3.2, which indicate that the DNA site for NarL at the hcp promoter is not required for 
maximal activity. To reinvestigate the effects of NarL and NarP on hcp promoter activity, the 
expression from the hcp383-1::lacZ fusion and the hcp383-2::lacZ fusion (in which the DNA 
site for NarL is deleted) was measured in cells that contained both NarL and NarP, NarL only, 
NarP only, or neither. 
Results illustrated in Figure 3.9, panel A, show that expression of promoter::lacZ fusions, 
measured in JCB387 cells, which contain both NarL and NarP, is very similar to that in 
results illustrated in Figure 3.2. Expression of the hcp383-1::lacZ fusion is maximally induced 
by nitrite but is also induced to a lesser extent by nitrate. Expression of the hcp383-2::lacZ 
fusion is also maximally induced by nitrite, but is not induced by nitrate. This indicates that 
the DNA site for NarL centred at position -104.5 is not required for maximal activation of the 
hcp promoter by nitrite but is required for the smaller nitrate-dependent induction.  
The results illustrated in Figure 3.9, panel B show the expression of the promoter::lacZ 
fusions measured in JCB3875 cells, which contain NarL but not NarP. Both fusions show a 
similar pattern of induction to that observed in JCB387 cells that express NarP. Thus, 
expression of the hcp383 1::lacZ fusion is induced by nitrate and is maximally induced by 
nitrite, whilst expression of the hcp383-2::lacZ fusion is not induced by nitrate but is 
maximally induced by nitrite. This demonstrates that NarP is not required for maximal 










Figure 3.9: Activity of the hcp promoter and a derivative lacking the DNA site for NarL 
Panel A shows expression of the hcp383-1::lacZ and hcp383-2::lacZ fusions cloned in 
pRW50 and measured in JCB387 cells. Cells were grown to mid exponential phase (OD650 
0.5-0.7) in minimal salt medium anaerobically, anaerobically with medium supplemented 
with 20 mM sodium nitrate or anaerobically with medium supplemented with 2.5 mM sodium 
nitrite. Data shown are means of 3 biological repeats and error bars show one standard 
deviation from the mean.  
 
Panel B shows expression of the hcp383-1::lacZ and hcp383-2::lacZ fusions cloned in 
pRW50 and measured in JCB3875 cells, which do not express NarP. Cells were grown to mid 
exponential phase (OD650 0.5-0.7) in minimal salt medium anaerobically, anaerobically with 
medium supplemented with 20 mM sodium nitrate or anaerobically with medium 
supplemented with 2.5 mM sodium nitrite. Data shown are means of 3 biological repeats and 























































The results illustrated in Figure 3.10, panel A, show expression of the promoter::lacZ 
fusions measured in JCB3883 cells, which contain NarP but not NarL. In JCB3883 cells, 
levels of nitrite dependent induction are lower than in cells that contain NarL, which indicates 
that NarL is required for maximal activity of the hcp promoter. There is no significant 
difference between the activities of the two fusions and this indicates that the DNA site for 
NarL at position -104.5 plays no role in the absence of NarL. 
The results illustrated in Figure 3.10, panel B, show expression of the promoter::lacZ 
fusions measured in JCB3884 cells, which lack both NarL and NarP. Both fusions show a 
similar pattern of expression to that observed in JCB3883 cells that express NarP but not 
NarL. Expression of both fusions is induced to similar levels by both nitrate and nitrite and 
the maximal induction seen in cells that contain NarL is not observed.  
These results, taken together, show that NarL is required for maximal activation of the hcp 
promoter and this activation is independent of the DNA site for NarL at position -104.5. 
Hence it is possible that NarL activates hcp expression indirectly. Recall that NsrR strongly 
represses hcp transcription and the hcp promoter is induced when reactive nitrogen species 
accumulate in the cell. Therefore, the indirect role of NarL in the induction of the hcp 
promoter may well be because NarL plays a role in the generation of reactive nitrogen 
species.  
To test this hypothesis, expression from the hcp383-1n::lacZ and hcp383-2n::lacZ fusions, 
which carry mutations in the DNA site for NsrR, was measured in JCB3884 cells that lack 
both NarL and NarP. Results illustrated in Figure 3.11 show that NarL is not required for 
maximal activation of the hcp promoter if the DNA site for NsrR at position +6 is mutated. As 
expected, removal of the DNA site for NarL has no significant effect on activity of the hcp 










Figure 3.10: Activity of the hcp promoter and a derivative lacking the DNA site for 
NarL in cells that do not contain NarL 
Panel A shows expression of the hcp383-1::lacZ and hcp383-2::lacZ fusions cloned in 
pRW50 and measured in JCB3883 cells, which do not express NarL. Cells were grown to mid 
exponential phase (OD650 0.5-0.7) in minimal salt medium anaerobically, anaerobically with 
medium supplemented with 20 mM sodium nitrate or anaerobically with medium 
supplemented with 2.5 mM sodium nitrite. Data shown are means of 3 biological repeats and 
error bars show one standard deviation from the mean.  
 
Panel B shows expression of the hcp383-1::lacZ and hcp383-2::lacZ fusions cloned in 
pRW50 and measured in JCB3884 cells, which do not express NarL or NarP. Cells were 
grown to mid exponential phase (OD650 0.5-0.7) in minimal salt medium anaerobically, 
anaerobically with medium supplemented with 20 mM sodium nitrate or anaerobically with 
medium supplemented with 2.5 mM sodium nitrite. Data shown are means of 3 biological 
























































Figure 3.11: Activity of derivatives of the hcp promoter with mutations in the NsrR site 
in cells that do not contain NarL or NarP 
Expression of the hcp383-1n::lacZ and hcp383-2n::lacZ fusions, which contain mutations in 
the DNA site for NsrR, cloned in pRW50 and measured in JCB3884 cells, which do not 
express NarL or NarP. Cells were grown to mid exponential phase (OD650 0.5-0.7) in minimal 
salt medium anaerobically, anaerobically with medium supplemented with 20 mM sodium 
nitrate or anaerobically with medium supplemented with 2.5 mM sodium nitrite. Data shown 
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3.10. NarL binds in vitro to the predicted site at position -104.5 in the hcp 
promoter 
Filenko et. al. (2005) predicted a single DNA site for NarL at position -104.5 and 
although promoter truncation and mutation experiments support this conclusion, the 
possibility remains that NarL might bind to other sites in the hcp promoter region. To 
investigate this possibility, in vitro protein binding of purified NarL to the hcp promoter 
region was studied. Initially, radiolabelled hcp383-0 fragment and purified NarL protein were 
analysed by EMSA and results in Figure 3.12 show 3 shifts with increasing concentrations of 
NarL protein which confirms that observed by Filenko et. al. (2007). In order to explore the 
possibility that NarL and FNR might act collaboratively in binding to the hcp promoter, 
radiolabelled hcp383-0 fragment, a concentration of purified FNR protein that is known to 
bind the hcp promoter and increasing concentrations of purified NarL protein were used in an 
EMSA. Results show that the NarL-concentration dependent shifts occur at the same 
concentrations of NarL regardless of whether FNR is present, indicating that FNR bound to 
the hcp promoter does not enable NarL to bind to the fragment at lower concentrations. 
The EMSA results do not preclude the existence of multiple DNA sites for NarL and so 
binding was examined with a DNase I protection assay. Results in Figure 3.13 show a single 
zone of protection that corresponds to the predicted site at position -104.5. It is therefore 
likely that the multiple shifts observed in the EMSA correspond to: initial occupation of a 
half-site by NarL (first shift); occupation of both half-sites by NarL (second shift); 
non-specific supershift (third shift). 
3.11. Random mutagenesis of the hcp promoter region  
To identify DNA elements in the hcp promoter that are necessary for its activity, random 
mutagenesis by error prone PCR was used. A reduced fragment was constructed, hcp383-1ns, 
to improve the efficiency of mutagenesis (Figure 3.14, panel A). The hcp383-1ns fragment, 




Figure 3.12: NarL and FNR bind to the hcp promoter fragment 
The figure shows the results of an electrophoretic mobility shift assay using the end-labelled 
hcp383-0 promoter fragment, incubated with increasing concentrations of NarL, with or 
without a fixed concentration of Ala154 FNR. The concentrations of NarL used were: lanes 1 
and 6, no protein; lanes 2 and 7, 0.4 μM; lanes 3 and 8, 0.8 μM; lanes 4 and 9, 1.6 μM; lanes 5 
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Figure 3.13: DNase I assay of NarL bound to the hcp promoter region 
The figure shows a footprint of purified NarL binding at the hcp promoter. End-labelled 
hcp383-0 AatII-HindIII fragment was incubated with increasing concentrations of NarL and 
subjected to DNase I footprint analysis. The concentration of NarL was: lane 1, no protein; 
lane 2, 0.4 μM; lane 3, 0.8 μM and lane 4, 1.6 μM. The gel was calibrated using a Maxam-
Gilbert „G+A‟ sequencing reaction and relevant positions are indicated. The location of the 
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for NsrR, was cloned into pRW50. Expression of the resulting lacZ fusion and the hcp383-
1n::lacZ fusion was measured in JCB387 cells. Results illustrated in Figure 3.14, panel B, 
show that the promoter carried by the hcp383-1ns fragment is active but displays reduced 
activity when compared to that carried by the hcp383-1n fragment. 
The hcp383-1ns fragment was mutated by error prone PCR and resulting fragments were 
cloned into pRW50. Plasmids were transformed into JCB387 cells and recovered on 
MacConkey-lactose plates to allow identification of Lac
-
 colonies. In an experiment 
performed together with a visiting project student, Gregory Farrant, over 500 transformants 
were screened and the plasmids of Lac
-
 colonies were isolated and the hcp promoter 
sequenced to determine mutations. The promoter activity was measured in JCB387 cells and 
results are shown in Figure 3.15. Seven mutations were identified as giving rise to Lac
-
 
phenotypes and the mutations can be considered as falling into 2 groups: those that did or did 
not contain at least one mutation in the DNA site for FNR. That most mutations producing a 
Lac
-
 phenotype contained at least one mutation in the DNA site for FNR demonstrates the 
importance of that site for activation of the hcp promoter. Two mutant fragments contained 
mutations in both the DNA sites for FNR and NarL, but promoter activity was not greatly 
decreased in comparison to that that of fragments containing only a mutation in the DNA site 
for FNR. No Lac
-
 transformants were identified that contained only a mutation in the DNA 
site for NarL.  
One transformant contained a single mutation at position -36 relative to the hcp 
transcription start site, a position that does not fall into any known motifs. The region 
surrounding position -36 includes an imperfect inverted repeat with the sequence GAAAAA-
TCCCT-TTTATC and so may function as an activator binding site, whilst another possibility is 
that the mutation fell in the currently uncharacterised -35 element.  
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          GAATTCTTTCTCTGCGTAATACCTCTCTGGCGGTAGATCC 
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Figure 3.14: Sequence and activity of a truncated fragment containing the hcp promoter 
and mutations in the NsrR site 
Panel A shows the sequence of the hcp383-1ns promoter fragment. Emboldened TAA is the 
stop codon for ybjE. DNA sites for NarL, FNR and NsrR are underlined and marked with 
coloured arrows underneath the sequence. The consensus binding sequences for predicted 
DNA sites are shown in bold text beneath the site and the positions of the centres of the sites 
are given in brackets beneath the arrows. The -10 and -35 elements identified in this study are 
underlined and labelled, as is the published start codon. 
Panel B shows expression of the hcp383-1n::lacZ and hcp383-1ns::lacZ fusions, cloned in 
pRW50 and measured in JCB387 cells. Cells were grown in minimal salt medium 
anaerobically to mid-exponential phase (OD650 0.5-0.7) and data shown are the mean of 3 
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Figure 3.15: Mutations in the hcp promoter region that affect promoter activity 
Figure shows a partial sequence of the hcp promoter fragment hcp383-1ns and derivatives containing randomly introduced mutations. Promoter 
fragments were cloned into pRW50 and activity measured in JCB387 cells. . Cells were grown in minimal salt medium anaerobically to mid 
exponential phase (OD650 0.5-0.7). Relative activity was calculated by dividing the activity of the promoter fragment in question by that of hcp383-1ns 
and multiplying by 100.  
 NarL (-104.5)                                                         FNR (-72.5) 
TACY MTnnAKRRGTA         TTGATnnnn TCAA 
TAC TCTCTGGC GTAGATCCCTGC GC AAAATTGCGC AAATCAATCTCCCTTAAAGTTGCATGAAAAATCCC TTTATCC 
TAC TCTCTGGC GTAGATCCCTGC GC AAAATTGCGC AAACCAATCT CCTTAAAGTTGCATGAAAAATCCC TTTATCC 
CAC TCTCTGGC GTAGATCCCTGC GC AAAATTGCGC AAACCAATCT CCTTAAAGTTGCATGAAAAATCCC TTTATCC 
TAC TCTCTGGC GTAGATCCCTGC GC AAAATCGCGCTAAATCAATCCCCCTTAAAGTTGCATGAAAAATCCC TTTATCC 
CAC TCTCTGGC GTAGATCCCTGC GC AAAAGTGCGCTAAATCGATCTCCCTTAAAGTTGCATGAAAAATCCC TTTATCC 
TAC TCTCTGGC GTAGATCCCTGC GC AAAATTGCGC AAATCGATCTCCCTTAAAGTTGCATGAAAAATCCC TTTATCC 
TAC TCTCTGGC GTAGATCCCTGC GC AAAATTGCGC AAATCGATCTCCCTTAAAGTTGCATGCAAAAT CCTTTTATCC 
TAC TCTCTGGC GTAGATCCCTGC GC AAAATTGCGC AAATCAATCTCCCTTAAAGTTGCATGAAAAATCCC CTT TCC 
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3.12. The inverted repeat near position -36 does not function as an activator 
binding site 
To identify conserved regions of the hcp promoter, the sequence of the hcp383-1 fragment 
was aligned to the relevant region from other bacterial genomes in a study with a visiting 
student, Gregory Farrant. Results in Figure 3.16 show that the DNA site for NarL is poorly 
conserved whilst there are regions of conservation that include the DNA site for FNR, the 
region around position -36 and the region surrounding the transcription start site.  
To investigate whether a transcription factor is binding to the inverted repeat near 
position -36, the inverted repeat was included on a multicopy plasmid in order to titrate out 
the factor. The fragment hcp383-3ns was selected as it contains few other known binding 
sites. JCB387 cells were used to measure the expression of the hcp383-1ns::lacZ fusion and 
the hcp383-32J::lacZ fusion, which has a mutation at position -36. Cells also contained either 
the plasmid pSR, which has a high copy number, or pSR carrying the hcp383-3ns fragment.  
Results illustrated in Figure 3.17 show that there is slightly greater expression of the 
hcp383-1ns::lacZ fusion when hcp383-3ns/pSR is present in cells grown anaerobically or 
anaerobically with nitrite. This may indicate that the hcp383-3ns fragment contains the DNA 
site for a repressor, rather than an activator as hypothesised. If cells are grown anaerobically 
with nitrate then there is no difference between expression of the hcp383-1ns::lacZ fusion in 
cells containing hcp383-3ns/pSR and expression of the hcp383-1ns::lacZ fusion in cells 
containing pSR. The hcp383-32J::lacZ fusion is expressed at lower levels in all conditions 
and the presence of hcp383-3ns/pSR does not appear to greatly affect expression. These 














                                                                                 
 
       
 







NarL (-104.5) FNR (-72.5) 
NsrR (+6) 
 
Figure 3.16:  Phylogenetic analysis of hcp promoter regulatory region  
The figure shows an alignment of the E. coli K-12 hcp-hcr operon promoter region sequence with corresponding sequences from related bacteria, 
downloaded from the xBASE database (xbase.bham.ac.uk)[29]. The different bacteria (and corresponding xbase Taxon ID) are: ECO, E. coli K-12 
(83333); SEN, Salmonella enterica subspecies enterica serovar Choleraesuis str. SC-B67 (321314); STY, Salmonella typhimurium LT2 (99287); YEN, 
Yersinia enterocolitica (393305); YPE, Yersinia pestis (229193); YPS, sequence from Yersinia pseudotuberculosis (349747). DNA targets for NarL 
(and NarP), FNR and NsrR are indicated by shaded horizontal inverted arrows. For each target, the consensus binding sequence is shown in bold, 
aligned with the actual sequence, and the centre of the site is noted. In the consensus sequences, Y denotes either C or T, M denotes A or C, K denotes 
G or T, R denotes A or G, W denotes A or T, and N denotes any base. The transcription start point in the E. coli K-12 sequence is shown in lower case. 
Bases that are identical in each strain‟s genome are highlighted with black shading. 
-10 
• • • • 






Figure 3.17: Titration of factors regulating expression of the hcp promoter  
Expression of the hcp383-1ns::lacZ and  hcp383-32J::lacZ fusions, cloned in pRW50 and 
measured in JCB387 cells. Cells also contained either the plasmid pSR or pSR carrying the 
truncated hcp promoter fragment hcp383-3ns. Cells were grown in minimal salt medium to 
mid exponential phase (OD650 0.5-0.7) anaerobically, anaerobically with medium 
supplemented with 20 mM sodium nitrate or anaerobically with  medium supplemented with 


























3.13. Identification of the hcp promoter-35 and -10 elements 
To uncover the role of the conserved region around position -36, the -35 element was 
characterised. The -35 element was predicted on the basis of distance from the published 
transcription start site and similarity to the consensus σ
70
 -35 element (TTGACA). Mutations 
designed make the sequence more or less resemble the consensus sequence were introduced 
into the hcp383-1ns fragment and resulting fragments were then cloned into pRW50. 
The results in Table 3.1 show that mutations that alter the sequence of the predicted -35 
element away from the consensus -35 sequence cause greatly reduced promoter activity. 
These results agree with those of a similar study by Kobayashi et al. (1990). The P35G 
mutation that alters the sequence of the predicted -35 element to better resemble the 
consensus sequence produces much higher promoter activity. These results indicate that the 
region between position -37 and -32 does function as a -35 element. Site directed mutagenesis 
was also used to construct a derivative of the hcp383-1ns fragment with a consensus -35 
element but was unsuccessful as all resulting fragments contained at least one secondary 
mutation. 
The -10 element was predicted on the basis of distance from the reported transcription 
start site and similarity to the consensus sequence for the -10 element, TATAAT. Site directed 
mutagenesis was used to introduce mutations as before and results in Table 3.1 show that 
mutations that alter the sequence of the predicted -10 element away from the consensus 
sequence result in greatly reduced promoter activity. These results support the hypothesis that 
the region between position -14 and -9 functions as a -10 element. 
3.14. Transcriptional fusions of the hcp promoter to lacZ are highly active 
The hcp383-1ns::lacZ fusion, which was constructed by truncation of the downstream 
region of the hcp383-1n fragment, is expressed 2-fold less than is the hcp383-1n::lacZ fusion. 




















Mutations in the -35 element   
TTGTAT TAACCT -35G 20.0 246.0 
TCTTAT TAACCT -36C 1.1 13.0 
CTTTAT TAACCT -37C 0.4 6.1 
ATTTAT TAACCT -37A 0.4 3.3 
Mutations in the -10 element   
TTTTAT TAACCA -9A 0.4 6.2 
TTTTAT TAACCC -9C 0.4 2.8 
TTTTAT TGACCT -13G 0.5 2.9 
TTTTAT AAACCT -14A 0.2 15.0 
TTTTAT GAACCT -14G 0.4 3.6 
TTTTAT CAACCT -14C 0.4 8.7 
 
-37        -32 -14       -9 
• • • • 
 
Table 3.1: Effect of point mutations in the hcp promoter region on activity 
β-Galactosidase expression was measured in JCB387 cells carrying pRW50 containing the 
hcp383-1ns promoter fragment with single point mutations at different locations in the 
proposed -35 or -10 hexamer elements. The different base changes are shown in the first two 
columns and the consensus -35 and -10 hexamers for E. coli promoters are given at the head 
of each column. Cells were grown aerobically or anaerobically at 37ºC in minimal medium. 
Each measurement is the average of three biological replicates and is expressed as a 
percentage of the measured β-Galactosidase activity during anaerobic growth with the starting 




site might contribute to the high activity of the hcp promoter. Also, the lacZ fusion vector, 
pRW50, uses the Shine-Dalgarno sequence of the inserted fragment but has a fragment of the 
trpBA operon between the inserted fragment and the lacZ gene, making it possible that the 
trpBA operon is interfering with expression of lacZ. To address these concerns, the 
hcp383-1ns fragment was cloned into pRW224, a derivative of pRW50 that lacks the trpBA 
operon, as a transcriptional fusion so that lacZ is expressed from the plasmid encoded galK 
Shine-Dalgarno sequence. A further truncated derivative of the hcp383-1ns fragment was 
constructed to remove the Shine-Dalgarno box of hcp. The resulting fragment, hcp383-1nvs 
was cloned into both pRW50 and pRW224.  
JCB387 cells were grown anaerobically and contained fragments in either pRW50 or 
pRW224 vectors. The expression of the promoter::lacZ fusions was measured and results in 
Figure 3.18 show that, when both fusions are carried by pRW50 as a translational fusion, the 
expression of the hcp383-1nvs::lacZ fusion was 3-fold less than was that of the hcp383-
1ns::lacZ fusion. When fragments are carried by pRW224 as a transcriptional fusion, the 
expression of the hcp383-1ns::lacZ fusion was roughly 10-fold less than when it was 
expressed as a translational fusion from pRW50. The expression of the hcp383-1nvs::lacZ 
fusion was 3-fold greater when it was expressed as a transcriptional fusion, which means that 
the hcp383-1nvs::lacZ fusion is as active when using the galK Shine-Dalgarno element as is 
the hcp383-1ns::lacZ fusion when using the hcp Shine-Dalgarno. This demonstrates that the 
high activity observed from the hcp promoter is not due to using a distinct Shine-Dalgarno 
element and start codon. 
3.15. Discussion 
3.15.1. Unusual promoter organisation of the hcp promoter 
The hcp promoter is highly active when optimally induced but analysis of the DNA 




Figure 3.18: Expression of hcp promoter::lacZ fusions expressed as either a translational 
or a transcriptional fusion 
Expression of the hcp383-1ns::lacZ and  hcp383-1nv:lacZ fusions, cloned in either pRW50 or 
pRW224 and measured in JCB387 cells. Cells were grown in minimal salt medium to mid 
exponential phase (OD650 0.5-0.7) anaerobically and data are the mean of 3 biological 

























resemblance to the consensus sequences for such elements, which normally indicates a weak 
promoter. FNR is an effective activator of promoter activity that can overcome imperfect core 
promoter elements. However, at the hcp promoter, FNR acts from a class I position rather 
than a class II position, which typically results in weaker activation (Wing et al., 1995). 
Finally, the DNA site for NarL is in a position where it could contribute to activation but 
results show that it plays a minor role and is unnecessary in some circumstances. 
3.15.2. Direct vs. indirect activation of the hcp promoter 
The hcp promoter is activated by FNR in response to anaerobiosis, which is crucial for 
maximal activity. FNR activates directly from its site at position -72.5. Nitrate induces the 
hcp promoter and the DNA site for NarL at position -104.5 plays a minor role. When the site 
is deleted, there is still a low level of nitrate dependent induction, which suggests that NarL 
activates hcp promoter activity both directly and indirectly. Nitrite induces activity of the hcp 
promoter maximally and this induction is completely independent of the DNA site for NarL at 
position -104.5. However, maximal activity of the hcp promoter is dependent on NarL being 
expressed by the cell, which corroborates the hypothesis that NarL activates hcp promoter 
activity both directly and indirectly.  
The NarL dependence of the the hcp promoter is relieved if NsrR is unable to repress 
activity by binding to its site at position +6. This suggests that NarL may activate by 
preventing repression by NsrR and it is possible that NarL directly activates by interfering 
with NsrR binding to the promoter.  
The mechanism by which NarL activates indirectly has recently been confirmed, namely 
that NarG is the major producer of NO in E. coli (Claire Vine and Sukhjit Purewal, personal 
communication). Note that expression of narG is strongly induced by NarL (Walker and 
DeMoss, 1994). In cells lacking NarL, narG would not be expressed as highly and so RNS 
would not accumulate in the cell. Therefore, NsrR would be able to repress hcp promoter 
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activity. If NsrR is unable to bind to the hcp promoter then the RNS generated by NarG will 
not be important. 
Another hypothesis to explain NarL-dependent activation by nitrite is that there may be 
other DNA sites for NarL in the hcp promoter region that are currently unknown. NarL bound 
to such sites may directly prevent NsrR repressing activity. This hypothesis is at odds with 
reports that NarL is less active in the presence of nitrite than is NarP. The expectation is that 
NarP, rather than NarL, would activate directly in response to nitrite. Sequence analysis 
reveals that there are some regions around the transcription start site (where the DNA site for 
NsrR is located) that partially resemble the NarL consensus. However, no protection of these 
sites by NarL was observed by DNase I protection assay.  
3.15.3. Factors determining high activity of the hcp promoter 
In this study, the factors crucial for high activity of the hcp promoter were found to be: the 
core promoter elements; activation by FNR from its site at position -72.5; and the absence of 
repression by NsrR. However, when the region downstream of the hcp transcript start was 
deleted, around 50% of promoter activity was lost. To explain this observation, the secondary 
structure was predicted for the mRNA that would result from both the longer hcp383-1n 
fragment and the truncated hcp383-1ns fragment. The predicted structures shown in Figure 
3.19 show that the longer hcp383-1n fragment potentially produces mRNA that adopts a 
hairpin structure and may present the Shine-Dalgarno to a ribosome. Such structures are 
reported to amplify translation. The truncated fragment is not predicted to give rise to such a 
structure, which could explain the reduced expression of hcp383-1ns::lacZ fusions. 
It is possible that the hcp promoter is moderately active and that activity is driven by non-
consensus but functional core promoter elements and activation by FNR from a non-optimal 
position. Expression of HCP might then be amplified by the hcp mRNA secondary structure. 




Figure 3.19: Predicted secondary structure of RNA resulting from hcp383-1n and 
hcp383-1ns 
Figure shows predicted secondary structure of hcp383-1n and hcp383-1ns mRNA. Structures 
were predicted using mfold (Zuker, 2003). Blue dots denote predicted interaction between 




fused to lacZ as a transcriptional fusion or to study in vitro transcription. To investigate the 
predicted secondary structure of the hcp mRNA, mutations could be introduced to disrupt the 
stem of the predicted hairpin. Complementary mutations on the other side of the stem should 
then recover expression levels. 
There remains the possibility that a ‟mystery activator‟ may be responsible for the high 
activity observed of the hcp promoter  and that there are DNA sites for it in the hcp promoter 
region that have yet to be identified. One method of identifying such activators is DNA 
sampling, a technique where the DNA fragment of interest is isolated from cells and analysed 
by mass spectroscopy to identify bound proteins (Butala et al., 2009). This technique could be 
applied to determine if there are any factors acting at the hcp promoter that have not been 
previously detected.  
3.15.4. Importance of the region near position -36 of the hcp promoter 
The region near position -36 of the hcp promoter was identified as important for promoter 
activity by error prone PCR. Further study demonstrated that mutation of position -36 affects 
hcp promoter activity by disrupting the -35 element. However, bioinformatics reveals that the 
region upstream of and including position -36 is well conserved in other bacteria, which 
indicates that it may play a role in regulation of hcp expression. An explanation for the 
conservation of this region may be found in the work of Partridge et al. (2009), in which a 
bioinformatics analysis of NsrR sites predicted a second site in the hcp promoter from 
position -56 to -34. The results of this study corroborate the hypothesis of a second, weaker, 
DNA site for NsrR in the hcp promoter. 
The EMSA with NsrR-containing cell lysate shows that NsrR binds weakly to an hcp 
promoter fragment with mutations in the site at position +6. Taken together, these results can 
be interpreted in two ways: either the mutations in the DNA site for NsrR do not entirely 
dissuade NsrR from binding to that site, or that there is a second, low-affinity, DNA site for 
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NsrR. Partridge et al. (2009) report that NsrR is able to bind both 11 bp half-sites and 11-1-11 
inverted repeats. The mutations introduced into the DNA site for NsrR at position +6  of the 
hcp promoter do not affect the upstream half of the site, meaning it is possible that NsrR still 
binds weakly to the promoter. Finally, hcp promoter activity is increased by introducing the 
hcp383-3ns fragment on a multicopy plasmid that contains the predicted upstream DNA site 
for NsrR and mutations in the site at position +6. This indicates that a repressor is being 
titrated out, which supports the existence of a second site for NsrR 
3.15.5. The role of HCP 
An aim of this study was to better our understanding of the regulation of hcp expression in 
the hope of clarifying the role of HCP in the cell. HCP is produced optimally in anaerobic 
conditions with nitrite present, although nitrate also induces expression. High activity is 
absolutely dependent on FNR being bound to its site and the inactivation of NsrR. NarL is 
necessary for high levels of expression although it appears that NarL merely indirectly 
produces the RNS that inactivate NsrR. Work by Almeida et al. (2006) indicates that hcp 
expression is repressed by the transcription factor OxyR, which is inactivated by hydrogen 
peroxide. The predicted DNA site for OxyR is between positions -105 and -65, which 
overlaps the DNA sites for NarL and FNR. Unfortunately, Almeida and colleagues do not 
report quantitative values for expression, which complicates comparison and analysis. 
However, their and my results show that anaerobiosis induces activity of the hcp promoter in 
the absence of hydrogen peroxide, indicating that FNR is able to displace OxyR bound to its 
DNA site.  
Almeida et al. (2006) suggested a role for HCP in defence from reactive oxygen species 
and reported that HCP reduces hydrogen peroxide. It is possible that the role of HCP is to 
protect the cell from ROS generated by Hmp, the primary aerobic NO reductase. Like 
expression of hcp, expression of hmp is repressed by NsrR so that in the presence of RNS, 
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hmp expression is up-regulated. Despite detoxifying NO, Hmp presents a risk to the cell 
because in the presence of oxygen, it produces ROS (Gilberthorpe et al., 2007). Expression of 
hmp is therefore tightly regulated to ensure low expression in the absence of RNS, but high 
activity in the presence of RNS. It is plausible that bacteria would have evolved a protein to 
mitigate this risk, and it would be logical that expression of said protein would be up-
regulated in response to reactive nitrogen species. However, expression of hcp and hmp is 
differentially regulated by FNR. Expression of hcp is activated by FNR, while expression of 
hmp is repressed by FNR. If the role of HCP were to protect the cell from ROS generated by 
Hmp in aerobic conditions, then hcp would be expected to be expressed aerobically. Further 
study could examine the interplay between OxyR and FNR. 
Activity of the hcp promoter is maximal anaerobically and in the presence of RNS, which 
strongly suggests that HCP protects the cell from reactive nitrogen species that occur 
anaerobically, possibly those that result from nitrite reduction. It is perhaps telling that hcp 
promoter activity is low in a narL mutant, despite the observation that the DNA site for NarL 
in the hcp regulatory region is unnecessary. It is curious that hcp promoter activity is activated 
by FNR because FNR is known to be inactivated by RNS (Pullan et al., 2007). This suggests 
that hcp expression may be up-regulated in response to a gradual increase of RNS, so that 
there is still functional FNR in the cell. This could be examined by studying the relative 
sensitivity of hcp expression to anaerobiosis and the presence of RNS. Alternatively, positive 
regulation of hcp expression by FNR may introduce a „time delay‟. Figure 3.20 depicts this 
model, in which a strong burst of RNS would initially inactivate FNR and NsrR. In such 
conditions, expression of the iron-sulphur cluster repair protein YtfE is up-regulated (Overton 
et al., 2008). YftE then repairs the iron-sulphur cluster of FNR, perhaps damaging itself in the 
process. As FNR becomes re-activated, hcp expression would be up-regulated and HCP may 
then repair damaged YtfE. Eventually NsrR would be repaired and hcp expression shut down. 
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For this model to be true, YtfE would need to repair the iron-sulphur cluster of FNR before 
that of NsrR, which could be tested experimentally.  
Finally, HCP is known to possess 2 different iron-sulphur clusters, which may indicate 
dual function. It is possible that HCP has a role in defence from both reactive oxygen species 
and reactive nitrogen species. It may deal with either threat when they occur in the cell 
naturally or may have a role in defence from the host immune system. ROS and RNS are 
known to be used by the host immune system to kill bacteria. If HCP is involved in protection 
from macrophages, its role must not be crucial, as an hcp mutant of S. enterica does not 
appear to be adversely affected in assays with immune cells (Kim et al., 2003). 
The regulation of hcp expression is reasonably complex, with multiple factors regulating, and 
can vary from low expression to very high expression depending on the stimuli. This makes 
assigning function particularly difficult, but suggests that it is important for the cell to have 
the right amount of HCP at the right time. It should be noted that assigning function based on 
regulation can be flawed, for example, the function of the Ogt protein as a DNA repair 
enzyme would not be inferred from regulation of its expression by nitrate (covered in Chapter 
4). The function of HCP will therefore likely be solved by biochemical studies of the active 
protein and by studying the phenotype of hcp knockout cells. The evidence from this work 
and others does however support the hypothesis that HCP is involved in defence from reactive 






Figure 3.20 Model of regulation of hcp expression 
The figure is a diagram showing a proposed model for the regulation of hcp expression. The 
figure is organised by the sequence of events from an initial pulse of NO. Red arrows indicate 
a disruptive effect and green arrows indicate a reparative effect. Black arrows indicate a 
general progression, i.e. “leads to”. Dashed black arrow indicates the order of events 
temporally. 
  



























In the absence of oxygen, E. coli is able to utilise alternative electron acceptors. The most 
efficient of these acceptors is nitrate, followed closely by nitrite (Richardson et al. 2000) . 
E. coli has evolved systems to reduce nitrate and nitrite and to deal with the by-products of 
reduction, RNS. The major transcriptional regulators in response to nitrate and nitrite, NarL 
and NarP, are able to up or down regulate transcription of relevant operons. However, the 
majority of promoters that are activated by NarL and NarP are also activated by FNR, the 
master anaerobic sensor / regulator. This is logical as oxygen is a more powerful oxidiser than 
is nitrate and so proteins to process nitrate would only be required in the absence of oxygen. 
However, NarL and NarP are members of the LuxR protein family, other members of which 
are able to activate transcription by contacting polymerase (Choi and Greenberg 2001). 
Therefore the question has arisen, are NarL and NarP able to activate transcription 
independently of FNR? 
The work of Constantinidou et al. (2006) identified several genes that were upregulated 
by NarL / NarP in Δfnr cells. Further investigation by Lin et al (2008) and Squire et al. (2009) 
confirmed that the yeaR-yoaG and ogt operons are activated by NarL independently of FNR. 
The yeaR-yoaG operon encodes genes of currently unknown function, while ogt encodes an 
O6-alkylguanine DNA methyltransferase, the function of which is to repair DNA damage 
such as that caused by RNS.  
The yeaR and ogt promoters both contain DNA sites for NarL, which were confirmed by 
Squire et al. (2009) (see Figure 4.1). There is a single DNA site for NarL at the yeaR 
promoter, which is centred at position -43.5 relative to the yeaR transcription start site, which 









Figure 4.1: Diagrams and partial sequences of the yeaR100 and ogt100 fragments 
Panel A shows sketch diagrams of the yeaR100 and ogt100 DNA fragments, which contain 
the E coli yeaR and ogt promoters respectively. The capital E and H at the ends of the 
fragments denote EcoRI and HindIII restriction sites. The mapped transcription start site is 
denoted with a bent arrow and “+1”. The DNA sites for NarL are indicted with inverted 
arrows, which are labelled, and the central position of the site is given beneath the arrows 
relative to the transcription start site. A position ending in .5 denotes that the centre falls 
between two positions. 
 
Panel B is reproduced from Squire et al. (2009) and shows a partial sequence of the yeaR100 
fragment from positions −64 to +86 with respect to the transcription start site (+1). The −10 
hexamer element is boldface and underlined, the transcription start point is designated by a 
lower-case letter and a bent arrow, and the translation start ATG codon is underlined. The 
DNA sites for NarL and NsrR are identified by shaded arrows and a rectangle respectively, 
and the centre of each site is numbered with respect to the transcription start site.  
 
Panel C is reproduced from Squire et al (2009) and shows a partial sequence of the ogt100 
fragment, from position −106 to +57 with respect to the transcription start site (+1). Then −10 
hexamer element is emboldened and underlined. The transcription start site is designated by a 
lower-case letter and a bent arrow, and the translation start ATG codon is underlined. The 
DNA sites for NarL are identified by shaded arrows and the centre of each site is numbered 







sites for NarL, which are centred at positions -78.5 and -45.5 relative to the ogt transcription 
start which had been mapped using primer extension by Potter et al. (1987). The organisation 
of DNA sites for NarL suggests that NarL activates the yeaR promoter by a class II 
mechanism and the ogt promoter by a class III mechanism. Squire et al. (2009) confirmed that 
NarL was required for activation of the yeaR promoter and that it bound to the predicted site. 
They also investigated the ogt promoter and some of their results are reproduced in Figure 
4.2. 
Figure 4.2, panel A, shows that expression of an ogt promoter::lacZ fusion was induced 
by nitrate in a NarL-dependent fashion. Figure 4.2, panel B shows that results of an EMSA 
with NarL and radiolabelled DNA fragments containing the ogt promoter. NarL was seen to 
bind the ogt promoter region at higher concentrations only. By comparison, NarL bound to 
the yeaR promoter at much lower concentrations, which suggests that the single DNA site for 
NarL is a better target for NarL than are either of the sites in the ogt promoter region (Squire 
et al. 2009). Figure 4.2, panel C, shows the results of a DNase I protection assay with NarL 
and a radiolabelled DNA fragment containing the ogt promoter. NarL was seen to protect 2 
regions of the fragment that correspond to the DNA sites for NarL predicted by sequence 
analysis. Finally, Figure 4.2, panel D, shows the expression of an ogt promoter::lacZ fusion in 
JCB387 cells and a Δfnr derivative. The results confirmed that the presence or absence of 
FNR do not affect activity of the ogt promoter.  
Squire et al. (2009) also reported that nitrate induction of the ogt promoter was prevented 
if either of the DNA sites for NarL were mutated to prevent NarL binding. This indicated that, 
at the ogt promoter, NarL activates by a cooperative class III mechanism, as both DNA sites 
are required. 
The aim of this work was to continue the work of Squire et al. (2009) and to study further 








Figure 4.2: NarL regulates the E coli ogt promoter 
Reproduced from Squire et al (2009).  
Panel A shows the measured β-Galactosidase activities in JCB387 and JCB3883 (ΔnarL) cells 
carrying pRW50, containing the ogt100 promoter fragment. Cells were grown in minimal 
medium and, where indicated, sodium nitrate or nitrite was added to a final concentration of 
20 and 2.5 mM respectively. β-Galactosidase activities are expressed as nmol of ONPG 
hydrolysed/min per mg of dry cell mass.  
 
Panel B shows EMSA experiments with purified NarL protein. End-labelled ogt100 promoter 
fragment was incubated with increasing concentrations of NarL and protein–DNA complexes 
were separated by PAGE. The concentration of NarL was: lane 1, no protein; lane 2, 0.2 μM 
NarL; lane 3, 0.8 μM NarL; lane 4, 1.6 μM NarL; lane 5, 3.2 μM NarL.  
 
Panel C shows an in vitro DNase I footprint experiment with purified NarL. End-labelled 
ogt100 AatII– HindIII fragment was incubated with increasing concentrations of NarL and 
subjected to DNase I footprint analysis. The concentration of NarL was: lane 1, no protein; 
lane 2, 0.4 μM; lane 3, 0.8 μM; lane 4, 1.6 μM; lane 5, 3.2 μM. The gel was calibrated using a 
Maxam–Gilbert „G+A‟ sequencing reaction and relevant positions are indicated. The location 
of NarL-binding sites is shown by boxes and a hypersensitive site due to NarL binding is 
marked with a star.  
 
Panel D shows the measured β-Galactosidase activities in JCB387 and a Δfnr derivative, 
carrying pRW50 containing the ogt100 promoter fragment. Cells were grown in minimal salt 
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investigate the range of promoter organisations from which NarL / NarP can activate. 
4.2. Activation of promoter activity by NarL from a single DNA site 
The results of Squire et al. (2009) contain a curious result: that NarL induction of the yeaR 
promoter was 5-fold greater than was NarL induction of the ogt promoter. Induction of the 
yeaR promoter demonstrated that NarL was able to activate transcription from a single site, 
which suggests that the different induction of the two promoters might result from differences 
between the promoter proximal DNA sites for NarL. There are 2 important differences 
between the promoter proximal DNA sites for NarL at the yeaR and ogt promoters. First, the 
DNA site for NarL at the yeaR promoter is centred at position -43.5, whilst the promoter 
proximal DNA site for NarL at the ogt promoter is centred at position -45.5, which may be 
suboptimal. Secondly, the DNA site for NarL at the yeaR promoter corresponds better to the 
consensus DNA site for NarL, which is why NarL binds more readily to the yeaR promoter 
than it does to the ogt promoter. 
The starting fragment for this work was the ogt100 fragment, a 320 bp EcoRI-HindIII 
DNA fragment that contains the region from position -270 to +51 relative to the mapped ogt 
transcription start site (see Figure 4.1, Panel C). Both DNA sites for NarL identified by Squire 
et al. (2009) are included in the fragment as is the Shine-Dalgarno element and start codon for 
ogt. To investigate the differing induction of the yeaR and ogt promoters, derivatives of the 
ogt100 fragment were constructed (see Figure 4.3, panel A). The ogt106 fragment was 
constructed by deleting 2 bases between the NarL II site and the transcription start site in 
order to move the NarL II site so that it is centred at position -43.5. The bases deleted were 
chosen so as not to disrupt the potential -35 element immediately downstream of the NarL II 
site. The ogt107 fragment was constructed by mutating the sequence of the NarL II site to that 
of the DNA site for NarL at the yeaR promoter. The resulting fragments were then cloned into 










Figure 4.3: NarL can activate from a single strong DNA site 
Panel A shows a partial sequence of the ogt100 and yeaR100 fragments and derivatives of the 
ogt100 fragment, ogt106 and ogt107. The promoter proximal DNA site for NarL is marked 
with coloured text with the consensus sequence for such sites given above the sequences in 
emboldened text. The promoter proximal DNA site for NarL from the ogt100 fragment is 
marked in green and the DNA site for NarL from the yeaR100 fragment is marked in yellow. 
The transcription start site is denoted by an emboldened and underlined character with a “+1” 
above the sequence. 
 
Panel B shows expression from the ogt100, yeaR100, ogt106 and ogt107 fragments cloned as 
promoter::lacZ fusions in pRW50, which was measured in E. coli strain JCB387 during 
exponential growth (OD650 = 0.5-0.6) in minimal salt medium. Cells were grown 
anaerobically or anaerobically in medium supplemented with 20 mM sodium nitrate. Data 
shown are averages from at least 3 biological repeats, and error bars show one standard 
deviation from the mean.  
 
Panel C shows expression from the ogt100, yeaR100, ogt106 and ogt107 fragments cloned as 
promoter::lacZ fusions in pRW50, which was measured in E. coli strain JCB3884 (ΔnarXL 
ΔnarP) during exponential growth (OD650 = 0.5-0.6) in minimal salt medium. Cells were 
grown anaerobically or anaerobically in medium supplemented with 20 mM sodium nitrate. 
Data shown are averages from at least 3 biological repeats, and error bars show one standard 






































































cells, which lack NarL. Cells were grown in minimal salt medium anaerobically or 
anaerobically with nitrate-supplemented medium. 
The results in Figure 4.3, panel B show expression of the promoter::lacZ fusions in 
JCB387 cells. As expected, expression of the ogt100::lacZ fusion was induced by nitrate, as 
was expression of the yeaR100::lacZ fusion. In agreement with Squire et al. (2009), induction 
of the yeaR promoter was ~5-fold greater than induction of the ogt promoter. The 
ogt106::lacZ fusion was expressed poorly under all conditions. This is possibly because the 
spacing of core promoter elements was disturbed by the deletion of bases in constructing the 
fragment. Nitrate induced expression of the ogt107::lacZ fusion and the yeaR100::lacZ fusion 
to a similar degree, which indicates that the sequence of the DNA site for NarL is the 
important determinant of efficient induction by NarL. The results in Figure 4.3, panel C show 
expression of the promoter::lacZ fusions in JCB3883 cells, which lack NarL. No nitrate-
dependent induction of promoter activity was observed, which indicates that induction 
observed in the results in Figure 4.3, panel B, is NarL dependent.  
Taken with the results of Squire et al. (2009), these data confirm that NarL can activate 
promoter activity independently of FNR and that it can do this from a single DNA site, 
providing the site is a strong target. The results also demonstrate that NarL can activate 
efficiently regardless of whether the DNA site is centred at position -43.5 or position -45.5. 
4.3. Effect of consensus DNA sites for NarL on ogt promoter activity 
The results of the previous section indicate that activity of the ogt promoter is increased if 
the promoter proximal DNA site for NarL is modified to better resemble the consensus 
sequence for such elements. To investigate the effects of modifying one or both DNA sites for 
NarL to match the consensus sequence, a series of ogt promoter fragments was constructed. 
Derivatives of the ogt100 fragment were prepared, in which one or both DNA sites for NarL 







TACYYMTnnAKRRGTA          TACYYMTnnAKRRGTA 
ogt100  TACTTACTATTCGTTA          TATCTTTTTGGTGGTA 
ogt101  TACTTATTAATGGGTA          TATCTTTTTGGTGGTA 
ogt105  TACTTACTATTCGTTA          TACCTCTTTAGAGGTA 






Figure 4.4: Effect of consensus DNA sites for NarL on ogt promoter activity 
Panel A shows the sequence of the DNA sites for NarL in the ogt100, ogt101, ogt 105, and 
ogt1051 fragments. The consensus sequence for DNA sites for NarL is given above the site in 
emboldened text. The central position of the site relative to the ogt transcription start is given 
above the site. Mutations introduced to modify the site to better match the consensus 
sequence are highlighted in yellow. 
Panel B shows sketches of promoters contained on fragments and measured β-Galactosidase 
units. A wild type DNA site for NarL is indicated in the sketch by a slim yellow bar and an 
improved site is denoted with a thick yellow bar. The transcription start site is denoted with a 
bent arrow. β-Galactosidase units were measured in JCB387 cells grown anaerobically in 
minimal salt medium, with or without 20 mM sodium nitrate, as indicated. Cells contained 
fragments carried by pRW50. Data shown are the mean of 3 biological repeats and numbers 
in brackets indicate one standard deviation from the mean.  
  
Fragment  Anaerobic 
Anaerobic + 
nitrate 
ogt100  104 (12) 445 (55) 
ogt101 
 
150 (7) 1897 (40) 
ogt105 
 
1623 (166) 3432 (130) 
ogt1051 
 
1234 (61) 5350 (170) 
NarL II 
 
  -45.5 
NarL I 
 





Resulting fragments were cloned into pRW50 and plasmids were transformed into JCB387 
cells. Promoter activity was measured following growth in minimal salt medium 
anaerobically or anaerobically with nitrate. 
Results in Figure 4.4, panel B, show that expression of the ogt100::lacZ fusion, which 
contains the wild type ogt promoter, was induced ~4-fold by nitrate. Expression of the 
ogt101::lacZ fusion, in which the NarL I site is modified to better resemble the consensus, 
was induced ~13-fold by nitrate. Anaerobic expression of the ogt105::lacZ fusion, in which 
the NarL II site is modified to better resemble the consensus, was ~16-fold greater than was 
anaerobic expression of the ogt100::lacZ fusion. Nitrate induced expression of the 
ogt105::lacZ fusion by a further 2-fold. Anaerobic expression of the ogt1051::lacZ fusion, in 
which both DNA sites for NarL were modified to better resemble the consensus sequence, 
was around 12-fold greater than was anaerobic expression of the ogt100 fragment. Nitrate 
further induced expression of the ogt1051::lacZ fragment by ~4-fold. 
These results demonstrate that ogt promoter activity is increased if DNA sites for NarL 
are improved by modifying them to resemble better the consensus binding sequence for NarL. 
The results also reveal that anaerobic expression of the ogt105::lacZ fusion and the 
ogt1051::lacZ fusion is greater than the wild type. It is possible that in the absence of nitrate 
there is still a small amount of activated NarL, which occupies the improved NarL II site. This 
suggests that NarL readily binds to and efficiently activates from the NarL II site. 
4.4. NarL can activate by class I, II, and III mechanisms 
The work of Squire et al. (2009) and Lin et al. (2008) suggests that NarL can function as a 
class II activator of the yeaR promoter and as a class III activator of the ogt promoter. My 
results suggest that NarL activates by a class III mechanism at the ogt promoter, rather than a 
class II mechanism, because the DNA sites for NarL bear poor resemblance to the consensus 
sequence. It is reasonable to expect that NarL may also be able to act as a class I activator if 
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the upstream site is improved, as Squire et al. (2008) demonstrated that NarL uses the 
upstream NarL I site at the ogt promoter during class III activation. To investigate the range 
of promoter organisations that NarL can activate from, a series of DNA fragments was 
constructed by improving or worsening the DNA sites for NarL in the ogt100 promoter 
fragment (see Figure 4.5, panel A). Fragments were then cloned into pRW50 and plasmids 
were transformed into JCB387 cells. Cells were grown in minimal salt medium anaerobically 
or anaerobically with nitrate and β-Galactosidase activity was measured.  
Initially, the effect of disrupting DNA sites for NarL was confirmed. Results presented in 
Figure 4.5, panel B, show that expression of the ogt100::lacZ fusion was induced by nitrate. 
The ogt102::lacZ fusion, which contains a disrupted NarL I site, was poorly induced by 
nitrate, as was the ogt104::lacZ fusion, which contains a disrupted NarL II site. This agrees 
with the data from Squire et al. (2009). As expected, nitrate did not induce expression of the 
ogt1042::lacZ fusion, in which both the NarL I and NarL II sites are disrupted. These results 
confirm that NarL can only activate by a class III mechanism at the ogt promoter if both DNA 
sites for NarL are present. 
To investigate the effect of improving one DNA site for NarL whilst the other is 
disrupted, the expression of the ogt1041::lacZ fusion and the ogt0152::lacZ fusion was 
measured. Anaerobic expression of the ogt1041::lacZ fusion, which contains an improved 
NarL I site but a disrupted NarL II site, was lower than was that of the wild type ogt100::lacZ 
fusion. However, nitrate induced expression of the ogt1041::lacZ fusion by ~10-fold. This 
indicates that NarL can activate by a class I mechanism if the DNA site is modified to 
resemble better the consensus binding sequence for NarL. Anaerobic expression of the 
ogt1052::lacZ fusion, which contains a disrupted NarL I site and an improved NarL II site, 








TACYYMTnnAKRRGTA          TACYYMTnnAKRRGTA 
ogt100  TACTTACTATTCGTTA          TATCTTTTTGGTGGTA 
ogt102  TAGTTACTATTCGCTA          TATCTTTTTGGTGGTA 
ogt104  TACTTACTATTCGTTA          TAGCTTTTTGGTGCTA 
ogt1042  TAGTTACTATTCGCTA          TAGCTTTTTGGTGCTA 
ogt1041  TACTTATTAATGGGTA          TAGCTTTTTGGTGCTA 






Figure 4.5: NarL can activate by class I, II or III mechanisms 
Panel A shows the base sequence of the two DNA sites for NarL in the ogt100, ogt102, ogt 
104,  ogt1042, ogt1041 and ogt1052 fragments. The consensus sequence for DNA sites for 
NarL is given above the site in emboldened text. The central position of the site relative to the 
ogt transcription start is given above the site. Mutations introduced to modify the site to better 
match the consensus sequence are highlighted in yellow and mutations introduced to disrupt 
the DNA site for NarL are highlighted in red. 
Panel B shows sketches of promoters contained on fragments and measured β-Galactosidase 
units. A wild type DNA site for NarL is denoted in the sketch with a slim yellow bar, an 
improved site is denoted with a thick yellow bar and a disrupted site is denoted with a red X. 
The transcription start site is denoted with a bent arrow. β-Galactosidase units were measured 
in JCB387 cells grown anaerobically in minimal salt medium, with or without 20 mM sodium 
nitrate, as indicated. Cells contained fragments carried by pRW50. Data shown are the mean 




Fragment  Anaerobic 
Anaerobic + 
nitrate 
ogt100  104 (12) 445 (55) 
ogt102 
 
169 (40) 187 (64) 
ogt104 
 
115 (4) 180 (5) 
ogt1042 
 
67 (2) 67 (1) 
ogt1041 
 
63 (4) 641 (73) 
ogt1052 
 
1161 (29) 3710 (14) 
NarL II 
 
  -45.5 
NarL I 
 





induced expression of the ogt1052::lacZ fusion by ~3-fold. This adds to the evidence that 
NarL can activate ogt promoter activity by a class II mechanism if the NarL II site is modified 
to better resemble the consensus binding sequence.  
Taken together, these results show that NarL can activate the ogt promoter by class I, II 
and III mechanisms. However, near consensus DNA sites for NarL are required for NarL to 
activate by class I and class II mechanisms. 
4.5. NarL/P dependent activation of ogt promoter derivatives 
The results in the previous section indicate that NarL can activate by class I, II and III 
mechanisms. NarP is known to bind to DNA sites for NarL if the site is organised as an 
inverted repeat and so it is therefore possible that NarP may also activate ogt promoter 
derivatives that contain improved NarL sites. To investigate this possibility, the activity of ogt 
promoter derivatives that are induced by nitrate was measured in cells that contain both NarL 
and NarP, just NarL, just NarP or neither.  
Plasmids containing ogt promoter fragments were transformed into: JCB387, which 
contain both NarL and NarP; JCB3875, which contain NarL but not NarP; JCB3883, which 
contain NarP but not NarL; and JCB3884, which do not contain either NarL or NarP. Cells 
were grown in minimal salt medium anaerobically with or without nitrate and expression of 
promoter::lacZ fusions was measured. 
Results illustrated in Figure 4.6, panel A, show expression of promoter::lacZ fusions 
measured in JCB387, which contain both NarL and NarP. Expression of the ogt100::lacZ 
fusion, which contains the wild type ogt promoter, was induced by nitrate. Expression of the 
ogt101::lacZ fusion, which contains an improved NarL I site, was induced efficiently by 
nitrate to a higher level than was the wild type ogt promoter. Expression of the ogt1041::lacZ 






Figure 4.6: Activity of ogt promoter derivatives in cells that lack NarL, NarP, or both. 
Panel A shows expression from the ogt100, ogt101, ogt1041, ogt105, ogt1051, and ogt1052 
fragments cloned as promoter::lacZ fusions in pRW50. The status of the NarL I and NarL II 
sites in the fragments are given below the fragment name. WT indicates the site is wild type, 
an upwards arrow indicates the site is modified to better resemble the NarL consensus binding 
site and a downwards arrow indicates that that site has been disrupted. For example, “I: WT 
II: ↑” indicates that the NarL I site is wild type whilst the NarL II site has been modified to 
better resemble the consensus. Expression of promoter::lacZ fusions was measured in E. coli 
strain JCB387 during exponential growth (OD650 = 0.5-0.6) in minimal salt medium. Cells 
were grown anaerobically or anaerobically in medium supplemented with 20 mM sodium 
nitrate. Data shown are averages from at least 3 biological repeats, and error bars show one 
standard deviation from the mean.  
 
Panel B shows expression from the ogt100, ogt101, ogt1041, ogt105, ogt1051, and ogt1052 
fragments cloned as promoter::lacZ fusions in pRW50. Expression was measured in JCB3875 
cells, which lack NarP, during exponential growth (OD650 = 0.5-0.6) in minimal salt medium. 
Cells were grown anaerobically or anaerobically in medium supplemented with 20 mM 
sodium nitrate. Data shown are averages from at least 3 biological repeats, and error bars 
show one standard deviation from the mean. 
 
Panel C shows expression from the ogt100, ogt101, ogt1041, ogt105, ogt1051, and ogt1052 
fragments cloned as promoter::lacZ fusions in pRW50. Expression was measured in JCB3883 
cells, which lack NarL, during exponential growth (OD650 = 0.5-0.6) in minimal salt medium. 
Cells were grown anaerobically or anaerobically in medium supplemented with 20 mM 
sodium nitrate. Data shown are averages from at least 3 biological repeats, and error bars 
show one standard deviation from the mean. 
 
Panel D shows expression from the ogt100, ogt101, ogt1041, ogt105, ogt1051, and ogt1052 
fragments cloned as promoter::lacZ fusions in pRW50. Expression was measured in JCB3884 
cells, which lack NarL and NarP, during exponential growth (OD650 = 0.5-0.6) in minimal salt 
medium. Cells were grown anaerobically or anaerobically in medium supplemented with 20 
mM sodium nitrate. Data shown are averages from at least 3 biological repeats, and error bars 
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was induced by nitrate to a similar level as the wild type ogt promoter. The ogt105::lacZ 
fusion, which contains an improved NarL II site, wass expressed highly anaerobically and 
nitrate induced expression further. The ogt 1051::lacZ fusion, in which both the NarL I and 
NarL II sites are improved, was expressed highly anaerobically and nitrate induced further. 
The ogt1052::lacZ fusion, in which the NarL I site is worsened and the NarL II site improved, 
showed a similar pattern of expression to that of the ogt105::lacZ fusion. This confirms that 
promoter::lacZ fusions with improved DNA sites for NarL are expressed more highly than is 
the wild type ogt100::lacZ fusion. 
Results illustrated in Figure 4.6, panel B, show expression of promoter::lacZ fusions 
measured in JCB3875 cells, which contain NarL but not NarP. Absolute expression levels of 
the ogt101::lacZ fusion and the ogt1051::lacZ fusion were marginally lower in cells that do 
not contain NarP, which may indicate a subtle repressive effect of NarP. Overall, expression 
of the fusions was very similar to that observed in cells that contained both NarL and NarP. 
This indicates that none of the fusions rely solely on NarP for activation of expression. 
Results illustrated in Figure 4.6, panel C, show expression of promoter::lacZ fusions in 
JCB3883 cells, which contain NarP but not NarL. Expression of the ogt100::lacZ fusion was 
not induced by nitrate, which agrees with that reported by Squire et al (2009). Neither 
expression of the ogt101::lacZ fusion nor that of the ogt1041::lacZ fusion was induced by 
nitrate, which indicates that NarP is unable to activate from the promoter-distal NarL I site. 
That expression of the ogt1041::lacZ fusion was not activated by NarP indicates that NarP is 
unable to activate by a class I mechanism. Expression of the promoter::lacZ fusions that 
contain improved NarL II sites, ogt105, ogt1051 and ogt1052, was induced by nitrate, which 
indicates that NarP is able to activate by a class II mechanism from the promoter proximal 




Results illustrated in Figure 4.6, panel D, show expression of promoter::lacZ fusions in 
JCB3884 cells, which do not contain NarL or NarP. As expected, nitrate did not induce 
expression of any of the fragments. This suggests that the induction observed in JCB387 cells 
is entirely dependent on either NarL or NarP and that no other factors are mediating induction 
by nitrate. 
Taken together, these results suggest that NarL is able to activate by class I, II and III 
mechanisms, whilst NarP is only able to act via a class II mechanism. However, a good target 
site is required for NarL to activate by class I or II mechanisms.  
4.6. ogt promoter derivatives that are induced by nitrite 
Squire et al. (2009) demonstrated that an ogt100::lacZ fusion is induced by nitrate but not 
by nitrite. Recall that when cells are grown in nitrate, NarL is thought to be active whilst 
when cells are grown in nitrite, NarP is thought to be most active. The results in Figure 4.6 
indicate that NarP cannot induce expression of the ogt100::lacZ fusion and so it follows that 
nitrite would not induce expression. However, NarP can activate expression of the 
ogt105::lacZ, ogt1051::lacZ and 1052::lacZ fusions and so nitrite induction of these fusions 
was investigated. Plasmids were transformed into JCB387 cells and cells were grown in 
minimal salt medium anaerobically, anaerobically with nitrate and anaerobically with nitrite.  
Results in Figure 4.7 confirm that expression of the ogt100::lacZ fusion was induced by 
nitrate but was not induced by nitrite. Anaerobic expression of the ogt105::lacZ fusion, in 
which the NarL II site is improved, was higher than that of the ogt100::lacZ fusion and both 
nitrate and nitrite induced activity further. 
Expression of the ogt1051::lacZ fusion, in which both NarL I and NarL II sites are 
improved, was induced by nitrate and nitrite. Expression of the ogt1052::lacZ fusion, in which 





Figure 4.7: ogt promoter derivatives that are induced by nitrite 
The figure shows expression from the ogt100, ogt105, ogt1051, and ogt1052 fragments 
cloned as promoter::lacZ fusions in pRW50. The status of the NarL I and NarL II sites in the 
fragments are given below the fragment name. WT indicates the site is wild type, an upwards 
arrow indicates the site is modified to better resemble the NarL consensus binding site and a 
downwards arrow indicates that that site has been disrupted. For example, “I: WT II: ↑” 
indicates that the NarL I site is wild type whilst the NarL II site has been modified to better 
resemble the consensus. Expression of promoter::lacZ fusions was measured in E. coli strain 
JCB387 during exponential growth (OD650 = 0.5-0.6) in minimal salt medium. Cells were 
grown anaerobically, anaerobically in medium supplemented with 20 mM sodium nitrate, or 
anaerobically in medium supplemented with 2.5 mM sodium nitrite. Data shown are averages 
























I: WT   II: WT I: WT     II:↑ I: ↑    II: ↑ I: ↓      II: ↑ 
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nitrate and was maximally induced by nitrite.  
These results, in combination with previous results, suggest that NarP can activate by a 
class II mechanism in a nitrate and nitrite-dependent manner. 
4.7. Induction kinetics of the hcp and ogt promoters 
The results strongly suggest that NarL induces ogt expression directly in a nitrate 
dependent manner. By contrast, NarL is thought to induce expression of hcp indirectly, by its 
involvement in the production of RNS, which cause de-repression by NsrR (see Chapter 3). It 
is therefore predicted that, following the addition of nitrate, induction of ogt expression would 
occur more rapidly than would induction of hcp expression. 
To test this prediction, JCB387 cells were transformed with pRW50 plasmids containing 
either the ogt100 fragment or the hcp383-0 fragment to generate lacZ fusions. Cells were 
grown in minimal salt medium anaerobically and pulsed with nitrate. The results in Figure 4.8 
show that expression of the ogt100::lacZ fusion increased ~12 minutes after the culture was 
pulsed with nitrate. Expression of the hcp383-0::lacZ fusion did not increase until ~21 
minutes after the culture was pulsed with nitrate. These results support the hypothesis that 
NarL directly activates the ogt promoter but indirectly activates the hcp promoter. It is likely 
that the difference of 9 minutes between induction of the ogt promoter and induction of the 
hcp promoter represents the time taken for RNS to be generated from nitrate. 
4.8. Discussion 
4.8.1. Regulation of ogt expression 
The E. coli Ogt protein has been shown to repair methylated DNA, as has another protein, 
Ada (Potter et al., 1987). Ada is a fascinating example of self-regulation since it is both a 
methyltransferase and a transcription factor: the structure of Ada is modified when it repairs a 





Figure 4.8: Induction kinetics of the hcp and ogt promoters 
Cultures of strain JCB387 carrying pRW50 containing the hcp383-0 or ogt100 promoter 
fragments were grown anaerobically at 37 ºC in minimal medium. 20 mM sodium nitrate was 
added when cells reached OD650 of ~0.4. β-Galactosidase activities were measured 
immediately prior to the addition of sodium nitrate (timepoint 0) and at 3 minute intervals 
following addition. The figure shows the ratio of the measured activity relative to timepoint 0 

























(Teo et al., 1986). This elegant mechanism directly connects expression of ada to DNA 
damage. By contrast, the ogt gene was initially reported to be constitutively expressed at a 
low level, although recent work has shown that expression is activated by NarL in a nitrate-
dependent manner (Squire et al., 2009). Squire et al. (2009) also demonstrated that FIS 
regulates ogt expression by repressing promoter activity when cells are growing in rich media. 
It is interesting that the expression of a gene encoding a DNA repair enzyme is activated 
by NarL. NarL is activated in response to the presence of nitrate and is partially activated in 
response to the presence of nitrite, neither of which is reported to cause DNA damage 
directly. However, recall that nitrate and nitrite are reduced when E. coli is growing 
anaerobically and by-products of this reduction include RNS, which are reported to cause 
DNA damage (Weiss, 2006). It is therefore possible that the regulation of ogt expression by 
NarL is a prophylactic mechanism designed to protect cells from future products of nitrate 
reduction, which in turn suggests that Ada is a general-purpose DNA repair enzyme whilst 
Ogt mitigates a particular threat. It is curious that Ogt is not upregulated in response to nitrite. 
Expression of ogt may be repressed by FIS may because, in rich media, cell growth and 
division is faster than it is in non-rich media and the energy expended by the cell on 
generating Ogt might be more advantageously used for cell growth and division.  
4.8.2. NarL regulation of the ogt promoter 
NarL has been found to activate ogt promoter activity by a class III mechanism from 2 
DNA sites that differ significantly from the consensus NarL binding sequence. However, even 
when fully induced, the ogt promoter is not highly active, which means that Ogt would be 
expected to accumulate slowly in the cell. This work has shown that NarL can activate by a 
class I mechanism from an upstream DNA site that matches the consensus sequence for NarL 
binding. Results in Figure 4.4 show that expression of the ogt100::lacZ fusion, which contains 
the wild type ogt promoter, and expression of the ogt1041::lacZ fusion, which contains a 
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consensus upstream NarL I site and a disrupted NarL II site, are similar. This indicates that 
NarL could activate the ogt promoter by either a class III or class I mechanism and produce a 
similar level of expression, leading to the question: why has the ogt promoter evolved to be 
activated by a class III mechanism rather than a class I mechanism? 
First, it is possible that NarL and FIS interact in the regulation of ogt expression. The 
NarL I site and the DNA site from which FIS represses overlap (see Figure 4.9) and therefore 
it is possible that if there were not a promoter proximal DNA site for NarL, then NarL would 
be unable to overcome FIS repression. Alternatively, if NarL activated ogt expression from a 
site centred at position -45.5 only, then FIS might not be able to repress. Interaction of FIS 
and NarL at the ogt promoter could be investigated using a wild type ogt promoter::lacZ 




 cells. Competitive in vitro studies of FIS 
and NarL binding to the ogt promoter fragment may also help to elucidate the relative 
functions of the proteins. 
The second possibility is that two poor DNA sites for NarL may ensure that ogt will only 
be optimally expressed when higher levels of activated NarL are present in the cell due to 
higher concentrations of nitrate. NarL is thought to activate target promoters hierarchically as 
weaker target sites are only bound once stronger target sites are already occupied. If the ogt 
promoter contained a single strong target for NarL, then expression of ogt might be induced in 
response to a lower concentration of nitrate than is optimal for the cell. This could be 
investigated by studying induction of the wild-type ogt promoter and a derivative activated by 
a class I mechanism in response to a range of nitrate concentrations. The relative fitness of 
cells could be gauged using a competitive growth experiment in a chemostat with cells where 
ogt expression is driven by the natural promoter and cells where ogt expression is driven by a 





Figure 4.9: DNA site for FIS and NarL overlap at the ogt promoter 
Reproduced from Squire et al. (2009). The figure is a diagram that shows the NarL I and II 
sites and the Fis I site at the ogt promoter. The Fis I site is represented by a diagonally shaded 
box and Fis protein is shown as diagonally shaded circles. The DNA sites for NarL are 
inverted horizontal arrows and NarL is represented as vertically shaded circles. The ogt 
transcription start site is denoted with a bent arrow and the label “+1”. The positions given 
below the DNA sites represent the centre point for the site relative to the ogt transcription 
start. The partial sequence below the diagram shows the sequence from position -91 to -69 of 
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4.8.3. NarL can activate by class I, II and III mechanisms 
This work has shown that NarL can activate transcription independently of FNR by Class 
I, II and III mechanisms. This is to be expected, as other members of the LuxR family (to 
which NarL belongs) are able to activate directly.  
NarL activation of ogt promoter derivatives by a class I mechanism appears to be less 
efficient than is activation by a class II mechanism. It is possible that this is because the NarL 
I site in the ogt promoter is at a sub-optimal location. However, experiments to move the 
NarL I site to a different position relative to the ogt transcription start do not markedly 
improve promoter activity (Patawarachin Ruanto, personal communication). It is also possible 
that if the NarL I site is made to match the consensus NarL binding sequence, then 
transcription will start from a different position than it does in the wild type ogt promoter. 
Patawarachin Ruanto (University of Birmingham, UK) has shown that if the confirmed ogt -
10 element is disrupted in the ogt1041 fragment, which contains a consensus NarL I site and a 
disrupted NarL II site, then promoter activity is minimal (Figure 4.10). This indicates that the 
same ogt promoter is functioning in the ogt1041 fragment and observed activity is not due to 
the chance activation of a second promoter. 
My work has shown that NarL can activate the ogt promoter very efficiently from a class 
II position. Derivatives of the ogt promoter that contain a consensus NarL II site are over 10-
fold more active than the wild type promoter. Interestingly, derivatives of the ogt promoter 
that contain a consensus NarL II site are also highly active in the absence of nitrate, when 
NarL is not thought to be active. It is to be expected that there are small levels of active NarL 
in the absence of nitrate and that this active NarL is enough to activate promoter activity. 
However, the yeaR promoter has a near consensus DNA site for NarL in a class II position but 
does not show high levels of promoter activity in the absence of nitrate (Squire et al. 2009). A 




Figure 4.10: Mutation of the -10 element in the ogt1041 fragment abrogates promoter 
activity 
Data from Patawarachin Ruanto (University of Birmingham) that shows expression of either 
an ogt1041::lacZ fusion or and derivative with a guanine substitution at position -12. 
Expression was measured in JCB387 cells following growth in minimal salt medium 
anaerobically or anaerobically and with medium supplemented with 20 mM nitrate. Data 
shown are the average of 3 biological repeats and error bars denote one standard deviation 
























NarL in the ogt promoter may be more optimal than is the position of the DNA site for NarL 
in the yeaR promoter. This hypothesis is disproved however by the results in Figure 4.3, panel 
B, which shows that a derivative of the ogt promoter that contains the sequence of the DNA 
site for NarL from the yeaR promoter, but at the ogt NarL II site position, is not highly active 
in the absence of nitrate. 
Another possible explanation is that the improved NarL sites in the ogt promoter 
derivatives are a better target for NarL than is the DNA site for NarL in the yeaR promoter. 
Figure 4.11 shows the sequences of the improved NarL I / II sites from ogt promoter 
derivatives used in this study and that of the DNA site for NarL from the yeaR promoter 
aligned with the consensus binding sequence for NarL. It shows that the improved DNA sites 
for NarL in the ogt promoter match the consensus binding sequence for NarL at all 14 
positions, whilst the sequence of the DNA site for NarL at the yeaR promoter only matches 
the consensus sequence at 9 of the 14 positions. This implies that the consensus NarL II site at 
the ogt promoter would present a stronger target for NarL than would the DNA site for NarL 
at the yeaR promoter. 
Overall, my results show that NarL can activate the ogt promoter by a class III mechanism 
from two weak DNA sites, both of which are crucial. However, if one site is modified to 
match the consensus sequence for DNA sites for NarL, then the other site becomes 
unnecessary. Thus, when a site is improved, it is no longer clear by which mechanism NarL 
activates. Results in Figure 4.4 show that the ogt101::lacZ fusion, in which the NarL I site is 
improved and the NarL II site is wild type, is expressed 3-fold greater than is the 
ogt1041::lacZ fusion, in which the NarL I site is improved and the NarL II site is disrupted. 
This indicates that the wild type NarL II site in the ogt101 fragment has a role in NarL-
dependent activation of expression of the ogt101::lacZ fusion, but that the NarL II site is no 





Figure 4.11: Alignment of DNA sites for NarL to the consensus sequence 
Figure shows the consensus sequence for DNA sites for NarL, the sequences of improved 
NarL I and II sites from ogt promoter derivatives and the sequence of the DNA site for NarL 
from the yeaR site. Fasta standard ambiguity codes are used: a Y denotes C or T; an M 
denotes A or C; a K denotes G or T and an R denotes A or G. Positions that match the 
consensus sequence are highlighted purple and score shows how many positions match out of 







Consensus DNA site for NarL 
Improved NarL I site (ogt105 fragment) 
Improved NarL II site (ogt105 fragment) 




14 / 14 
14 / 14 
9 / 14 
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activates transcription from such a promoter derivative. For example, a tethered nuclease such 
as FeBABE could be used to locate the positions of the CTD of the RNAP α subunit when 
bound to the ogt promoter, which may help clarify the mechanism of NarL activation (Miller 
and Hahn, 2006). 
4.8.4. NarP is a more discriminating activator than is NarL 
An interesting observation from the results of this work is that NarL can activate from 
positions, and by mechanisms, that NarP cannot. Hence, NarL must be capable of an 
activation mechanism that NarP is not. Specifically, NarP appears to be able to activate by a 
class II mechanism only, whilst NarL can activate by class I, II and III mechanisms. Also, 
NarP is unable to activate the yeaR promoter and the ogt promoter derivative carried by the 
ogt107 fragment, whilst NarL is able to activate both (see Figure 4.3, panels B and C). 
These observations pose two separate problems. The inability of NarP to activate by class 
I or class III mechanisms is likely to be a functional problem that arises from the structural 
differences between NarL and NarP. Although NarL and NarP are homologous, they are not 
identical. The inability of NarP to activate transcription of the yeaR promoter is possibly 
because the DNA site is too poor a target for NarP. An EMSA study of NarP binding to a 
radiolabelled DNA fragment containing the yeaR promoter did not find evidence of binding 
(personal communication from Derrick Squire, University of Birmingham, UK). Some of 
these issues are tackled in the work described in Chapter 5. 
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NarL belongs to the LuxR-GerE-TraJ family of transcription factors. Members of this 
family such as LuxR, have been reported to activate transcription by directly interacting with 
RNA polymerase (Choi and Greenberg, 1991). Because of its similarity to other family 
members, NarL would also be expected to be able to interact directly with RNAP to activate 
transcription. This hypothesis is supported by the work of Lin et al. (2007) and Squire et al. 
(2009), which showed that NarL can activate the yeaR and ogt promoters independently of 
other factors.  
Like many of the LuxR-GerE-TraJ family, NarL has 2 distinct domains, the NTD and the 
CTD. The CTD contains a LuxR type helix-turn-helix DNA binding motif and has been 
shown to be competent to bind DNA independently of the NTD (Maris et al., 2002). The 
NTD is thought to regulate DNA binding by the CTD by obscuring the helix-turn-helix motif. 
When NarL is phosphorylated by NarX or NarQ, it is thought to undergo a conformational 
change that repositions the NTD away from the CTD and permits DNA binding. 
The research described in this chapter seeks to examine whether NarL interacts directly 
with RNAP and to understand the relative contributions of the NTD and CTD with regard to 
promoter activation. 
5.2. Residues of αCTD important for activation by NarL at the ogt 
promoter 
The results of this work and those of Squire et al. (2009) indicate that NarL activates 
transcription from the ogt promoter by binding to sites at positions where it might directly 
interact with the RNAP polymerase α subunit. To investigate whether this is the case, the 
effect on NarL-dependent activation of 69 alanine substitutions within the RNA polymerase α 
subunit, covering residues 255 to 239, was measured. 
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To ascertain the effect of alanine substitutions of the RNAP α on NarL-dependent 
activation, JCB387 or JCB3875 (ΔnarP)cells were transformed with pRW50 carrying an ogt 
promoter fragment. Cells were then transformed with plasmids expressing either wild-type α 
or derivatives carrying alanine substitutions in the CTD. Cells were grown anaerobically in 
minimal salt medium and in the presence of nitrate to ensure NarL was phosphorylated before 
the β-Galactosidase activity was measured. Mutation of a residue was said to improve or 
impair activation if it resulted in average activity of the ogt promoter that was equal to or 
greater than 15% different from the activity of the ogt promoter in cells containing wild type 
RNA polymerase α subunit. 
5.2.1. Class III activated, wild type ogt promoter 
Results in Figure 5.1 show expression of the ogt100::lacZ fusion, which contains the wild 
type, class III activated ogt promoter, in JCB387. The NarL-dependent expression of the 
ogt100::lacZ fusion was affected, positively and negatively, by substitution of different 
residues in the αCTD with alanine. Alanine substitution of residues 258, 266, 273, 287, 288, 
290, 293, 307 impaired class III activation by NarL. Alanine substation of residues 259, 260, 
262, 263, 265, 268, 269, 278, 283, 284, 291, 297, 298 and 303 notably improved class III 
activation by NarL. These results indicate that, when activating transcription by a class III 
mechanism, NarL does interact with RNAP via the αCTD.  
Residues of αCTD identified by the alanine scan as being involved in class III activation 
by NarL were mapped onto the structural model of αCTD. Figure 5.2 shows that many 
residues identified are surface exposed, which supports the hypothesis that they are involved 
in interaction with NarL. The majority of the residues that, when mutated to alanine, 
negatively affect class III activation by NarL can be seen to cluster into a band around the 
outside of the α CTD. This could represent multiple distinct contacts with NarL, such as is 




Figure 5.1 Residues of αCTD that are important for NarL-dependent activation of the ogt promoter 
JCB387 cells containing pRW50 carrying the ogt100 fragment were transformed with derivatives of plasmids pHTf1 (substitutions at 255 to 271 and 
302) or pREII (substitutions at remaining positions). Wild type pHTf1 and pRE11 are labelled pHT and pRE respectively. Each plasmid encoded an α 
derivative with a single alanine substitution between residues 255 and 329 as indicated in the figure. Galactosidase activities are expressed as 
percentages of the activity obtained with cells transformed with plasmids encoding wild-type α (100% = 648 Miller units). Residues 267, 272, 274, 
308, 324, and 327 are alanines in the wild-type protein. Each bar shows the average of 3 biological replicates and errors bars indicate 1 standard 





























































































































































































































       
Figure 5.2 Model of αCTD indicating position of residues implicated in class III 
activation by NarL 
Structure of αCTD (Jeon et al., 1995) showing side chains identified as critical for class I 
activation by NarL. Two views of the structure, related by a 180° rotation on the vertical axis, 
are shown. Residues where alanine replacement impairs class I activation by NarL are 






contact with  the αCTD. Residue 266 appears to be inside the core structure of the αCTD 
Some of the residues that, when mutated to alanine, improved NarL-dependent class III 
activation fall in the DNA binding domain of the αCTD. Residues 268, 269 and 298 have all 
been identified as being involved in recognition of UP sites (Gourse and Gaal, 2000). It is 
possible that by disrupting the interaction of the αCTD with DNA, NarL is better able to 
sequester the αCTD. Together these results support the hypothesis that NarL interacts directly 
with RNAP to recruit it to the ogt promoter. 
5.2.2. Class I activated derivative of the ogt promoter  
If NarL interacts with RNAP directly during class III activation then it is highly likely that 
it does so during class I activation as well. Recall that class III activation can be viewed as a 
hybrid of class I and class II activation (see Figure 1.7). Thus, the contacts that NarL makes 
with the αCTD for class I activation would be expected to be a subset of those contacts it 
makes for class III activation.  
Results in Figure 5.3 show expression of the ogt1041::lacZ fusion, which contains a class 
I activated derivative of the ogt promoter, in JCB3875. The NarL-dependent expression of the 
ogt1041::lacZ fusion is affected, positively and negatively, by mutation of residues in the 
αCTD to alanine. Alanine substitution of residues 259, 261, 271, 273, 280, 288, 290, 293, 
296, 302, and 328 impaired class I activation by NarL. Alanine substitution of residues 257, 
260, 262, 268, 269, 270, 278, 281, 284, 291, 298, 300, 303, 304, 305, 307, 314, and 316 
notably improved class I activation by NarL. These results suggest that NarL interacts with 
RNAP via the αCTD when activating by a class I mechanism. As expected, there is an overlap 
between the residues of αCTD involved in class I activation by NarL and those involved in 
class III activation. Class III activation typically involves more contacts with polymerase that 
does class I activation (see Section 1.10). Therefore, it is unexpected that more residues of 




Figure 5.3 Residues of αCTD that are important for class I activation by NarL 
JCB3875 cells containing pRW50 carrying the ogt1041 fragment were transformed with derivatives of plasmids pHTf1 (substitutions at 255 to 271 and 
302) or pREII (substitutions at remaining positions). Wild type pHTf1 and pRE11 are labelled pHT and pRE respectively. Each plasmid encoded an α 
derivative with a single alanine substitution between residues 255 and 329 as indicated in the figure. β-Galactosidase activities are expressed as 
percentages of the activity obtained with cells transformed with plasmids encoding wild-type α (100% = 405 Miller units). Residues 267, 272, 274, 
308, 324, and 327 are alanines in the wild-type protein. Each bar shows the average of 3 biological replicates and errors bars indicate 1 standard 









































































































































































































































NarL. One possible explanation for this observation is that less overall contacts are needed for 
class III activation because both αCTDs are bound by NarL. At class I activated promoters 
NarL is only predicted to bind one αCTD, which may necessitate more contacts. 
Residues of αCTD identified by the alanine scan as being involved in class I activation by 
NarL were mapped onto the structural model of αCTD. Figure 5.4 shows that all residues 
identified are surface exposed, which supports the hypothesis that they are involved in 
interaction with NarL. As was observed with class III activation, αCTD residues implicated as 
necessary for class I activation cluster in a band around the outside of the αCTD, although 
one, residue 320, is towards the linker region. Residue 320 could be a target for NarL or, 
when mutated to alanine, might impair flexibility of the linker / αCTD and therefore the 
ability of NarL to bind the αCTD. As with class III activation, many of the residues that, when 
mutated to alanine, improve NarL-dependent class III activation fall in the DNA binding 
determinant of the αCTD. However, many residues also are not surface exposed and are 
inside the structure of the αCTD. This indicates that mutation of such residues may disrupt the 
3D structure of the αCTD, although it is unclear by what mechanism that this improves NarL-
dependent class I activation.  
5.2.3. Class II activated derivative of the ogt promoter 
Results so far indicate that NarL interacts with the αCTD when activating by class I and, 
III mechanisms. However, recall that transcription factors that activate by a class II 
mechanism are placed where they might contact the αNTD, σ or even β (see Section 1.10). 
Therefore, it is entirely possible that NarL makes no contacts with the αCTD when activating 
transcription by a class II mechanism.  
Results in Figure 5.5 show expression of the ogt1052::lacZ fusion, which contains a class 
II activated derivative of the ogt promoter, in JCB3875. The NarL-dependent expression of 
the ogt1052::lacZ fusion is affected, positively and negatively, by mutation of residues in the 
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Figure 5.4 Model of αCTD indicating position of residues implicated in class I activation 
by NarL 
Structure of αCTD (Jeon et al., 1995) showing side chains identified as critical for class I 
activation by NarL. Two views of the structure, related by a 180° rotation on the vertical axis, 
are shown. Residues where alanine replacement impairs class I activation by NarL are 




Figure 5.5 Residues of αCTD that are important for class II activation by NarL 
JCB3875 cells containing pRW50 carrying the ogt1052 fragment were transformed with derivatives of plasmids pHTf1 (substitutions at 255 to 271 and 
302) or pREII (substitutions at remaining positions). Each plasmid encoded an α derivative with a single alanine substitution between residues 255 and 
329 as indicated in the figure. Galactosidase activities are expressed as percentages of the activity obtained with cells transformed with plasmids 
encoding wild-type α (100% = 405 Miller units). Residues 267, 272, 274, 308, 324, and 327 are alanines in the wild-type protein. Each bar shows the 









































































































































































































































αCTD to alanine. Mutation of a residue is said to improve or impair activation if it results in 
average activity of the ogt promoter that is equal to or greater than 15% different from the 
activity of the ogt promoter in cells containing wild type RNA polymerase α subunit. Alanine 
substitution of residues 259, 261, 268, 273, 287, 288, 293, 295, 296, 299, 302, 310, 312, 313, 
and 320 impaired class II activation by NarL. Alanine substitution of residues 257, 260, 269 
303, 304, 307 and 314 improved class II activation by NarL. These results indicate that NarL 
interacts with RNAP via the αCTD when activating by a class II mechanism. 
Residues of αCTD identified by the alanine scan as being involved in class II activation 
by NarL were mapped onto the structural model of αCTD. Figure 5.6 shows that all residues 
identified are surface exposed, which supports the hypothesis that they are involved in 
interaction with NarL. As was observed with class I and class III activation, αCTD residues 
implicated as necessary for class II activation cluster in a band around the outside of the 
αCTD. The residues of αCTD implicated in class II activation are broadly similar to those 
implicated as important in class I activation. However, the residues from 307-313 of αCTD 
appear to have a small effect on class II activation by NarL, but no effect on class I activation 
by NarL. Class II activation by NarL appears to involve similar residues of αCTD as are 
involved in class III activation. However, as with class I activation, more residues of αCTD 
are needed for class II activation by NarL than are by class III activation by NarL. The results 
indicate that NarL contacts the αCTD when activating by a class II mechanism. However, the 
results do not eliminate the possibility that NarL contacts other parts of the transcription 
machinery when activating by a class II mechanism. 
5.3. The CTD of NarL is competent to activate transcription by a class II 
mechanism 
The results in Figures 5.1 – 5.6 indicate that NarL directly interacts with RNAP,
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Figure 5.6 Model of αCTD indicating position of residues implicated in class II 
activation by NarL 
Structure of αCTD (Jeon et al., 1995)showing side chains identified as critical for class II 
activation by NarL. Two views of the structure, related by a 180° rotation on the vertical axis, 
are shown. Residues where alanine replacement impairs class II activation by NarL are 










potentially in order to recruit polymerase at the ogt promoter. Structural studies of NarL 
indicate that it has 2 distinct domains that are joined by a flexible linker and that the CTD is 
competent to bind DNA (see Figure 5.7, panel A) (Baikalov et al., 1996, Maris et al., 2002). 
To investigate what, if any, role the NarL NTD plays in activating transcription, full length 
NarL and the CTD of NarL were expressed from a plasmid and the activity of NarL-
dependent promoters was measured in cells lacking chromosomal narL and narP. 
The NarL CTD and full length NarL were amplified from the E. coli chromosome as NsiI-
HindIII fragments (producing the NarL-CTD and NarL-Full fragments respectively). The 
NarL-CTD and NarL-Full fragments were cloned into the NsiI –HindIII sites of the high 
copy-number vector pJW15 Δ100 (see Figure 5.7, panel B). The plasmid pJW15 Δ100 carries 
an EcoRI-HindIII fragment  that contains the melR promoter and the coding sequence of melR 
with an NsiI site engineered at codons 1 and 2. The NarL-CTD and NarL-Full fragments 
replaced the melR coding sequence and yielded plasmids pDLC1 and pDLC2 respectively 
(see Figure 5.7, panel C). This fused the NarL-CTD and NarL-Full fragments to the melR 
translation start. 
JCB3884 cells, which lack NarL and NarP, were transformed with pRW50 carrying one of 
the ogt100, ogt1041 or ogt1052 fragments as promoter::lacZ fusions. Cells were also 
transformed with pJW15 Δ100, pDLC1 or pDLC2. Cells were then grown anaerobically in 
minimal salt medium with or without nitrate and expression of promoter::lacZ fusions was 
measured. 
Results in Figure 5.8, panel A, show expression of the ogt100::lacZ fusion, which 
contains the class III activated ogt promoter. In cells that contain pJW15 Δ100, which does 
not carry narL, minimal expression of the ogt100::lacZ fusion is observed and nitrate fails to 
induce expression. In cells that contain pDLC1, which expresses the NarL-CTD fragment, 
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Figure 5.7 Structure of NarL and diagrams of NarL fragments 
Panel A, The amino acid sequence of NarL. Shaded regions indicate residues involved in the 
NarL secondary structure and the identity of those structural elements is given above the 
alignment. Sequence underlined in red is that reported as constituting the NTD and that 
underlined in green constitutes the CTD. Linker helix and flexible linker are denoted. Adapted 
from Baikalov et al. (1996). 
 
Panel B shows a map of the pJW15 Δ100 plasmid with the region between the EcoRI and 
HindIII sites enlarged and diagrams of the NarL-CTD fragment and NarL-Full fragment. A 
capital „E‟ denotes an EcoRI site, a capital „N‟ denotes an NsiI site and a capital „H‟ denotes a 
HindIII site. The bent arrow indicates the melR promoter. Curved arrows indicate the ampR 
and galK ORFs carried by pJW15 Δ100. In the diagrams of fragments, the narL coding region 
is indicated by a labelled grey box and the specific domains marked with a labelled clear box. 
Diagram is not to scale 
 
Panel C is a table of plasmids used in this section. The table lists the vector used in 
construction of the plasmid, the relevant DNA fragment carried in the plasmid and the 












Plasmid Background Carries fragment Promoter 
pDLC1 pJW15 Δ100 NarL-CTD PmelR 



































Figure 5.8 Expression of promoter::lacZ fusions with plasmid encoded NarL CTD and 
full length protein 
Figure shows expression of promoter::lacZ fusions measured in JCB3884 cells containing 
empty vector pJW15 Δ100 or derivatives that express the NarL CTD or full-length protein. 
NarL fragment carried by plasmid is given below plasmid name in italicised text. Cells were 
grown anaerobically or anaerobically in minimal salt medium supplemented with 20 mM 
sodium nitrate. Data shown are averages from at least 3 biological repeats, and error bars 
show one standard deviation from the mean. Panel A shows expression of the ogt100::lacZ 
fusion, carried by pRW50, panel B shows expression of the ogt1031::lacZ fusion, carried by 








































































minimal expression is observed and nitrate fails to induce expression. This suggests that the 
CTD of NarL is not competent to activate transcription by a class III mechanism. Minimal 
expression of the ogt100::lacZ fusion is observed in cells that contain pDLC2, which carries 
the NarL-Full fragment, and nitrate fails to induce expression. This indicates that the NarL 
expressed from the NarL-Full fragment is not able to activate transcription by a class III 
mechanism. This observation disagrees with the results of Squire et al. (2009) and previous 
results of this work, which indicate that the wild-type NarL is able to activate by a class III 
mechanism. 
Figure 5.8, panel B, shows expression of the ogt1041::lacZ fusion, which contains a 
NarL-dependent, class I activated promoter. In cells that contain pJW15 Δ100, which does not 
carry narL, minimal expression of the ogt100::lacZ fusion is observed and nitrate fails to 
induce expression. In cells that contain either pDLC1 or pDLC2, which carry the NarL-CTD 
and NarL-Full fragments respectively, minimal expression is observed and nitrate fails to 
induce expression. This indicates that neither the CTD of NarL, nor the NarL expressed from 
the NarL-Full fragment, is competent to activate transcription by a class I mechanism. This 
observation disagrees with the previous results of this work, which indicate that the wild-type 
NarL is able to activate by a class I mechanism.  
Figure 8, panel C, shows the expression of the ogt1052::lacZ fusion, which is NarL-
dependent and is activated by a class II mechanism. In cells that contain pJW15 Δ100, which 
does not carry narL, minimal expression is observed and nitrate fails to induce expression. In 
cells that contain pDLC1, which carries the NarL-CTD fragment, maximal expression of the 
ogt1052::lacZ fragment is observed although nitrate fails to induce expression further. This 
indicates that the CTD of NarL is competent to activate transcription by a class II mechanism 
and that the CTD does not itself require activation in response to nitrate in order to do so. A 
high level of expression is observed in cells that contain pDLC2, which carries the NarL-Full 
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fragment, and nitrate fails to induce further. This agrees with previous results that indicate 
that NarL can activate transcription by a class II mechanism. Previous results also indicate 




) cells, expression of the ogt1052::lacZ fusion is high in the absence of 
nitrate. This is possibly because the ogt1052 fragment contains a consensus DNA site for 
NarL at an optimal location, and therefore residually active NarL would bind and activate 
transcription. 
These results indicate that the NarL CTD is competent to activate transcription by a class 
II mechanism but not by class I or class III mechanisms. These results also indicate that the 
NarL encoded by the NarL-Full fragment is able to activate by a class II mechanism but not 
by class I or class III mechanisms, an observation which is at odds with earlier results. There 
are two possible explanations for this discrepancy. First, in order to clone narL, the second 
codon was changed from AGT, which encodes Serine, to CAT, which encodes Threonine. It 
is possible that this modification, or another product of the cloning strategy used, prevents 
NarL from adopting its correct secondary and tertiary structure. Alternatively, it is possible 
that NarX does not function correctly in JCB3884 cells. This is because narX and narL are in 
an operon and so when JCB3875 (from which JCB3884 was derived) was constructed by 
disruption of narL with a transposon, narX expression may have been affected. Therefore 
NarL would not be phosphorylated in response to nitrate and would be unable to activate 
transcription. 
5.4. Plasmid encoded NarL functions similarly when supplied in trans 
To investigate the inability of plasmid-encoded full-length NarL to activate class I and III 




 strain JCB387. As before, 
expression of promoter::lacZ fusions was measured following anaerobic growth in minimal 
salt medium with or without nitrate. 







Figure 5.9 Expression of promoter::lacZ fusions with plasmid encoded NarL CTD and 
full length protein supplied in trans 
Figure shows expression of promoter::lacZ fusions measured in JCB387 cells containing 
control plasmid pJW15 Δ100 or plasmids that express the NarL CTD or full-length protein. 
NarL fragment carried by plasmid is given below plasmid name in italicised text. Cells were 
grown anaerobically or anaerobically in minimal salt medium supplemented with 20 mM 
sodium nitrate. Panel A shows expression of the ogt100::lacZ fusion, carried by pRW50, 
Panel B shows expression of the ogt1041::lacZ fusion, carried by pRW50 and Panel C shows 








































































III wild-type ogt promoter. In cells that contained the empty pJW15 Δ100 vector plasmid, 
minimal expression was observed in the absence of nitrate and expression was induced by 
nitrate as expected. In cells that contained pDLC1 or pDLC2, which carry the NarL-CTD 
fragment and the NarL-Full fragment respectively, the pattern and levels of expression of the 
ogt100::lacZ fusion was identical to that of cells that contain pJW15 Δ100. This indicates that 
neither the NarL CTD nor the NarL encoded by the NarL-Full fragment can activate 
transcription by a class III mechanism when supplied in trans. 
Figure 5.9, panel B, shows expression of the ogt1041::lacZ fusion, which is activated by a 
class I mechanism. In cells that contain the empty pJW15 Δ100 vector plasmid, minimal 
expression was observed in the absence of nitrate and expression was induced by nitrate. In 
cells that contain pDLC1 or pDLC2, which carry the NarL-CTD fragment and the NarL-Full 
fragment respectively, the pattern and levels of expression of the ogt1041::lacZ fusion were 
identical to that of cells that contained pJW15 Δ100. This indicates that neither the NarL CTD 
nor the NarL encoded by the NarL-Full fragment can activate transcription by a class I 
mechanism when supplied in trans. 
Figure 5.9, panel C, shows expression of the ogt1052::lacZ fusion, which is activated by a 
class II mechanism. In cells that contain empty pJW15 Δ100 vector plasmid, expression of the 
ogt1052::lacZ fusion was high and nitrate induced further. In cells that contain pDLC1, which 
carries the NarL-CTD fragment, expression of the ogt1052::lacZ fusion was maximal 
anaerobically and nitrate did not induce further. This indicates that the CTD of NarL 
contributes to activity of a class II promoter when supplied in trans. In cells that contain 
pDLC2, which carries the Narl-Full fragment, expression of the ogt1052::lacZ fusion was 
high and similar whether cells were grown in the presence or absence of nitrate. This indicates 
that the NarL encoded by the NarL-Full fragment can activate by a class II mechanism when 
supplied in trans. These results confirm that the NarL CTD can activate by a class II 
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mechanism when supplied in trans, but that it cannot activate by class I or III mechanisms. 
Results also show that the NarL encoded by the NarL-Full fragment is able to activate by a 
class II mechanism but not by class I or III mechanisms. As functional NarX was present in 
the JCB387 cells used, these results suggest that the NarL-Full fragment does not produce a 
functional NarL protein.  
5.5. Plasmid encoded NarXL can activate by class I, II and III mechanisms 
The above results indicate that the NarL-Full fragment in pDLC2 does not produce a NarL 
protein that can function similarly to the wild-type NarL. To mitigate any errors introduced by 
cloning narL downstream of the melR promoter and translation start, the narXL operon was 
ligated into a plasmid complete with its own promoter region.  
The NarXL fragment was prepared by amplifying the narXL operon from the 
chromosome as an EcoRI-HindIII DNA fragment. Plasmid pJW15 Δ100 (see Figure 5.7, 
panel B) was prepared with EcoRI and HindIII to remove melR and its regulatory region and 
the NarXL fragment was ligated in its place. However, it was not possible to recover 
transformants and it has been suggested that such a construct is toxic to the cell because of the 
high-copy nature of pJW15 Δ100 (Douglas Browning, personal communication). Thus, the 
NarXL, NarL-CTD and NarL-Full fragments were cloned into the lower copy-number 
plasmid pLG339 (see Figure 5.10).  
To make the tetracycline and kanamycin resistant pLG339 compatible with pRW50, it 
was necessary to clone into, and therefore disrupt, the tetracycline resistance gene. BamHI-
EcoRI DNA fragments beNarL-CTD and beNarL-Full were constructed by amplifying the 
EcoRI-HindIII fragments from pDLC1 and pDLC2 (see Figure 5.7) and changing the 
restriction sites (see Figure 5.10, panel A). The BamHI-EcoRI fragments were then cloned 
into prepared pLG339 producing pDLC3 and pDLC4 (see Figure 5.10, panel B). The 




Plasmid Background Carries fragment Promoter 
pDLC3 pLG339 beNarL-CTD PmelR 
pDLC4 pLG339 beNarL-Full PmelR 
pDLC5 pLG339 beNarXL PnarXL 
 
Figure 5.10 pLG339 and cloned NarL fragments 
Panel A, shows a map of the pLG339 plasmid and diagrams of the beNarL-CTD, beNarL-Full 
and beNarXL DNA fragments. A capital „B‟ denotes a BamHI site, a capital „E‟ denotes an 
EcoRI site and a capital „N‟ denotes an NsiI site. The bent arrow indicates a promoter, which 
is labelled. The curved arrows labelled TcR indicates a tetracycline resistance gene and the 
curved arrow labelled KmR indicates a kanamycin resistance gene. A shaded box indicates 
the narL coding region. Diagram is not to scale 
Panel B is a table of plasmids used in this section. The table lists the vector used in 
construction of the plasmid, the relevant DNA fragment carried in the plasmid and the 































prepared pLG339, producing pDLC5. JCB3884 cells, which do not contain NarL or NarP 
were transformed with either pDLC3, pDLC4 or pDLC5. Cells were then transformed with 
pRW50 carrying ogt100, ogt1041 or ogt1052 DNA fragments. Cells were grown 
anaerobically with or without nitrate and expression of promoter::lacZ fusions was measured 
Figure 5.11, panel A, shows expression of the ogt100::lacZ fusion, which contains the 
wild-type ogt promoter and is activated by NarL by a class III mechanism. In cells that 
contained empty pLG339 ΔRS, expression of the ogt100::lacZ fusion was minimal and nitrate 
did not induce. In cells that contained pDLC3 or pDLC4, which carry the NarL-CTD and 
NarL-Full fragments respectively, expression of the ogt100::lacZ fusion was identical to that 
in cells that contained pLG339 ΔRS. This indicates that the NarL-CTD and the NarL encoded 
by the NarL-Full fragment are unable to activate by a class III mechanism when expressed 
from pLG339. In cells that contain pDLC5, which carries the NarXL fragment, expression of 
the ogt100::lacZ fusion is minimal when cells are grown anaerobically and nitrate induces 
expression. This indicates that the NarL encoded by the NarXL fragment in pDLC5 is able to 
activate by a class III mechanism and in a nitrate dependent manner.  
Figure 5.11, panel B, shows expression of the ogt1041::lacZ fusion, which contains a 
NarL-dependent promoter that is activated by a class I mechanism. In cells that contained 
empty pLG339 ΔRS, expression of the ogt1041::lacZ fusion was minimal and nitrate did not 
induce expression further. In cells that contained pDLC3 or pDLC4, which carry the NarL-
CTD and NarL-Full fragments respectively, expression of the ogt1041::lacZ fusion was 
identical to that in cells that contained pLG339 ΔRS. This indicates that the NarL-CTD and 
the NarL encoded by the NarL-Full fragment are unable to activate by a class I mechanism 
when expressed from pLG339. In cells that contained pDLC5, which carries the NarXL 
fragment, expression of the ogt1041::lacZ fusion was minimal when cells are grown 






Figure 5.11 Expression of promoter::lacZ fusions with plasmid encoded NarL CTD and 
full-length protein 
Figure shows expression of promoter::lacZ fusions measured in JCB3884 cells containing 
control plasmid pLG339 or plasmids that express the NarL CTD (pDLC3), full length NarL 
(pDLC4) or the narXL operon (pDLC5). NarL fragment carried by plasmid is given below 
plasmid name in italicised text. Cells were grown anaerobically or anaerobically in minimal 
salt medium supplemented with 20 mM sodium nitrate. Data shown are averages from at least 
3 biological repeats, and error bars show one standard deviation from the mean. Panel A 
shows expression of the ogt100::lacZ fusion, carried by pRW50, panel B shows expression of 
the ogt1041::lacZ fusion, carried by pRW50 and panel C shows expression of the 
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NarXL fragment is able to activate by a class I mechanism and in a nitrate dependent manner. 
Figure 5.11, panel C, shows expression of the ogt1052::lacZ fusion, expression of which 
is activated by NarL by a class II mechanism. In cells that contained empty pLG339 ΔRS, 
expression of the ogt1052::lacZ fusion was minimal and nitrate failed to induce. In cells 
containing pDLC3, which carries the NarL-CTD fragment, expression of the ogt1052::lacZ 
fragment was high when the cells are grown anaerobically and nitrate did not induce 
expression further. Absolute levels of expression of the ogt1052::lacZ fusion were lower in 
cells containing pDLC3, which is a low copy number plasmid, than in cells containing 
pDLC1, which is a high copy number plasmid. This supports the hypothesis that the NarL 
CTD can activate by a class II mechanism. In cells that contained pDLC4, which carries the 
NarL-Full fragment, expression of the ogt1052::lacZ fusion was higher than in cells that 
contained pLG339 ΔRS, but lower than in cells that contained pDLC3. This further indicates 
that the NarL encoded by the NarL-Full fragment can activate by a class II mechanism. In 
cells that contained pDLC5, which carries the NarXL fragment, expression of the 
ogt1052::lacZ fusion was maximal anaerobically and nitrate failed to induce further. This 
indicates that the NarL encoded by the NarXL fragment is able to induce by a class II 
mechanism and that it can do this in the absence of nitrate.  
These results show that it is possible to express NarL from a plasmid and that it acts 
similarly to wild-type, chromosomally encoded NarL. Furthermore, these results indicate that 
the NarL CTD is able to activate by a class II mechanism, while full length NarL is able to 
activate by class I, II and III mechanisms.  
5.6. The NarP CTD can activate by a class II mechanism.  
Previous results of this work indicate that NarP can activate by a class II mechanism but 
not by class I or III mechanisms. To investigate whether the CTD of NarP is able to activate 
transcription, the CTD was expressed from plasmid pJW15 Δ100. The structure of NarP has 
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not been solved so cloning was based on an alignment with NarL (see Figure 5.12, panel A). 
To ensure that a construct expressing a functional CTD was obtained, 3 fragments were 
prepared that start from different codons: NarP-CTD146, which starts from the same relative 
codon as the NarL-CTD fragment; NarP-CTD138 that starts from codon 138 and 
NarP-CTD148 that starts from codon 148. Fragments were amplified from the chromosome 
as NsiI-HindIII fragments and ligated into Nsi-HindIII prepared pJW15 Δ100 producing 
pDLC6 (NarP-CTD146), pDLC8 (NarP-CTD138) and pDLC9 (NarP-CTD148) (see, panel 
C). JCB3884 cells, which lack NarL and NarP, were transformed with NarL / NarP-dependent 
promoter::lacZ fusions and either plasmid pJW15 Δ100, pDLC6, pDLC8 or pDLC9. 
Expression of the promoter lacZ fusions was measured following anaerobic growth in 
minimal salt medium. 
Results in Figure 5.13, panel A, show expression of the ogt100::lacZ fusion, which 
contains the class III activated wild-type ogt promoter. In cells that contained the empty 
pJW15 Δ100 vector, expression of the ogt100::lacZ fusion was minimal. In cells containing 
pDLC6, pDLC8 or pDLC9, which carry the NarP-CTD146, NarP-CTD138 and NarP-
CTD148 fragments respectively, expression of the ogt100::lacZ fusion was also minimal. 
This indicates that none of the NarP CTDs expressed by the plasmids are able to activate by a 
class III mechanism.  
Results in Figure 5.13, panel B, show expression of the ogt1041::lacZ fusion, which 
contains a NarL-dependent promoter that is activated by a class I mechanism. In cells that 
contained the empty pJW15 Δ100 vector, expression of the ogt1041::lacZ fusion was 
minimal. In cells containing pDLC6, pDLC8 or pDLC9, which carry the NarP-CTD146, 
NarP-CTD138 and NarP-CTD148 fragments respectively, expression of the ogt1041::lacZ 
fusion was also minimal. This indicates that none of the NarP CTDs expressed by the 




Figure 5.12 Structure of NarP and DNA fragments used in this section 
Panel A, Alignment of the amino acid sequence of NarL and NarP. Shaded regions indicate 
residues involved in the NarL secondary structure and the identity of those structural elements 
is given above the alignment. Sequence underlined in red is that reported as constituting the 
NTD and that underlined in green constitutes the CTD. Linker helix and flexible linker are 
denoted. Adapted from Baikalov et al. (1996). 
 
anel B, shows a map of the pJW15 Δ100 plasmid with the region between the EcoRI and 
HindIII sites enlarged and diagrams of the NarP-CTD146, NarP-CTD138 and NarP-CTD148 
fragments. A capital „E‟ denotes an EcoRI site, a capital „N‟ denotes an NsiI site and a capital 
„H‟ denotes a HindIII site. The bent arrow indicates the melR promoter. Curved arrows 
indicate the ampR and galK ORFs carried by pJW15 Δ100. In the diagrams of fragments, the 
narP coding region is indicated by a labelled grey box and the specific domains marked with 
a labelled clear box. Diagram is not to scale 
 
Panel C is a table of plasmids used in this section. The table lists the vector used in 
construction of the plasmid, the relevant DNA fragment carried in the plasmid and the 













Plasmid Background Fragment Promoter 
pDLC6 pJW15 Δ100 NarP-CTD146 PmelR 
pDLC8 pJW15 Δ100 NarP-CTD138 PmelR 












































Figure 5.13 Expression of promoter::lacZ fusions with plasmids containing fragments of 
the NarP CTD  
Figure shows expression of promoter::lacZ fusions measured in JCB3884 cells containing 
control plasmid pLG339 or plasmids that express fragments of the NarP CTD. NarP fragment 
carried by plasmid is given below plasmid name in italicised text. Cells were grown 
anaerobically in minimal salt medium. Data shown are averages from at least 3 biological 
repeats, and error bars show one standard deviation from the mean. Panel A shows expression 
of the ogt100::lacZ fusion, carried by pRW50, panel B shows expression of the ogt1041::lacZ 
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Results in Figure 5.13, panel C, show expression of the ogt1052::lacZ fusion, which is 
activated by a class II mechanism. In cells that contained the empty pJW15 Δ100 vector, 
expression of the ogt1052::lacZ fusion was minimal. In cells that contained pDLC6, which 
carries the NarP-CTD146 fragment, minimal expression of the ogt1052::lacZ fusion was 
observed. In cells that contained pDLC8, which carries the NarP-CTD138 fragment, high 
expression of the ogt1052::lacZ fusion was observed. This indicates that the NarP CTD 
encoded by the NarP-CTD138 fragment is able to activate transcription by a class II 
mechanism. However, in cells that contained pDLC9, which carries the NarP-CTD148 
fragment, expression of the ogt1052::lacZ fragment was minimal, indicating that the NarP-
CTD encoded by the NarP-CTD148 fragment is not able to activate transcription by a class II 
mechanism. 
Taken together, these results indicate that the CTD of NarP is able to activate transcription 
by a class II mechanism, but not by class I or II mechanisms. Results also suggest that the 
NarP CTD that is encoded by the NarP-CTD138 fragment is functional, whilst the NarP 
CTDs encoded by the NarP-CTD146 fragment and the NarP-CTD148 fragment are not.  
5.7. Plasmid encoded full-length NarP can activate by a class II mechanism 
Previous results indicate that chromosomally expressed NarP can only activate by a class 
II mechanism and that this activation requires only the CTD of NarP. To ensure that this is 
also true of plasmid-expressed full-length NarP, the narP gene, complete with its own 
promoter region, was cloned into pLG339 (see Figure 5.14, panel A). The BamHI-EcoRI 
NarP-op fragment was constructed by amplification of the narP gene from the chromosome. 
The NarP-op fragment was ligated into BamHI-EcoRI-cut pLG339, producing pDLC14 (see 
Figure 5.14, panel B). JCB3884 cells, which do not contain NarL or NarP, were transformed 
with either pDLC14 or empty pLG339 ΔRS. Transformants were then transformed with 





Plasmid Background Fragment Promoter 
pDLC14 pLG339 NarP-op PnarP 
 
Figure 5.14 Map of pLG339 and NarP fragment used in this section 
Panel A, shows a map of the pLG339 plasmid and a diagram of NarP-op DNA fragment. A 
capital „B‟ denotes a BamHI site, a capital „E‟ denotes an EcoRI site. The bent arrow 
indicates the narP promoter, which is labelled. The curved arrows labelled TcR indicates a 
tetracycline resistance gene and the curved arrow labelled KmR indicates a kanamycin 
resistance gene. A shaded box indicates the narL coding region. Diagram is not to scale 
Panel B is a table of the plasmid used in this section. The table lists the vector used in 
construction of the plasmid, the relevant DNA fragment carried in the plasmid and the 





















mechanism. The β-Galactosidase activity was measured following cells growth in minimal 
salt medium, with or without nitrate. 
Figure 5.15, panel A, shows expression of promoter::lacZ fusions in cells containing 
empty pLG339 ΔRS. Expression of all promoter::lacZ fusions was minimal, and, as expected, 
nitrate did not induce expression. Figure 5.15, panel B, shows the expression of 
promoter::lacZ fusions in cells that contain pDLC14, which carries the complete narP gene 
controlled by its own promoter. Expression of the ogt100::lacZ fusion, which contains the 
wild-type ogt promoter and is activated by a class III mechanism, was minimal in the absence 
of nitrate, and nitrate failed to induce. Expression of the ogt1041::lacZ fusion, which is 
activated by a class I mechanism, was minimal in the absence of nitrate and nitrate failed to 
induce. However, expression of the ogt1052::lacZ fusion, which is activated by a class II 
mechanism, was high when cells were grown anaerobically and was induced by nitrate. 
 These results agree with previous results and confirm that NarP is able to activate 
transcription only by a class II mechanism. These results also indicate that the NarP expressed 
by pDLC14 is functional. 
5.8. Discussion 
5.8.1. NarL interacts directly with the αCTD 
There are many examples in the literature of promoters where NarL regulates 
transcription. However, proving a mechanism of regulation can be difficult and molecular 
mechanisms of NarL have only been detailed in a few cases. An example of such a case is that 
of the E. coli nirB promoter, where transcription is induced by NarL. Investigation showed 
that NarL does not activate in the classical sense, but instead overcomes the repressors IHF 
and Fis by „remodelling the nucleoprotein assembly‟(Browning et al., 2004). NarL is likely 






Figure 5.15 Expression of promoter::lacZ fusions in cells containing a plasmid carrying 
the narP operon 
Figure shows expression of promoter::lacZ fusions, carried by pRW50, measured in JCB3884 
cells containing control plasmid pLG339 (panel A) or pDLC14 (panel B), which carries the 
NarP-OP fragment. Cells were grown anaerobically or anaerobically with nitrate in minimal 
salt. Data shown are averages from at least 3 biological repeats, and error bars show one 
















































local helical structure (Maris et al., 2002). However, at some promoters, NarL binds to DNA 
sites in positions where it would be expected to be able to contact the αCTD of RNAP 
directly. Furthermore, other members of the protein family to which NarL belongs are able to 
interact with the αCTD, which would suggest that NarL is able to as well. 
The recently characterised ogt promoter presents the perfect tool for such a study. The 
wild-type promoter is activated by a class III mechanism and requires NarL bound at 2 
separate DNA targets upstream of the transcript start. Derivatives of the ogt promoter have 
been constructed that are activated either by class I or class II mechanisms. Furthermore, 
NarL has been shown to activate the ogt promoter independently of FNR. FNR is known to 
interact directly with the αCTD of RNAP and so the presence of FNR at a promoter would 
complicate such a study. 
The results show that there are residues in the αCTD that are important for NarL-
dependent activation at the ogt promoter and at the class I and class II derivatives. The 
positions identified in the αCTD are surface exposed, suggesting that they may be involved in 
interaction with another protein. The identified positions fall in a band around the outside of 
the αCTD and many of the positions were also identified by Savery et al. (1998, 2002) as 
important for promoter activation by CRP.  
Lin and Stewart (2010) recently investigated the NarL CTD by mutating surface exposed 
residues in order to identify residues that might interact with polymerase. They identified 
several residues that, when mutated to alanine, gave rise to a NarL protein that was able to 
bind its target DNA site, but was not able to activate transcription. The positions identified by 
Lin and Stewart (Lin and Stewart, 2010) are shown in Figure 5.16 and can be seen to group 
on one face of NarL in a possible „Activation Region‟ (Rhodius et al., 1997). It should be 
noted however that their study was not exhaustive, and instead focused on residues implicated 




Figure 5.16 Residues of NarL CTD implicated in transcription activation 
From Lin and Stewart (2010) X-ray model of a NarL-CTD dimer in complex with its DNA-
binding site from the nirB operon control region. Structure from Maris et al. (2005). The two 
protomers are colored blue and gold, and the two DNA strands are shaded light and dark gray. 
Residues are highlighted according to their phenotype: PC, red (Arg-178, Arg-179, Asp-181); 
functional, green (Asp-162, Leu-166, Gln-169, Met-175); deficient, magenta (Leu-171, Lys-
199); DNA-binding, orange (Lys-188, Val-189, Lys-192). 
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found in the NTD. 
5.8.2. The NTD of NarL plays a role in transcription activation 
This work and the work of Lin and Stewart (2010) has shown that the full length NarL 
protein is able to activate by class I, II and III mechanisms, whilst the CTD is only able to 
activate by a class II mechanism. This suggests that the NTD of NarL contains determinants 
of activation by class I and III mechanisms, and possibly contains an activation region that 
interacts with RNAP.  
A comparison can be made with CRP-dependent activation by class I and class II 
mechanisms. CRP requires determinants in its NTD for class II activation that are not required 
for activation by a class I mechanism because it contacts the NTD of α during class II 
activation (see Figure 1.7) (Niu et al., 1996). Conversely, NarL does not require its NTD for 
class II activation but it does require it for class I activation. This suggests that, unlike CRP, 
NarL makes no contact with the αNTD. 
To elucidate residues of the NarL NTD that are involved in transcription activation by 
class I and III mechanisms, an alanine scan of the NarL NTD could be done. Alternatively, 
random mutagenesis by error prone PCR could be used to identify key residues.  
5.8.3. The CTD of NarL may contact σ when activating by a class II mechanism 
An interesting observation from the results of the alanine scan is that, when the expression 
of a class II activated promoter::lacZ fusion is measured (See Figure 5.5), there is less 
deviation from the wild-type level overall than there is when expression of class I or class III 
activated promoter::lacZ fusions are measured (Figure 5.3). This could simply be due to the 
relative placement of the RNA polymerase α subunit and NarL, or potentially indicates that 
NarL makes less contact with the αCTD at class II promoters than it does at class I promoters. 
CRP has been found to interact with the σ subunit of RNAP and it is possible that NarL does 
as well (Hu and Gross, 1985). 
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5.8.4. NarP can activate by fewer mechanisms than can NarL 
This work and the work of Lin and Stewart (2010) indicate that NarP can activate by a 
class II mechanism only, whilst NarL can activate by all 3 classes. The results of both studies 
also indicate that the CTD of NarL and that of NarP are able to activate by a class II 
mechanism. This suggests that distinctions between the NTDs of NarL and NarP give rise to 
the different abilities of NarL and NarP.  
NarP is activated by NarQ in response to nitrite and NarL is activated by NarX in 
response to nitrate. However, recent studies have shown that there is some crosstalk between 
partners and that NarL can be activated by both NarQ and NarX whilst NarP is activated only 
by NarQ (Noriega et al., 2009). The NTD of both NarL and NarP is known to be the site of 
phosphorylation by the sensor regulator partner proteins, which supports the idea that the 
NTDs of NarL and NarP differ functionally. Because of this, it might be expected that the 
CTDs of NarL and NarP would be more similar than are the NTDs, but alignments show 
similar levels of resemblance (data not shown). A potentially interesting experiment would be 
to fuse the NTD of NarL to the CTD of NarP and vice versa. This could produce a non-
functional protein (see below) or could further demonstrate that class I and class III 
mechanisms of activation are dictated by the NTD. 
One theory as to the evolution of NarL / NarP is that NarP is the ancestral regulator 
because it appears in more species than does NarL and NarL has not been reported in a 
species that does not also encode NarP (Stewart, 2003). The originator of this theory does 
however point out a flaw in it: that it is difficult to distinguish by sequence alone whether an 
ORF codes for a NarL or a NarP, although a key indicator might be its proximity to narG. 
This work supports, but by no means proves, the theory that NarL evolved from NarP by 
gaining functions and becoming differentially phosphorylated. 
5.8.5. Cloning difficulties encountered and significance of problems 
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Various cloning difficulties were encountered in the construction of plasmid-encoded 
NarL and NarP. First, the NarL-Full fragment was designed to produce a full-length NarL 
protein, but the second codon was mutated to aid cloning, which appears to produce a non-
functioning protein. This protein was not able to activate by class I or III mechanisms but was 
able to activate by a class II mechanism. This pattern of activation is identical to that of the 
NarL CTD. NarL contains both a linker helix and an unordered flexible linker between the 
domains and so it is possible that this linker region acts as a buffer, possible because the CTD 
folds independently of the NTD. The mutated second codon therefore potentially causes a 
malformed NTD whilst not affecting the CTD. 
A similar problem was encountered with cloning the NarP CTD. Two constructs, the 
NarP-CTD146 fragment and the NarP-CTD148 fragment (see Figure 5.13), failed to produce 
a functional NarP CTD. Interestingly, the NarP-CTD148 fragment starts from the same 
position as the relevant fragment used by Lin and Stewart (2010), which was shown to be 
functional. However, constructs used by Lin and Stewart (2010) contained a 20 amino acid 
leader, derived from LacZ, fused upstream. This leader may aid correct folding and benefits 
of such a leader have been observed with GFP (personal communication from Jack Bryant, 
University of Birmingham, UK). 
Finally, it was found to be impossible to obtain transformants with a high copy number 
plasmid carrying the narXL operon under the control of its own promoter. This is likely to be 
because such a construct is toxic to the cell. If so, it would indicate that NarL is an important 
protein and that overproduction causes undesirable regulatory effects that the cell cannot 
tolerate. 
5.8.6. Summary 
This work has produced evidence that NarL interacts with RNAP directly, via the α 
subunit. This work also demonstrates that the NarL CTD is able to activate class II promoters, 
205 
 
whilst the full-length protein is required for class I and II mechanisms. The results of this 
work agree with those of Lin and Stewart (2010) but have the benefit that only promoters 
where NarL activates independently of other factors were used in the current study. In 
contrast, Lin and Stewart (2010) study used promoters where FNR also activates, which may 
have interfered with results. 
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Chapter 6: Closing comments 
Escherichia coli is able to survive in anaerobic conditions by utilising alternative electron 
acceptors such as nitrate and nitrite. This ability may aid the survival of E. coli in the more 
oxygen-poor regions of the digestive system and / or outside the body (in soils for example). 
However, with the benefits of utilising nitrate / nitrite come the threats posed by the toxic by-
products of nitrate / nitrite reduction, reactive nitrogen species. RNS can cause bacteriostasis 
or even cell death by damaging the iron-sulphur clusters of certain proteins or by damaging 
DNA. Therefore, it is expected that E. coli cells that synthesize proteins to utilise nitrate / 
nitrite would also synthesize proteins to protect cells from damage by RNS, using common 
regulation mechanisms. 
The Hybrid Cluster Protein (HCP) has been previously implicated in the cellular response 
to reactive nitrogen species and work described in chapter 3 examined the regulation of hcp 
expression. My work confirms that the hcp expression is activated by FNR in response to 
anaerobiosis and is repressed by NsrR in the absence of RNS. Contrary to previous reports, 
my work shows that NarL / NarP do not have a direct effect on hcp expression, despite 
binding to the promoter at a location from where they would be expected to activate. Random 
mutagenesis of the hcp promoter failed to reveal novel activator binding sites. This work also 
confirms that the hcp promoter is highly active when fully activated, and indicates that 
activity may be driven by core promoter elements and FNR activation. This work has 
contributed to the understanding of hcp expression, although the function of HCP remains 
enigmatic.  
Regulation of the hcp promoter is complex and, even with the contributions of this work, 
is not fully understood. Reports of regulation of hcp expression by OxyR need to be 
investigated in the context of regulation by FNR / NsrR. The exact mechanism(s) producing 
the high level of promoter activity also needs to be better understood. This work shows that 
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NarL has an indirect effect on hcp expression that is relieved if NsrR is unable to bind to the 
hcp promoter. This strongly suggests that NarL plays a crucial role in the generation of 
reactive nitrogen species from nitrate / nitrate. The hcp promoter can be used as a reporter of 
RNS in vivo and, as is being used to investigate endogenous sources of RNS in E. coli (Claire 
Vine, University of Birmingham, unpublished results).  
The Ogt protein is a DNA repair enzyme whose expression is activated by NarL in 
response to nitrate. NarL typically co-activates with FNR although is the sole (discovered) 
activator of Ogt expression. The work described in chapter 4 examines the positions and 
sequences of DNA sites from which NarL can activate ogt expression. The work shows that 
NarL can activate by class I, II and III mechanisms, although activation by class I or II 
requires DNA sites that closely match the consensus binding sequence, and that NarP is able 
to activate by a class II mechanism only, although this activation requires a DNA site that 
closely resembles the consensus binding sequence. 
The work in chapter 5 further examined activation by the NarL and NarP proteins. 
Previous studies of positive regulation by NarL at the nirB and nrfA promoters has shown that 
NarL activates by displacing a repressor bound to the promoter (Browning et al., 2004,2006). 
This work presents the first evidence that NarL is able to activate transcription by directly 
contacting RNA polymerase. Plasmids were made that express NarL, NarL CTD, NarP or the 
NarP CTD and transcription activation of the expressed proteins was studied. The NarL CTD, 
full-length NarP and NarP CTD are able to activate transcription by class II mechanisms 
whilst the full-length NarL can activate by class I, II and III mechanisms. The CTD of NarL is 
also able to activate the nirB promoter, which indicates that it can displace bound IHF (data 
not shown and Lin et al., 2010)). The plasmids constructed in this study will be useful for 
future studies of activation by NarL. Future studies should focus on mechanisms of activation 
and explore the regions of NarL and NarP that contact RNA polymerase although some work 
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towards this goal has been reported in Lin et al. (2010). Because the NarL CTD can displace 
bound repressors and activate by a class II mechanism, it might be useful to do a 
transcriptomics study of cells containing either NarL or the NarL CTD. This might identify 
promoters that are directly activated by class I or III mechanisms. If the PC mutations 
identified in Lin et al. (2010) are included, it might be possible to identify promoters that are 
activated by a class II mechanism as well. Such techniques may rapidly increase our 
understanding of the important NarL regulon.  
Rather than considering the expression of HCP and Ogt as regulated in response to nitrate, 
it may be useful to regard their expression as regulated in response to RNS. In this model, 
expression of HCP is regulated in response to NO directly, while expression of Ogt is 
regulated in response to a precursor of RNS, nitrate. NsrR therefore acts as an immediate 
regulator of HCP expression in response to RNS and NarL acts as a prophylactic regulator of 
Ogt expression in response to RNS. This difference in regulation is reflected in promoter 
activity. When maximally induced, the hcp promoter is highly active, possibly because it is 
up-regulated in response to an already present threat. The ogt promoter is not highly active, 
even when maximally induced. Because expression of Ogt is up-regulated in response to a 
precursor, the promoter does not need to be highly active as there would be time for Ogt to be 
synthesized before RNS are produced in the cell. 
HCP has been implicated in survival during infection of a human host, which may be 
because HCP protects the cell from RNS (or ROS) produced by the host immune system to 
kill invading cells. This study suggests that the hcp promoter would be activated by 
exogenous RNS, although for optimal promoter activity the cell would have to be in an  
anaerobic environment. However, Ogt is unlikely to be involved in protection from the host 
immune system. By responding to a metabolic precursor of NO rather than NO directly, 
expression of Ogt would not be expected to be up-regulated by exogenous RNS such as that 
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produced by macrophages. DNA damage resulting from exogenous RNS is likely to be 
repaired by the adaptive response protein Ada.  
Whilst expression of Ogt is induced by nitrate, it is curious that it is not induced by nitrite. 
Reduction of nitrite is also believed to give rise to NO and so Ogt would be expected to be 
produced in response to the presence of nitrite. A possible explanation for this is that 
expression of Ogt might be optimally regulated by NarL and Fis and a promoter organisation 
that NarP could bind to may not be fully Fis regulated. That expression of Ogt is not regulated 
by nitrite may therefore be a trade-off. As with DNA damage caused by exogenous RNS, 
DNA damage from by-products of nitrite reduction is likely dealt with by Ada. 
One topic this work addresses is mechanisms of regulating the expression of a gene by 
multiple factors. Assuming a simple promoter that is regulated by 2 factors, there are 3 
possibilities for how it may be regulated: by two repressors; by an activator and a repressor or 
by two activators. With regards to regulating, a repressor is less efficient for a cell than is an 
activator, because the cell must synthesise the repressor in the absence of a signal. An 
activator can be synthesised and up-regulate expression of itself and other genes when a 
particular signal is present. This prevents some wasted energy on protein production, but 
conversely may mean the cellular response takes longer to occur as the activator needs to be 
synthesised. The hcp promoter is an example of a promoter that is regulated by an activator 
and a repressor, FNR and NsrR respectively. Synthesising NsrR in the absence of RNS may 
appear to be an unnecessary burden on the cell but is necessary if HCP is involved in 
protection from RNS. This is because when RNS are present (having been produced either 
endogenously or exogenously), the cell needs to rapidly commence synthesis of protective 
proteins to offset the damage that will be caused. If NsrR were an activator, precious minutes 
may be added to the cells response time. As expression of ogt is regulated by 2 copies of an 
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activator (that bind to poor sites), it is likely that ogt does not need to be synthesised in an 
especially time-sensitive fashion.  
In summary, this work has contributed to the understanding of transcription regulation by 
NarL and NarP and provided tools and initial data to aid further characterisation of these 
important transcription factors. My work also made significant progress in the understanding 
of regulation of the hcp promoter, that (combined with future functional studies) may help to 
elucidate the cellular role of HCP. 
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